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ABSTRACT
UNCOVERING NEW ROLES FOR THE CELL SURFACE PROTEASE ADAM13
IN NEURAL CREST MIGRATION
SEPTEMBER 2015
GENEVIEVE ABBRUZZESE, B.S., UNIVERSITY OF MASSACHUSETTS
AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS
Directed by: Professor Dominique Alfandari

The cranial neural crest (CNC) is a multipotent population of cells that gives rise
to many structures of the face and head in vertebrates, including cartilage, bone and
ganglia. The CNC forms at the border of the anterior neural plate and undergoes a
massive relocation during embryogenesis. These highly motile cells will travel long
distances to reach sites where they will ultimately differentiate into new cell types that
will form the various facial structures. Consequently, if CNC cells fail to migrate to the
correct locations or differentiate properly, craniofacial development can be severely
impaired. Craniofacial abnormalities comprise the largest group of congenital birth
defects and there is currently very little understanding of how to treat or prevent these
defects aside from reconstructive surgeries to repair malformed tissues. The overall goal
of this thesis, using the frog Xenopus laevis as a model system, is to better elucidate the
molecular mechanisms that drive and control CNC cell migration.
Two predominant components driving the migration of most cell types are the
activation of promigratory signaling pathways and modification of cell adhesion. On the
cell surface, regulation of these activities is largely controlled by a family of
transmembrane proteases called ADAMs (a disintegrin and metalloprotease). By cleaving
the extracellular domains of other membrane-bound proteins, ADAMs play a vital role in
controlling their level and function at the surface. Many ADAMs have proven key
regulators of critical signaling pathways including Notch, EGF, Eph/ephrin, and Wnt,
which control cell processes such as differentiation, growth and survival. In addition,
ADAMs have also been shown to cleave cell adhesion molecules and regulate migration.
In the CNC, at least three ADAMs have demonstrated roles in migration, ADAMs 9, 13,
and 19. ADAM9 and ADAM13 were previously shown to perform a critical processing
of the cell adhesion molecule cadherin-11 to shed its extracellular domain. In this thesis,
additional roles of ADAM13 in the CNC are investigated as well as how its activities are
regulated.
The majority of ADAM studies thus far have focused predominantly on their
proteolytic activity, and their cytoplasmic domains had previously only been implicated
in modifying the subcellular localization or activity of the protease domain. The work
presented in this thesis, however, demonstrates that the cytoplasmic domain is
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surprisingly capable of performing other essential activities that are independent of the
protease domain. We found that during CNC migration, the ADAM13 cytoplasmic
domain must be cleaved from the membrane-bound protease by γ-secretase and
translocate to the nucleus to modulate gene expression. Notably, at least one of the target
genes, Calpain8-a, is essential for promoting CNC migration in vivo. This work,
published in my second-author paper in Developmental Cell in 2011, highlights a novel
role that has not previously been shown for any ADAM in any species, and shows that
ADAM13 has at least two essential functions in the CNC both on the extracellular
surface and intracellularly. In addition, we demonstrate that while ADAM9 and
ADAM13 have overlapping roles in shedding cadherin-11, both ADAM13 and ADAM19
can regulate the expression of Calpain8-a in the nucleus.
This thesis also investigates mechanisms for regulating ADAM13 activity in the
CNC. To this end, we have identified two modes of post-translational control of
ADAM13 function. At the surface, we show that the several kinases, glycogen synthase
kinase 3 (GSK3) and Polo-like kinase (Plk), can successively phosphorylate ADAM13
and that these modifications appear to be important for the nuclear activity of the
ADAM13 cytoplasmic domain. This work was published in my first author paper in
Molecular Biology of the Cell in 2014. This thesis will also describe a novel role for a
Wnt receptor, Frizzled-4 (Fz4), in regulating an ADAM protease. We demonstrate an
interaction between Fz4 and ADAM13 during their transit to the cell surface that
consequently regulates both the activity and processing of ADAM13. This includes both
the levels of active ADAM13 that reaches the plasma membrane and the amount of
cleaved cytoplasmic domain that is generated in the CNC. This story was published in
2015 in my first author paper in the Journal of Cell Science.
Finally, much of the unpublished work presented in this thesis regards the
extracellular activity of ADAM13. ADAMs are able to directly modify cell-cell adhesion
by cleaving cadherins to remove their adhesive domain. Interestingly, however, a
previous study from our lab showed that the soluble fragment of cadherin-11 (EC1-3)
that is shed by ADAM13 in the CNC is itself biologically active and can stimulate cell
migration. However, it is unknown how this molecule functions to promote migration.
Thus, the final aim of this thesis sought to answer this question. The results presented
here will demonstrate that EC1-3 does not require its adhesive site to stimulate migration
in vivo. This suggests that rather than binding to remaining intact cadherin-11 molecules
to prevent them from participating in adhesive interactions, EC1-3 more likely binds to a
different receptor and possibly activates a promigratory signaling pathway. This work
comprises my third first-author manuscript that is currently in review at Developmental
Biology.
Together, these studies illustrate that ADAM proteases have the capacity to
perform a more diverse set of activities than previously thought. ADAM13 has critical
functions both on the cell surface and in the nucleus that equally contribute to the
migration of CNC cells. Ultimately, this dissertation illuminates a new understanding of
the catalytic and non-catalytic roles played by ADAMs within the cell.
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CHAPTER I
INTRODUCTION
Abstract
ADAMs are a family of transmembrane metalloproteases that control cell
behavior by cleaving both cell adhesion and signaling molecules. They play a variety of
roles in diverse tissue types during development and can affect cell processes such as
migration, differentiation, growth and survival. In the embryo, several ADAMs have
proven to be integral components of the cranial of neural crest (CNC), which is a
multipotent population of cells that gives rise to multiple structures of the face and head.
These cells are highly motile and undergo a large-scale migration throughout the embryo
that is essential for proper craniofacial development. The focus of this thesis is to better
understand the role of specific ADAMs during CNC migration and how their activity is
regulated.
In this chapter I will introduce the reader to the general mechanisms of CNC
migration as well as the family of ADAM metalloproteases. At least three ADAMs,
ADAM9, 13 and 19, have been shown to participate in CNC cell migration. The work
presented in this thesis will demonstrate that ADAMs play a more diverse role in cell
migration than previously thought. In addition to cleaving molecules on the surface of
CNC cells, the results in this thesis will show that ADAMs can also perform significant
intracellular functions such as regulating gene expression. This thesis will also explore
the extracellular functions of ADAM13 in more detail, and more specifically, how
cleavage of the cell adhesion molecule cadherin-11 stimulates CNC migration.
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Section I: Introduction to the cranial neural crest
Craniofacial development in vertebrates begins early in embryogenesis with a
multipotent highly motile population of cells called the cranial neural crest (CNC). These
cells will eventually differentiate to form a majority of the head and facial structures
including bone, cartilage, and peripheral neurons and glia (Le Douarin and Kalcheim,
1999). Consequently, any defect in the development of the CNC, including the induction,
migration, proliferation or differentiation, can lead to craniofacial abnormalities. Facial
defects are among the most common birth defects (approximately one third of all
congenital birth defects) and are observed in a variety of syndromes, such as Charge
Syndrome and Turners Syndrome, but can also be present as non-syndromic deformities,
including cleft palate or cleft lip. Depending on the severity, some of the congenital
anomalies can be life threatening, such as an airway obstruction, for example. There are
currently few treatment options aside from reconstructive surgeries to repair the
malformed tissue, if possible, for aesthetic or functional purposes, and this can entail a
lifetime of medical and surgical management (Trainor and Andrews, 2013). Thus,
clarifying the molecular mechanisms underlying the formation of these structures is a
pressing need for understanding how to prevent and develop new methods to treat these
birth defects.
The CNC first arises towards the end of gastrulation, which is the stage when the
three primary germs layers are positioned (Steventon et al., 2009). During the later half of
gastrulation, signals from the newly formed mesoderm on the dorsal side of the embryo
trigger the overlying ectoderm to become neural tissue and form a structure called the
neural plate (Figure 1.1). The neural plate will later fold in on itself during neurulation to
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create the neural tube and eventually become the central nervous system (brain and spinal
cord). The formation of the neural plate subdivides the ectoderm into neural and nonneural ectoderm. The group of cells that lie at the border between these two ectodermal
tissues receive their own unique set of signals prompting them to become neural crest and
placodal cells (CNC induction, Figure 1.1A). While there are several groups of neural
crest (trunk, vagal and sacral) that give rise to similar cell types throughout other parts of
the body such as peripheral nerves and melanocytes, this thesis will focus primarily on
the cranial neural crest, which populate the head region.
A coordination of tissue interactions and multiple signaling pathways are known
to contribute to the induction of the CNC. Signaling molecules are secreted from both the
nearby ectoderm and the underlying mesoderm to create signaling gradients of bone
morphogenetic protein (BMP), Wnt and fibroblast growth factor (FGF), which together
initiate CNC specification (reviewed in Stuhlmiller and Garcia-Castro, 2012). While the
onset of CNC induction requires inhibition of BMP and activation of Wnt signaling, the
maintenance of CNC identity during early neurulation requires both pathways to be
active (Steventon et al., 2009). In addition, crosstalk between FGF and Wnt pathways is
also important for inducing neural crest (Hong et al., 2008; Monsoro-Burq et al., 2003).
Acting through a set of transcription factors (Pax3, Myc, Msx1, Zic1, TFAP2a, and
Hes4/Hairy2) that have overlapping expression domains at the lateral neural plate
borders, these three signaling pathways coordinate to turn on the CNC specifier genes
(Twist, Slug, Sox10, and TFAP2α, FoxD3) to establish the new identity of these cells
(Stuhlmiller and Garcia-Castro, 2012).
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Once the CNC is formed, their next step in craniofacial development is to undergo
a massive relocation to distant sites throughout the anterior region of the embryo. During
the neurulation stage, the lateral edges of the neural plate will begin to rise to create the
neural folds and converge towards each other reshaping the neural plate into a groove
along the axis (Figure 1.2). When the two neural folds finally meet, they will fuse
resulting in the generation of the neural tube. The non-neural ectoderm will fuse on top of
this to cover the surface of the embryo. The CNC, which is now in a layer between the
dorsal neural tube and the surface ectoderm, will become more mesenchymal-like to
delaminate away from the neural tube and migrate ventrally throughout the head. After
they migrate along their defined routes into target tissues, CNC cells proliferate and
differentiate into specialized cell types depending on the local signals they receive
(reviewed in Santagati and Rijli, 2003).

While precise regulation of the induction,

motility and differentiation of the CNC cell population are all critical processes for
proper craniofacial development, the work presented in this thesis will address the
mechanisms of CNC migration using the frog Xenopus laevis as a model system. The
motility of CNC cells makes them a fantastic model for studying cell migration in an in
vivo system. In addition, many parallels can be drawn between the migratory behaviors
and characteristics of CNC cells and metastatic cancer cells (Powell et al., 2013), making
the knowledge gained from this study of additional interest to a broader audience
studying cell migration.
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Section II: General mechanisms of CNC migration

The CNC will begin its journey travelling between a layer of underlying
mesoderm and overlying ectoderm (Figure 1.2A). Shortly after departing from the edge
of the dorsal neural tube, the group of cells will collectively migrate into the head as well
as the three pharyngeal arches (mandibular, hyoid and branchial arches, Figure 1.2B and
C). The separation of the CNC into distinct segments is at least in part due to repulsive
signals from the ephrin/Eph receptor tyrosine kinase system as well as semaphorins that
act to maintain neural crest-free zones between the arches (Gammill et al., 2007; Osborne
et al., 2005; Robinson et al., 1997; Smith et al., 1997; Yu and Moens, 2005). The
pathways are lined with a laminin- and fibronectin-rich extracellular matrix (ECM),
which engage integrin receptors on the surface of the migrating CNC cells (Henderson
and Copp, 1997). In Xenopus laevis α5β1 binding to fibronectin is necessary and
sufficient to promote CNC cell migration in vitro (Alfandari et al., 2003).
CNC cells undergo two phases of migration: an initial cohesive phase where they
begin migrating collectively as a sheet, followed by a second phase of single cell
migration in order to reach their final destinations (Alfandari et al., 2003; Alfandari et al.,
2010; Sadaghiani and Thiebaud, 1987). Thus, a dynamic regulation of cell-cell adhesion
is required (reviewed in Taneyhill and Schiffmacher, 2013). In Xenopus, the cell
adhesion molecules cadherin-11, N-cadherin, and the protocadherins PAPC and PCNS
are all expressed in the CNC and have been shown to play various roles in regulating
migration (Borchers et al., 2001; Kashef et al., 2009; Rangarajan et al., 2006; Schneider
et al., 2014; Theveneau et al., 2010). Cadherin-mediated adhesion can be regulated in
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multiple ways. Some examples include modifying their expression levels or protease
induced cleavage of their extracellular domain to remove the homohpilic binding site.
This prevents the cadherin from engaging in homophilic interactions with a cadherin on a
neighboring cell (McCusker et al., 2009; Shoval et al., 2007). In addition to directly
modulating cell-cell adhesion, Cadherin-11 also links the plasma membrane to the
cytoskeleton by binding to β-catenin and can modify protrusion formation in CNC cells
via interactions with guanine nucleotide exchange factor Trio (Kashef et al., 2009).
Protrusion formation in Xenopus CNC is also dependent on the molecular motor MyosinX, which is required for proper migration. Myosin-X modulates the adhesive properties
of CNC, as it is essential for both the spreading of CNC cells onto a fibronectin substrate,
as well as for maintenance of cell-cell adhesion, possibly through a regulation of cadherin
activity (Nie et al., 2009).
The migrating CNC achieves directionality through interplay of several
mechanisms mediated by cell interactions and signaling. Among these are chemotaxis,
contact inhibition of locomotion (CIL), and coattatraction. The collectively migrating
group of cells utilizes CIL to control its polarity and achieve persistent migration in the
direction opposite of any homotypic cell-cell contacts (centrifugal migration). CNC cells
will continuously attempt to form protrusions on all edges of the cell. However, at sites of
cell-cell contact that are recognized by cadherin-11 and N-cadherin, Wnt/Planar Cell
Polarity (PCP) signaling activates RhoA to collapse protrusions upon contact (Becker et
al., 2013; Carmona-Fontaine et al., 2008; Theveneau et al., 2010). Thus, the cells within
the mass of the group are unable to polarize and only cells at the leading edge of the
group are able to make stable protrusions on their free edges where there is no CIL,
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enabling them to migrate away from the cell cluster and into the arches. In addition to
this polarity, it is clear that intact explants maintain a dorsal-ventral polarity as one side
of the explant always migrates preferentially compared to the other side. This appears to
be lost when explants are cut into smaller fragments possibly from wound healing
responses.
Chemoattraction also plays a role in providing directional guidance cues for the
CNC and this depends on the presence of cell-cell contacts for efficient signaling. Using
the receptor CXCR4 on the CNC cells, the stromal derived factor 1 (Sdf1) secreted from
the ectoderm surrounding the CNC arches stabilizes cell protrusions and Rac1 activity at
the leading edges of the collectively migrating group to attract the group towards the Sdf1
source (Theveneau et al., 2010). In addition, CNC cells express complement fragment
C3a and its receptor C3aR, which acts as an opposing force to the repulsive interactions
of CIL. In order to maintain the CNC in a migrating cluster instead of dispersing into
single cells, C3a promotes a mutual attraction of CNC cells to one another (CarmonaFontaine et al., 2011). Thus a number of external signals provide positive and negative
cues informing the path of CNC migration so that they reach their final destinations.

Section III: ADAM proteases in CNC development

ADAMs are integral membrane proteins that are named for containing a
disintegrin and metalloprotease domain. There are 33 identified ADAM family members
and they all have a similar domain structure (Fig 1.3), although several are missing the
conserved zinc metalloprotease active site. ADAMs are synthesized with an N-terminal
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prodomain, which has been implicated in supporting proper folding of the protein
(Anders et al., 2001). The prodomain coordinates with the active site of the
metalloprotease domain, which immediately follows, and restricts the proteolytic activity
until it is cleaved off by a furin-like protease in the Golgi apparatus (Anders et al., 2001;
Kang et al., 2002c). In addition, the extracellular portion of the protein contains a
disintegrin domain and a cysteine-rich domain, both of which are thought to participate in
binding and specifying substrates, as well as a small EGF-like domain of unknown
function. Following the transmembrane domain is the cytoplasmic domain, which is the
most variable domain among the different ADAMs and does not have any predicted
structural motifs. In addition to the removal of the prodomain, ADAMs can undergo
several additional processing events (Figure 1.3). Autoproteoloysis occurs within the
cysteine-rich domain of some ADAMs to release a soluble fragment containing the
metalloprotease and disintegrin domains (Gaultier et al., 2002; Kang et al., 2002a). In
addition, ADAM13 is subject to a processing that is predicted to be in the disintegrin
domain, based on the molecular weight of the remaining portion in the membrane, and
this appears to be performed by an alternative protease since it also occurs on an inactive
form of ADAM13 (Abbruzzese et al., 2014). At present, it is unclear what regulates the
various cleavages of ADAMs, however the protein kinase C (PKC) activator phorbol 12
myristate 13-acetate (PMA) has been shown to increase autocatalytic ectodomain
shedding of ADAM13 (Gaultier et al., 2002) and ADAM19 (Kang et al., 2002a).
ADAMs have a tremendous responsibility on the cell surface of regulating the
levels and functions of a diverse spectrum of membrane bound proteins by cleaving their
extracellular domains to shed them from the surface (Blobel, 2002). The purpose of these
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shedding events can serve a number of different functions. Some of the most well studied
examples ADAM-mediated shedding are performed by two ADAMs that are considered
the “principal sheddases”, ADAM10 and ADAM17. These ADAMs can activate
signaling pathways such as Notch by cleaving the Notch receptor (ADAM10) to initiate a
subsequent cleavage of the intracellular signaling domain by γ-Secretase (Pan and Rubin,
1997), and tumor necrosis factor alpha (TNF-α) by cleaving the membrane anchored
TNF-α precursor (ADAM17) to generate and release a soluble cytokine (Black et al.,
1997; Moss et al., 1997). ADAMs can alternatively inhibit signaling pathways by
removing a receptor or ligand from the membrane, as is the case with Ephrin/eph receptor
signaling (Janes et al., 2005). In addition, ADAMs can reduce cell adhesion or promote
an epithelial to mesenchymal transition by shedding ectodomains of cadherins, such as
N-cadherin and E-cadherin (Maretzky et al., 2005; Reiss et al., 2005). Ultimately, protein
processing at the cell surface by ADAMs can control a variety of cellular processes such
as proliferation, differentiation, adhesion and migration.
In vitro, many ADAMs have overlapping substrate preferences and in vivo, this
redundancy can cause ADAMs to functionally compensate for one another. This has left
much to be understood about how individual ADAMs function in specific tissues and at
different stages of development. Knockout studies have shown that mice lacking
ADAM10 or 17, which constitute the principal sheddases, are embryonic or perinatal
lethal (Hartmann et al., 2002; Peschon et al., 1998). Similarly, loss of ADAM19 or
ADAM22 results in severe developmental defects that lead to an early death shortly after
birth (Kurohara et al., 2004; Sagane et al., 2005; Zhou et al., 2004). In other cases such as
ADAM9 null mice, no obvious defects are observed, which may be due to substrate
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redundancies and the ability of other ADAMs to compensate for ADAM9 loss (Weskamp
et al., 2002). Inappropriate expression of ADAMs has been linked to multiple cancer
types and is often associated with tumor progression and metastasis (Murphy, 2008). In
order to develop strategies for controlling their function when dysregulated, it is
important to gain a better understanding of how individual ADAMs are regulated in vivo,
and how their regulation can occur in a spatial and temporal manner. It is also worthy to
note that several ADAMs do not contain the conserved zinc protease active site sequence
and thus lack the ability to cleave other proteins. Yet, knockout studies in mice still show
a phenotype in some cases. Loss of the non-proteolytic ADAM22, for example, results in
perinatal lethality, with defects in neuron myelination (Sagane et al., 2005). This
indicates that the other domains of ADAMs also have critical functions that can control
essential biological processes.
The Alfandari lab has previously identified at least three ADAMs that contribute
to CNC development in Xenopus laevis, ADAMs 9, 13 and 19, which, along with
ADAM12, belong to the meltrin subfamily of ADAMs. While ADAM9 has a more
ubiquitous expression in the embryo, ADAM13 and ADAM19 are expressed in the
neural tube and both premigratory and migrating CNC, as well as several other tissues for
ADAM19 (Alfandari et al., 1997; Cai et al., 1998; Neuner et al., 2009). Using translationblocking morpholinos to knockdown individual or combinations of ADAMs, our lab has
shown that while ADAM19 has a role in CNC induction, all three meltrins play a role in
CNC migration (McCusker et al., 2009; Neuner et al., 2009). ADAM9 and ADAM13
have partially redundant functions in the CNC as they both cleave the cell adhesion
protein cadherin-11 to stimulate cell migration (McCusker et al., 2009). In addition,
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ADAM13 cleaves and remodels the ECM protein fibronectin and is thought to be
involved in degrading the ECM within the CNC migration pathways (Cousin et al., 2012;
Gaultier et al., 2002). In a closely related species Xenopus tropicalis, ADAM13 is also
involved in CNC induction by cleavage of ephrinB ligands to upregulate Wnt signaling
(Wei et al., 2010). The results presented in the following chapter will discuss how
ADAM13 and ADAM19 have overlapping functions in CNC migration with respect to
their cytoplasmic domains.

Section IV: History of work presented in dissertation

The overall goal of this thesis is to better understand the regulation of neural crest
cell migration by ADAM13. The work presented here covers three separate projects that
all stem from the role of ADAM13 in the CNC.
Chapter II presents a newly identified role for the ADAM13 cytoplasmic domain
in gene regulation. This project was initiated in the Alfandari lab by Drs. Alfandari and
Cousin to investigate whether the cytoplasmic domain was critical for the overall
function of ADAM13 in the CNC. They found that not only is the cytoplasmic domain
essential for migration, but that it does not have to be synthesized on the same
polypeptide as the membrane bound protease. This result was unexpected because
cytoplasmic domains of ADAMs had previously only been shown to influence the
proteolytic activity or localization of the ADAM protein. This led to my involvement in
the project to answer the question of how the ADAM13 cytoplasmic domain functions
independently of the protease to stimulate migration. The work presented in this chapter
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will show that after being cleaved off at the membrane, the cytoplasmic domain from
ADAM13 translocates to the nucleus to regulate gene expression, and that at least one of
its target genes, Calpain8-a, is essential for CNC cell migration. This work was published
in (Cousin et al., 2011).
Chapter III investigates how ADAM13 is regulated by phosphorylation of the
cytoplasmic domain. In an effort to identify the mechanisms by which the cytoplasmic
domain functions, we generated a series of point mutations in ADAM13 to alter predicted
phosphorylation sites and protein interaction motifs. This work, published in (Abbruzzese
et al., 2014), demonstrates a pair of successive phosphorylations on ADAM13 by
glycogen synthase kinase 3 (GSK3) and Polo-like kinase, which ultimately controls the
ability of the cytoplasmic domain to regulate gene expression.
The results presented in Chapter IV address an additional mechanism of
regulating ADAM13 activity in cells. This project was initiated by our collaborator Dr.
Herbert Steinbeisser, who originally observed that the knockdown of the Wnt receptor
Frizzled 4 in Xenopus embryos had a similar CNC migration phenotype to what our lab
has published for the overexpression of ADAM13 (Alfandari et al., 2001).

Thus,

together we asked the question of whether the two proteins interact to regulate one or
both of their levels and/or functions. We found that ADAM13 processing and activity is
co-translationally regulated by Frizzled 4 and this has a significant impact on CNC
migration. This work was published in (Abbruzzese et al., 2015).
Finally, Chapter V focuses on cadherin-11 processing by ADAM13. It was
previously found that not only is cadherin-11 a substrate of ADAM13 in the CNC, but
also that the soluble cleavage fragment that is generated from this shedding event is a
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biologically active signaling molecule that can stimulate cell migration in vivo
(McCusker et al., 2009). Our aim for this project was to decipher whether the receptor for
shed fragment promotes migration by competitively binding to full length cadherin-11 to
prevent cell-cell adhesion, or if it binds to a different cell surface receptor. Our results
presented here indicate that homophilic binding is not a required feature for the activity
of soluble cadherin-11, suggesting that it acts through an alternative receptor than
cadherin-11 on the surface of CNC. This study is now currently in revision at
Developmental Biology (Abbruzzese et al, in revision).
Chapter VI will discuss implications of these findings for the study of CNC
development, cell migration, and ADAM metalloproteases, and offer potential
mechanisms for how ADAM13 cytoplasmic domain may be modulating gene expression.
Preliminary data will be presented on binding partners of ADAM13 that may participate
in its nuclear function, as well future experiments to address this question further.
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Figure 1.1: The neural crest is specified at the lateral edges of the neural plate. (A) Towards
the end of gastrulation, signals from the underlying axial mesoderm induce the ectoderm to
become neural tissue, forming what is called the neural plate. The neural crest is specified at the
region bordering the neural tissue, between the neural plate and the non-neural ectoderm (blue).
(B) Image of a Xenopus laevis embryo stained by in situ hybridization at the early neurula stage
for expression the cranial neural crest marker Snai2 (also known as Slug; blue). This figure has not
been published.
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Figure 1.2: Neural crest cells migrate away from the neural tube during neurulation. (A) (i)
During early neurulation, the neural crest (green) lies at the border between the neural plate (blue)
and the non-neural ectoderm (brown). (ii-iii) As neurulation progresses, neural folds begin to rise
and converge towards each other, causing the neural plate to form a groove. (iv) When the neural
folds meet, the neural ectoderm will fuse to create the neural tube, while the non-neural ectoderm
will fuse on top of this to become the surface ectoderm. The neural crest will delaminate from the
neural tube and migrate ventrally, between the overlying epidermis and underlying mesoderm.
(B) Schematic drawing of the segmentation pattern of the cranial neural crest (CNC) cells. CNC
cells will migrate as streams into the pharyngeal arches. The most anterior cells will migrate into
the mandibular arch (1, purple), with the more posterior CNC cells migrating into the hyoid (2,
green) and branchial (3 and 4, red and teal) arches. (C) Images of Xenopus laevis embryos stained
by in situ hybridization for the CNC marker Twist showing the segmentation patterns described
in (B). Part (A) of this figure was modified from an unpublished illustration by H. Cousin. Part (B) of this
figure was adapted from (Smith et al., 1997), and images in Part (C) have not been published.
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Figure 1.3: Domain organization of ADAM proteins. (A) Linear representation of ADAM
domains. The N-terminal prodomain (P) binds to the active site in the metalloprotease domain
(M) and functions as a chaperone to assist ADAM folding. The metalloprotease domain is
followed by the disintegrin (D), cysteine-rich (C), and EGF-like domains, which together
comprise the extracellular portion of the ADAM. These are followed by the transmembrane and
cytoplasmic domains (cy). Multiple cleavages within ADAMs have been documented,
represented here by scissors. First the prodomain is removed by a furin-like protease in the Golgi
apparatus. We have also observed a cleavage within the disintegrin domain of ADAM13 to
remove the metalloprotease domain (see Chapter III). Addditionally some ADAMs are known to
cleave themselves within the cysteine-rich domain. In this thesis, we will also demonstrate a
fourth processing event where the cytoplasmic domain is cleaved off from the membrane-bound
protease (Chapter II). (B) Homology model of ADAM13 generated using the structure of human
ADAM22 (PDB 3G5C). The three dimensional model revealed that the metalloprotease domain
is situated with the cysteine-rich and disintegrin domains next to it on either side. Importantly,
cysteine-rich domain, which has been implicated in binding to substrates, sits adjacent to the
metalloprotease domain with several loops very close the protease active site (key active site
residues His shown in yellow, glycine in red, and Zn++ shown as a blue sphere). This figure has not
been published.
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CHAPTER II
A NOVEL ROLE FOR THE ADAM13 CYTOPLASMIC DOMAIN IN GENE
EXPRESSION
Abstract
The studies described in this chapter investigate whether the ADAM13 protein
can function in the CNC without its cytoplasmic domain. We show that not only is this
domain required but it is cleaved off from the membrane-bound ADAM13 and goes on to
perform critical functions in the nucleus of cells. This finding challenges the traditional
perspective of the ADAM cytoplasmic domain, which is that its primary function is to
regulate the proteolytic activity by controlling the subcellular localization and/or the
activation of the protease domain. Here we demonstrate that the cytoplasmic domain of
ADAM13 regulates the expression of multiple genes in CNC, including the protease
Calpain8-a, which we show is required for cell migration. This study highlights that the
cytoplasmic domain of ADAM metalloproteases can perform essential functions in the
nucleus of cells and may contribute substantially to the overall function of the protein.

Section I: Introduction

Given that ADAMs often have redundant functions and overlapping substrates, it
remains an open question how individual ADAMs are regulated in the cell. The
cytoplasmic domain offers a potential site for unique posttranslational control of
individual ADAMs as it has the most varied amino acid sequence among the different
ADAM domains, and as a result, studies that have addressed the function of the
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cytoplasmic domain have largely focused on its contribution to regulating the activity of
the protease. A number of interacting partners have been identified that associate with the
ADAM cytoplasmic domain (reviewed in Edwards et al., 2008)), and are thought to
control the trafficking and compartmentalization as a mode of regulation in order to
localize ADAMs near the proper substrates (Murphy, 2009; Seals and Courtneidge,
2003). For example, a Src-homology 3 (SH3) binding site within ADAM10 is required
for trafficking the protease to adherens junctions in epithelial cells and subsequent
cleavage of E-cadherin (Wild-Bode et al., 2006). In the case of human ADAM12,
subcellular localization is enforced by the presence of a retention signal in the
cytoplasmic domain that prevents the protein from leaving the trans-Golgi network and
reaching the surface (Hougaard et al., 2000). The cytoplasmic domain of ADAM22 binds
to members of the 14-3-3 protein family and this interaction targets the ADAM to the cell
surface by masking an ER retention signal (Godde et al., 2006).
Some ADAMs have several splice variants that alter the cytoplasmic domain
sequence and length and likely affect the selection of intracellular binding partners. For
example, isoforms of human ADAM15 with varying cytoplasmic tails have unique
affinities for different SH3-containing proteins, which could contribute to their
differential involvement in tumor progression (Kleino et al., 2009; Zhong et al., 2008).
Splice variants ADAM15A and 15B were both increased in human breast cancer tissues,
while 15B was strongly linked with poor survival. When overexpressed in a breast cancer
cell line, ADAM15A was found to increase cell adhesion and migration while 15B
decreased adhesion (Zhong et al., 2008). Furthermore, ADAM15B, which contains an
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inserted Src-binding site, shows increased catalytic activity towards the FGF receptor in
the presence of Src kinase compared to ADAM15A (Maretzky et al., 2009).
Although poorly conserved, ADAM cytoplasmic domains often contain multiple
proline-rich motifs, which can function as SH3 binding sites. The ADAM13 cytoplasmic
domain binds to the SH3-containing adaptor protein PACSIN2 and this interaction is
thought to regulate ADAM13 activity or localization during CNC migration (Cousin et
al., 2000). ADAM13 cytoplasmic domain also contains numerous predicted
phosphorylation sites (which will be investigated further in Chapter III), as well as a
lysine and arginine-rich juxtamembrane region, which contains a predicted bipartite
nuclear localization signal sequence. The presence of the cytoplasmic domain appears to
be important for regulating the levels of ADAM protein, either by influencing translation
rate or stability/turnover, as the absence of this domain in ADAM13 leads to an 8-fold
increase in expression levels (Alfandari et al., 2001). SH3 domains in ADAM12 have
been shown to mediate an interaction with adaptor proteins that are necessary for proper
internalization of the protease (Stautz et al., 2012a).
The aim of the project presented in this chapter is to address the role of the
ADAM13 cytoplasmic domain in contributing to the overall function of the protein, and
how this domain accounts for the functional compensation by ADAM13 and ADAM19 in
the CNC. The results presented in the following sections were originally published in
(Cousin et al., 2011). I was involved in performing experiments for Figures 2.3, 2.6, 2.7
and 2.8, and experiments performed by other members of the lab include Figures 2.1, 2.2,
2.3, 2.4, 2.5, 2.6A-B, 2.8, 2.9.
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Section II: ADAM13 and ADAM19 cooperate to promote CNC cell migration!

We have previously shown that three ADAM proteins play a role during Xenopus
CNC migration. ADAM9 and ADAM13 both cleave cadherin-11, while ADAM19 does
not (McCusker et al., 2009). We have also shown that ADAM19 is important for the
expression of CNC-specific genes including sox8 and slug (Neuner et al., 2009). To
determine whether ADAM13 and 19 could compensate for each other in CNC migration,
we performed single and double knockdown (KD) using Morpholino oligonucleotides
(MO) that prevent the translation of the endogenous protein (McCusker et al., 2009;
Neuner et al., 2009). CNC cells from morphant embryos were dissected before migration
and grafted into host embryos and the migration of grafted cells was followed using the
green fluorescent protein (GFP) as a lineage tracer (Figure 2.1). While single ADAM13
or ADAM19 KD prevents CNC migration in less than 20% of the embryos, the double
KD inhibits migration in more than 80% of the embryos. CNC migration was rescued by
either ADAM13 or 19 but not by the protease inactive mutants (E/A) or a mutant lacking
the cytoplasmic domain (ΔCyto), suggesting that both the proteolytic activity and the
cytoplasmic domain are essential.
To determine if the effect on CNC migration was due to a defect in CNC
induction we tested the expression of several CNC markers in embryos lacking the
ADAM13 protein. Our results show that in the absence of detectable ADAM13 protein,
all of the CNC markers tested (snail2a, snail, slugb, sox8, sox9, sox10, twist1) were
expressed at the right place and the right level (Figure 2.9). These results show that in

!

20!

Xenopus laevis, ADAM13 KD affects CNC migration in the absence of any effect on
CNC induction.
These results show that ADAM13 and ADAM19 can compensate for each other
even though their role in CNC migration during normal embryo development is distinct.
They also show that the cytoplasmic domain of ADAM13 is essential for CNC migration.
We next investigated how the cytoplasmic domain of ADAM13 could control cell
migration.

Section III: The ADAM13 cytoplasmic domain is cleaved! by γ-secretase and translocates
into the nucleus

The ADAM13 extracellular domain is cleaved by autoproteolysis in the cysteinerich domain, releasing the active metalloprotease from the cell surface (Gaultier et al.,
2002) (Figure 2.2A). Ectodomain shedding of transmembrane proteins is often followed
by a cleavage by γ-secretase (GS) that releases the cytoplasmic domain (Hass et al.,
2009). To investigate if a similar processing occurs for ADAM13, we transfected Cos-7
and 293T cells with the various ADAM13 constructs. After transfections, the cytoplasmic
and nuclear fractions were separated and analyzed for the presence of the cytoplasmic
fragment using an antibody directed against this domain (6615F) (Alfandari et al., 1997).
When ADAM13 is transfected into 293T cells, a 17 kDa fragment is detected in the
nuclear extract (Figure 2.2B, arrowhead). This is also the case following transfection with
a fusion protein containing the cytoplasmic domain of ADAM13 fused to GFP (GFPC13) but not with GFP alone. To determine if the same cleavage also occurs in vivo, we
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analyzed protein extract from either control embryos or embryos injected with MO13. As
seen in transfected cells, the ADAM13 antibody recognizes a 17 kDa fragment present in
control embryos but absent in morphant embryos (Figure 2.2C, Cyto). To test if GS is
responsible for the cleavage of ADAM13 we treated Cos-7 cells with two
pharmacological inhibitors of GS. Indeed, both ILCHO (McLendon et al., 2000) and
DAPT (Hemming et al., 2008) prevented the accumulation of the ADAM13 cytoplasmic
domain in the nuclear fractions (Figure 2.2D). GS is known to cleave proteins just distal
to the transmembrane domain, which for ADAM13 would release a fragment of 21 kDa.
Our results showing that the fragment is approximately of 17 kDa and that the GFP-C13
fusion protein is also cleaved, although never associated with the plasma membrane,
suggest that subsequent cleavage by a different enzyme may occur following the initial
GS cleavage. The absence of the 17 kDa fragment in cells treated with the GS inhibitors
suggests that this first step is critical. Using immunofluorescence, the cytoplasmic
domain of endogenous ADAM13 was also detected in the nucleus of Xenopus S3 cells in
foci that stained less intensely for DAPI suggesting that the DNA in this region is
euchromatic and potentially transcriptionally active (Figure 2.4A).
The nuclear localization depends on the lysine/arginine-rich (KR) subdomain
while the proline-rich (PR) subdomain directs a GFP-fusion protein to membrane ruffles
and actin stress fibers (Figure 2.3). This is consistent with a predicted bipartite nuclear
localization signal in the KR region (Hulo et al., 2008), and suggests that, as shown for
ADAM12, the cytoplasmic domain of ADAM13 may interact with proteins of the
cytoskeleton (Cao et al., 2001a). The nuclear localization of GFP-C13 was also visible
when the protein was expressed in Xenopus embryos (Figure 2.4C).
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To assess the contribution of nuclear localization to the function of the ADAM13
protein, we introduced a nuclear export signal (NES), based on the net-NES prediction
software (la Cour et al., 2004), by adding one leucine at position 877 in the PR domain of
both ADAM13 (ADAM13-NES) and GFP-C13. To test if the NES was functional we
expressed GFP-C13NES in XTC cells and detected its localization in live cells.
Depending on the cell, GFP-C13NES was either entirely cytoplasmic (Figure 2.3) or was
present in both the nucleus and the cytoplasm of XTC cells (data not shown), suggesting
that the NES is functional but that it does not prevent the translocation into the nucleus.

Section IV: Translocation of the Cytoplasmic Domain Is Critical !for ADAM13 Function
during CNC Cell Migration!

To investigate the role of the cytoplasmic domain of ADAM13 in vivo, we
injected embryos with MO13 alone or together with MO19. The injections were
performed at the 8- to 16-cell stage in a single cell that contributes to the CNC, and GFP
or RFP was used as a lineage tracer to follow the ability of cells to migrate in vivo
(McCusker et al., 2009) (Figure 2.5). Injection of MO13 inhibited CNC migration in 30%
of the embryos, while the coinjection of MO13 and MO19 inhibited migration in 79% of
the embryos. As seen for the grafts, injection of RNA encoding ADAM13, but not ΔCyto,
rescued CNC migration. This technique presents two main advantages over the graft.
First, it allows the injection and analysis of a greater number of embryos enabling us to
test multiple proteins and mutants. Second, since the embryos do not have to be
dissected, the migration pathways between the epidermis and the mesoderm remain
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intact, which could potentially explain why the targeted injection of MO13 inhibits CNC
migration more efficiently than in the grafts. For these reasons, we used the targeted
injection for the remainder of this study.
We then performed complementation experiments by coinjecting ΔCyto together
with GFP-C13 in the morphant embryos, and this combination rescued migration as
efficiently as ADAM13 (Figure 2.5B, C). Neither the single point mutant of ADAM13
containing a NES (A13-NES), nor GFP-C13 alone, was capable of rescuing migration.
While mutations in the cytoplasmic domain affected the ability of ADAM13 to promote
CNC migration they did not affect the proteolytic activity, as shown by the ability to
cleave the protocadherin PAPC (Figure 2.5D).
Taken together, these results show that both the proteolytic activity and the
cytoplasmic domain of ADAM13 are essential for CNC migration in vivo. They also
show that the cytoplasmic domain does not need to be attached to the extracellular
domain or to the plasma membrane, but only needs to translocate and remain in the
nucleus (absence of rescue by ADAM13-NES) to perform its critical function.
Since ADAM13 is capable of cleaving itself in the cysteine-rich domain, we
tested whether the autocatalysis of ADAM13 was essential to generate the cleaved
cytoplasmic domain. We injected the ADAM13-E/A, which is incapable of selfprocessing, together with ΔCyto mRNA in morphant embryos. This combination did not
rescue CNC migration (Figure 2.6A) suggesting that, in vivo, the initial autocatalytic
cleavage is required for the secondary cleavage by GS.
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Section V: The ADAM19 cytoplasmic domain can compensate !for ADAM13!

To investigate if other ADAMs could compensate for the loss of the ADAM13
cytoplasmic domain, we made GFP-fusions with the cytoplasmic domains of Xenopus
ADAM9, 10 and 19 which all translocated into the nucleus of transfected XTC cells
(Figure 2.6C). In complementation experiments, the cytoplasmic domain of ADAM19
was able to rescue migration when expressed with ADAM13-ΔCyto, while neither the
ADAM9 nor the ADAM10 cytoplasmic domains could (Figure 2.6A, B). Given that
ADAM9 can cleave Cadherin-11 (McCusker et al., 2009) and ADAM19 can compensate
for the loss of the ADAM13 cytoplasmic domain, the presence of both proteins in the
CNC may explain why the loss of ADAM13 only produces defective migration in 30%–
50% of the embryos, while the double KD of ADAM13 and 19 inhibits migration in 80%
of the embryos.

Section VI: The functionality of the ADAM13 cytoplasmic domain !is evolutionarily
conserved!

To test whether the function of the ADAM13 cytoplasmic domain is
evolutionarily conserved, we cloned the cytoplasmic domains of the putative ADAM13
orthologs from worm (adm-2), zebrafish (ADAM19a), marsupial (ADAM13), and mouse
(ADAM33) in frame with GFP. While the C. elegans (ceCm), zebrafish (drC13), and the
opossum (mdC13) constructs all translocated into the nucleus and rescued CNC
migration, the mouse (mmC33) construct did neither (Figures 2.6). Using the mouse
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constructs, the cytoplasmic domain of ADAM19 but not ADAM12 was able to rescue
CNC migration (Figure 2.6A, B). This demonstrates that even within the meltrin
subfamily, the cytoplasmic domains, which share proline-rich repeats and basic residues,
possess a relatively strict specificity in regulating cell migration.

Section VII: Role of the ADAM13 cytoplasmic domain

To understand the role of the cytoplasmic domain of ADAM13 in the nucleus, we
then tested if this domain could regulate gene expression in the CNC. We dissected CNC
from embryos injected with either a control MO (CMO), MO13 alone, or with both
MO13 and GFP-C13. Gene expression was assayed using microarrays on independent
triplicate experiments (Affimetrix, BioMicro Center MIT core facility). The results of the
overall analysis of gene expression show that the variation between experiments is
greater than the variation between samples within each experiment, suggesting that the
level of gene expression in outbred Xenopus populations is highly variable, and that the
analysis should be carried out within each batch of sibling embryos before comparing
multiple experiments. These data have been submitted in NCBI’s Gene Expression
Omnibus (Edgar et al., 2002) and are accessible through GEO series accession number
GSE21517.
We therefore used paired student t test (TM4 software suite; Saeed et al., 2006) to
identify genes that were significantly affected by the loss of ADAM13 (p < 0.01). A
surprisingly large number (40%) of genes were identified (matrix2). However within
these 6121 genes, only 172 were increased or decreased by more than 40%, suggesting
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that ADAM13 is required for the correct expression of a large number of genes, and that
it serves to modulate target gene expression rather than switch them on or off.
We then performed another t test within this first set of genes (6121) to identify
those that were also significantly affected by the presence of the ADAM13 cytoplasmic
domain (p < 0.01), and found that one third of these genes were (2096, matrix3). We
further consolidated the data by keeping only the genes that were either reduced or
increased with a minimum variation of 40% (174 genes). Examples of genes affected by
the ADAM13 knockdown and the cytoplasmic domain rescue are given in Figure 2.7A.
These data show that the ADAM13 cytoplasmic domain can modulate the expression of
multiple genes in the CNC cells.

Section VIII: Calpain8-a can rescue migration in CNC lacking! the ADAM13 cytoplasmic
domain!

To identify genes regulated by the ADAM13 cytoplasmic domain that are
essential for CNC migration we performed quantitative PCR on CNC with MO13 alone
or MO13 plus GFP-C9, -C13, or -C19 (Figure 2.7B). We expected that genes important
for CNC migration would be regulated by GFP-C13 and GFP-C19, but not GFP-C9 since
this construct does not rescue migration (Figure 2.6A). We found that Calpain8-a
(Capn8-a) was the only gene tested that fit the hypothesis. To test whether any of these
genes were important for CNC migration, we injected mRNA encoding each of the
candidates together with MO13 and ΔCyto in complementation assays. Only Capn8-a
was able to rescue CNC migration confirming that at least one gene regulated by the

!

27!

ADAM13 cytoplasmic domain is required for CNC migration (Figure 2.8A, B). The role
of Capn8-a in CNC migration was confirmed using both a DN (Cao et al., 2001c) and a
KD (MO to prevent splicing) approach. Using these two reagents in targeted injections,
we found that CNC migration was inhibited by ~40% with the MO and ~30% with the
DN (Figure 2.8A). Together these results demonstrate the importance of Capn8-a in CNC
migration and confirm that one of the essential roles of the ADAM13 cytoplasmic
domain is to increase Capn8-a expression.

Section IX: Chapter II Discussion

This chapter highlights a novel function for ADAM metalloproteases. Given that
the cytoplasmic domains of ADAMs had previously only been implicated in modifying
the subcellular localization or activity of the protease domain, it was unexpected to
discover that they also possess the ability to regulate gene expression independently of
the extracellular protease. We demonstrate here that during cranial neural crest (CNC)
cell migration in Xenopus, C13 must be cleaved from the membrane-bound protease by
γ-secretase and translocate to the nucleus to modulate gene expression. Specifically,
increasing Calpain8-a expression is critical to promote CNC migration. To our
knowledge this is the first evidence for a critical role of a Calpain protease in the CNC.
Calpains have been linked to cell migration but their role is not entirely solved. They may
affect cell migration by cleaving components of focal adhesions such as integrins, focal
adhesion kinase and talin at the trailing edge of the cell to control the release of the cell
membrane from the substrate (Franco and Huttenlocher, 2005). Other studies have shown
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that they can cleave β-catenin to remove the GSK3 phosphorylation sites and generate a
stable form that can translocate into the nucleus and induce the expression of target genes
including those involved in epithelium to mesenchyme transition (Abe and Takeichi,
2007). The MO that prevents Calpain8-a splicing will be useful to test the various
hypotheses and determine the exact contribution of this protease during CNC migration.
Although this was the first evidence in any system that the cytoplasmic domain of
an ADAM protease possesses a function independent from its extracellular activity, we
predict that this may be a global feature of ADAMs. In this chapter, we demonstrated that
the cytoplasmic domains of multiple ADAMs, including those from worm, fish,
marsupial and mouse, could replace C13 in the CNC and stimulate migration.
Interestingly, nuclear translocation has also now been observed for the cytodomain of
human ADAM10 and is thought to contribute to prostate cancer progression (Arima et
al., 2007; Tousseyn et al., 2009). Strikingly, about one-third of ADAM family members
encode inactive proteases, and yet several are still implicated in cancer and disease
progression. Our discovery raises the question of whether the cytoplasmic domain is in
fact responsible for the deleterious effects of these non-proteolytic ADAMs in
pathological situations, and highlights a pressing need for the field to reevaluate the
activities of ADAMs in the context of their gain- or loss-of-function phenotypes.
Furthermore, our findings challenge the interpretation of results using “dominant
negative” forms of ADAMs, which lack proteolytic activity but may still retain the ability
to modify gene expression.
This study identified that ADAM13 and ADAM19 in Xenopus can functionally
compensate for each other in the CNC, despite the fact that they do not have overlapping
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substrate preferences as we have previously shown (McCusker et al., 2009). However,
the observation that C19 can replace C13 in the CNC and that both of these proteins can
regulate Calpain8-a expression indicates that their redundancy lies in the intracellular
signaling abilities rather than their extracellular activities. It is clear that different
ADAMs have different specificities in the nucleus, as we showed here that each
cytoplasmic domain can regulate a specific set of genes in the CNC. How they function
to control gene expression is an ongoing goal of this research project and will be
discussed in more detail in Chapters III and VI.

Section X: Chapter II Materials and Methods

Morpholinos
Morpholino antisense oligonucleotides (Genetool) against ADAM13 and ADAM19 have
been described previously (McCusker et al., 2009; Neuner et al., 2009). Two controlmorpholinos were used. One corresponds to a randomly generated sequence of 25 mer
and

the

other

corresponds

to

a

standard

sequence

(CCTCTTACCTCAGTTACAATTTATA). The morpholino antisense oligonucleotide to
Calpain8-a (GAAAGTTATGAGACAACACCTGCTT) was designed to prevent splicing.
The realtime PCR primers were used to amplify genomic DNA containing an intron,
which was cloned and sequenced. The efficiency was tested by realtime PCR from
polyA-RNA purified from embryos injected with 25, 12.5, and 6.25 ng of MO-capn.
Eighty percent to 90% KD of calpain8-a mRNA was achieved using the lowest dose. A
dose of 1 ng at the 8-cell stage was chosen for the migration assay.
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DNA constructs
All constructs were cloned into the pCS2 or pCS2-GFPmt vectors containing both a
CMV promoter for cell transfection and the SP6 promoter for mRNA synthesis. Wildtype ADAM13 was mutated using QuikChange mutagenesis (Stratagene) and Pfu
polymerase according to the manufacturer’s instruction. Seven silent mutations were
introduced in the region recognized by the morpholino in order to prevent MO13
inhibition. All cytoplasmic domains were amplified using PCR to introduce an EcoR1
site in frame with GFP (AAT) and an Xba1 site after the stop. The NES mutant was
performed by introducting a leucine at position 877 with the QuikChange mutagenesis
kit. The cytoplasmic deletion was made by adding a premature stop codon after the end
of the transmembrane domain. All constructs were sequenced (GENEWIZ) and tested by
western blot to control for the correct reading frame. The cytoplasmic domain of various
ADAMs were obtained by PCR on the following templates: Zebrafish ADAM13 from
cDNA of 26 hours post fertilization embryos, C.elegans adm-2 from plasmid (generous
gift from Dr. Dan Chase), the monodelphis domestica ADAM13 from one day old
postnatal embryos cDNA (generous gift from Dr. Kathleen Smith), mouse ADAM12 and
ADAM33 from plasmid (generous gift from Dr. Judith White), mouse ADAM19 from
adult mouse heart cDNA, Xenopus ADAM9 and 10 from plasmid.

Antibodies
The following antibodies were used: 6615F: rabbit polyclonal antibody to the ADAM13
cytoplasmic (Alfandari et al., 1997), gA13: goat polyclonal antibody to the ADAM13
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cytoplasmic, 7C9: mouse monoclonal to the ADAM13 cysteine-rich domain (Gaultier et
al., 2002). PARP: mouse monoclonal C2-10 (BD, PharMingen). GAPDH: mouse
monoclonal antibody 6C5 (Millipore). PAPC: mouse monoclonal to the extracellular
domain (Chen and Gumbiner, 2006).

Injections
Capped mRNA were synthesized using SP6 RNA polymerase on DNA linearized with
NotI as described before (Cousin et al., 2000). For the CNC migration assays, embryos
were injected at the 16-cell stage in one dorsal animal blastomere with 1 ng of MO, 200
pg of RFP mRNA, and 80 pg of mRNA encoding various constructs. For the graft assays,
embryos were injected at the two-cell stage with 5 ng of MO, 300 pg of GFP mRNA, 400
pg of ADAM13 mRNA, or 200 pg of ADAM19 mRNA. Embryos were raised at 15°C
until tail bud stage (St. 24-28) at which time CNC migration was scored. The percentage
of inhibition was normalized to embryos injected with RFP or GFP alone.
For the gene expression analysis, embryos were injected at the one-cell stage with
10 ng of either CMO, MO13, or MO13 plus 0.5 ng of GFP-C13. Embryos were grown at
15°C for 48 hr until neurula stage (St. 15–17), at which point CNC were dissected and
immediately placed in a guanidium thioisocyanate solution to extract RNA. To control
for the viability of the explants, four CNC explants were placed on fibronectin and
imaged by time-lapse microscopy using a Zeiss 200M inverted microscope and the
openlab4 software (Improvision). CNC from each condition were capable of migrating in
vitro. RNA extraction was performed as previously described (Chomczynski and Sacchi,
1987). Total RNA was quantified by absorbance at 260 nm using a nanodrop (Thermo
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Scientific).

RNA Amplification/Affymetrix Microarray
RNA were processed by the MIT core facility as described in the supplemental
methods. Total RNA quality control was performed with the Bioanalyzer 2100 (Agilent).
Double stranded cDNA was generated and labeled with the Ovation RNA Amplification
System and Encore Biotin Module (NuGen), respectively. Purification was performed
using the Qiagen PCR Purification kits. Labeled cDNA were incorporated into a
hybridization solution from the Affymetrix GeneChip Hybridization kit. Each sample
was hybridized in separate arrays for 20 hr at 45°C. Each array were then washed and
scanned. Initial data analysis was generated with the Affymetrix Expression Console and
an R package was used to assess data quality. Sample normalization was done using the
gcrma method.

Quantitative PCR
Quantitative PCR was performed as previously described (Neuner et al., 2009).
All primers were tested for efficiency. Primer sequences are given in Table 1. cDNA was
produced using polyA mRNA purified from 10 CNC explants (QIAGEN) using direct
cDNA kit (Quanta) according to manufacturer’s instruction.

Cell Culture and Transfection
Cos-7 cells and 293T cells were obtained from ATCC and transfected using
Fugene-6 according to manufacturer’s instruction. Protein analysis was done 48 hr after
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transfection. Cos-7 cells were trypsinized while 293T cells were collected by pipetting
into ice cold PBS. Nuclear and cytoplasmic fractions were isolated using the NE-PER kit
(Pierce) following manufacturer’s instruction. For PAPC shedding assay, cells were
incubated with media containing 2% serum at 24 hr after transfection and conditioned
supernatants were collected at 48 hr. The shed extracellular domain was purified using
Concanavalin-A-agarose beads (Vector), eluted in reducing Laemmli and blotted using
the PAPC monoclonal antibody (Chen and Gumbiner, 2006).

Fluorescence
Xenopus XTC cells were transfected using Fugene-HD following manufacturer’s instruction and placed on FN-coated glass bottom plates (Matek Corp.). Cells
were transfected with the GFP-fusion proteins, and were incubated with Hoechst
(Invitrogen) to label nuclei. Photographs were taken using a Zeiss 200M inverted
microscope equipped with an Apotome and a 63x immersion lens to obtain optical
sections. For in vivo CNC migration assays, tailbud stage embryos were imaged using a
Nikon fluorescent dissecting microscope.
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Figure 2.1: ADAM13 and 19 cooperate during CNC migration (A) Schematic representation
of the grafts. Donor embryos are injected in one cell at the 2-cell stage with GFP, or combinations
of GFP, MO against ADAM13 and 19 and mRNA encoding various ADAM constructs. At stage
15, CNC are dissected and grafted into host embryos. CNC migration is visualized using a
fluorescent microscope. (B) Fluorescence photographs of representative grafted embryos at stage
24. A positive migration is only counted if cells have progressed ventrally in one or more of the
posterior arches. !(C) Histogram representing the analysis of CNC migration in at least three
independent experiments. The error bars correspond to the standard deviation (SD). n: number of
embryos. The experiments described in this figure were performed by H. Cousin. This figure was
published in (Cousin et al., 2011).
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Figure 2.2: ADAM13 cytoplasmic domain translocates to the nucleus. (A) Schematic
representation of ADAM13 proteolytic processing (left). The Pro-domain is cleaved during transit
to the cell surface (1). A second extracellular cleavage within the cysteine-rich domain has also
been documented (2), releasing the active protease. The cytoplasmic domain is cleaved by GS
(3). The GFP-fusion protein corresponding to the ADAM13 cytoplasmic domain and the various
mutants are represented (right). (B) Western blot of ADAM13 cytoplasmic domain. 293T Cells
were transfected with GFP, GFP-C13, and wild-type ADAM13 (A13). Cells were fractionated to
generate a cytoplasmic (C) and a nuclear (N) fraction. Fractions were analyzed by western blot
using a polyclonal antibody to the cytoplasmic domain of ADAM13, 6615F (arrowhead). All
membrane-bound fragments of ADAM13 are found both in the cytoplasmic fraction (plasma
membrane) and in the nuclear fraction (ER attached to the nuclear membrane). The nuclear
protein PARP is found in the nuclear fraction, while GAPDH is in the cytoplasm. (C) ADAM13
was immunoprecipitated from 10 embryos using a goat polyclonal antibody. Non-injected
embryos (NI) at stage 12 (gastrula) and stage 18 (neurula) are compared with sibling embryos
injected with MO13. The ADAM13 protein was detected using 6615F. !(D) Cos-7 cells
transfected with ADAM13 were treated for 4 hr with GS inhibitors (+, ILCHO 50 mM or DAPT
10 mM). The experiments described in this figure were performed by D. Alfandari. This figure was
published in (Cousin et al., 2011).
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Figure 2.3: GFP-C13 accumulates in the nucleus. Localization of GFP-fusion proteins
expressed in XTC cells. Hoechst was used to detect the nuclei in cells transfected with GFPC13NES (not shown). !See also Figure 2.4. This figure was published in (Cousin et al., 2011).!
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Figure 2.4: Detection of the ADAM13 cytoplasmic domain. (A-B) Immunofluorescence of
Xenopus S3 cells using the Goat (red) and Rabbit (green) polyclonal antibodies to the ADAM13
cytoplasmic domain, as well as DAPI to stain the DNA (blue). A) Optical section through the
nuclei using an Apotome confocal grid (Zeiss). The staining for both antibodies is perinuclear.
Two foci are also stained within the nuclei with both antibodies (white arrowhead). B) At the
level of the extracellular matrix (3 μm down), the staining is present at the plasma membrane. C)
Fluorescence of GFP-C13 and membrane cherry in tailbud stage embryos injected with both
plasmids. GFP-C13 is present in the nuclei of embryonic cells. The experiments described in this
figure were performed by D. Alfandari. This was published as a supplemental figure in (Cousin et al.,
2011).
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Figure 2.5: ADAM13 cytoplasmic domain is critical for cranial neural crest cell migration.
(A) Lateral view of representative embryos injected with RFP and a control MO (CMO) or with
MO13. (See also Figure 2.5). The white arrows point to the fluorescence observed in the three
main CNC segments (from left to right, Mandibular, Hyoid and Branchial).! (B) Histogram
representing the percentage of embryos in which CNC migration was inhibited by either MO13
(black bars) or MO13 and MO19 (2MO, gray bars). The numbers on the right indicate the number
of embryos scored for each construct (schematic representation to the left). Statistical significance
(at least three independent experiments) was calculated using a student’s t test p < 0.05.
Significant rescue is indicated with an asterisk (*), and error bars correspond to SD. (C)
Representative examples of each case from (B) are shown. Each photograph indicates the mRNA
that was co-injected with RFP and 2MO. (D) Western blot from Cos-7 cells transfected with
various ADAM13 constructs and the protocadherin PAPC. The cell extract (Cell) and the
glycoproteins purified from the culture supernatant (Media) were probed with an antibody to the
extracellular domain of PAPC. The cell extract was also probed with the 7C9, a mono- clonal
antibody to the cysteine-rich domain of ADAM13. The experiments described in this figure were
performed by H. Cousin and D. Alfandari. This figure was published in (Cousin et al., 2011).
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Figure 2.6: Cytoplasmic domains of ADAMs from multiple species can replace C13. (A)
Histogram representing rescue experiments using a complementation assay. Values are the
percentage of embryos in which CNC migration was inhibited, normalized to injection of RFP
alone. The number of embryos scored in at least three independent experiments is indicated on
the right (N). RFP was injected with MO13 alone or together with ADAM13-ΔCtyo plus the
various cytoplasmic domains fused to GFP. The ADAM number and the species are indicated
(xl: Xenopus laevis, dr: Danio rerio, mm: Mus musculus, ce: Caenorhadbitis elegans, md:
Monodelphis domestica). Asterisks indicate significant rescue (p < 0.05), error bars are SD. (B)
Representative embryos from each case in (A) are shown. (C) Fluorescence images of live XTC
cells transfected with GFP-fusion proteins corresponding to the various ADAM cytoplasmic
domains. The experiments described in this figure were performed by both H. Cousin and myself. This
figure was published in (Cousin et al., 2011).

!
!
!
!
!

40!

!

!

Figure 2.7: The cytoplasmic domain of ADAM13 regulates gene expression. !(A)
Representative genes were selected from the microarray data. The average fold change between
the control MO and MO13 (MO13) or between MO13 and the rescue MO13 plus GFP- C13
(MO13+C13) is represented as a Log2. Error bars represent the SD. Four groups of genes are
presented. Xmc (Xenopus Marginal Coil), pafr (Platelet-activating factor receptor), capn8-a (Calpain8-a), wnt3-A (Wingless-type MMTV integration site 3A), and pou50 (Pou-homeobox gene
50) are decreased in CNC injected with MO13 and are partially rescued by GFP-C13. nudc
(nuclear distribution gene C), rad1 (cell cycle check point), and vamp8 (vesicle-associated
membrane protein 8) are increased in CNC lacking ADAM13, and rescued by GFP-C13. dusp18
(dual specificity phosphatase 18) and mek-2 (Erk kinase) are increased in CNC with MO13, while
camK1 (Calcium/calmodulin-dependent protein kinase 1) and dap (Death-associated protein
kinase 1) are decreased, with no significant effect from GFP-C13. (B) Histogram representation
of quantitative PCR data. Amplification was performed on cDNA isolated from CNC of embryos
injected with either MO13 or a combination of MO13, plus the cytoplasmic domains of ADAM9
(blue), ADAM13 (red), or ADAM19 (green). Values are represented as the Log2 fold change
compared with MO13 alone. Error bars correspond to the SD between triplicates. (myt1: myelin
transcription factor 1, fst: follistatin, nubp1: nucleotide binding protein 1, inta6: Integrin alpha 6).
This figure was published in (Cousin et al., 2011).
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Figure 2.8: Calpain8-a can rescue migration in the absence of the ADAM13 cytoplasmic
domain. (A) Complementation assays with embryos injected with MO13 plus ΔCyto alone or
with MMP13, Calpain8-a, or Xmc. CNC migration was also measured in embryos injected with a
morpholino to Calpain8-a (MO Capn8-a) or a DN Calpain8-a construct (Capn8-a C105S). The
total number of embryos is given (n). Error bars correspond to the SD. Statistical analysis was
done using a student’s t test. Asterisk represents p values <0.01 for (a) or <0.05 for (b).
Representative examples are given in (B). The experiments described in this figure were performed by
H. Cousin and myself. This figure was published in (Cousin et al., 2011).
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Figure 2.9: Loss of ADAM13 does not affect CNC induction. (A) Whole mount in situ
hybridization. Embryos were injected at the 2-cell stage with 10 ng of MO13 (left) or 10 ng of
MO13 and 400 pg of GFP-C13 (right). slug and sox8 were used as probes to identify the neural
crests. B) Histogram of microarray data from CNC explants isolated from embryos injected with
either a control MO, MO13 or MO13 and GFP-C13. The relative expression of neural crest
specific genes (snail2- a, snail, slugb, sox9, sox10 and twist1) as well as the platelet activated
factor receptor pafr, are given as the Log2 of the fold change. A value of +1 reflects a two-fold
increase and -1 a two-fold decrease. Error bars correspond to the standard error compiled from
triplicate arrays. None of the CNC markers are significantly decreased by MO13 (blue), while
sox9 is significantly increased (asterisk). pafr is given as an example of a gene significantly
affected by MO13. The experiments described in this figure were performed by E. Kerdavid and D.
Alfandari. This was a supplemental figure published in (Cousin et al., 2011).
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Table 2.1: Chapter II real time quantitative PCR primers. Sequences of primers used to
screen candidate genes from the microarray.
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CHAPTER III
PHOSPHORYLATION OF ADAM13 IS ESSENTIAL FOR CNC MIGRATION

Abstract
The studies from the previous chapter revealed that ADAM13 performs more
roles in the CNC than ectodomain shedding of surface proteins. In addition to cleaving
cadherin-11 to release a promigratory extracellular fragment, ADAM13 controls
expression of multiple genes via its cytoplasmic domain. One of the genes regulated by
ADAM13, the protease Calpain8-a, is essential for CNC migration. In this chapter, we
sought to understand how this process might be regulated. We investigate the role of
phosphorylation in regulating ADAM13 function and show that the kinases GSK3 and
Polo-like kinase (Plk) perform essential modifications of ADAM13 in the CNC.
Importantly, we demonstrate these phosphorylations are not required for ADAM13
proteolysis of its substrates, but appear to instead regulate the nuclear activity of the
ADAM13 cytoplasmic domain. The results presented in this chapter indicate that
phospho-regulation plays a significant role in the intracellular signaling activity of
ADAM13.

Section I: Introduction

We have now shown that in Xenopus laevis ADAM13 plays a dual role in the
migration of cranial neural crest (CNC) cells. On the cell surface, ADAM13 promotes
migration by cleaving cadherin-11 to release its adhesive extracellular domain
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(McCusker et al., 2009). The results presented in Chapter II showed that intracellularly,
the ADAM13 cytoplasmic domain possesses a surprising ability to control gene
expression when it is cleaved from the membrane-bound protease and shuttled to the
nucleus. The cytoplasmic domains of ADAM13 and 19 both activate the expression of
the cytoplasmic protease Calpain8-a in order to stimulate CNC cell migration (Cousin et
al., 2011). However, the mechanisms by which the cytoplasmic domain functions or how
it is regulated are unknown. Therefore, we next sought to gain a better mechanistic
understanding of its activity by probing the importance of predicted phosphorylation sites
and interaction domains within the ADAM13 cytoplasmic domain (C13).
Many ADAMs possess multiple putative phosphorylation sites within their
cytoplasmic domains, some of which have a significant impact on ADAM function.
Studies of ADAM phosphorylation have largely focused on the effect on its protease
domain, and kinase activation has been shown to stimulate the proteolytic activity of
multiple ADAMs. ADAM9 cytoplasmic domain, for example, can bind to and be
phosphorylated by protein kinase C δ (PKCδ) and the activation of PKC by the phorbol
ester TPA stimulates ectodomain shedding of HB-EGF by ADAM9 (Izumi et al., 1998).
In response to either PKC activation by PMA or growth factor stimulation, ADAM17 is
phosphorylated by extracellular signal-regulated kinase (ERK). This phosphorylation is
required for efficient shedding of TrkA and has also been implicated in the trafficking of
ADAM17 to the cell surface (Diaz-Rodriguez et al., 2002; Soond et al., 2005). It is not
clear whether these phosphorylation events directly modify the catalytic efficiency of the
protease domain or mediate interactions with substrates and/or other regulatory
machinery.
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In this chapter we investigate whether ADAM13 is regulated by phosphorylation
during CNC migration. Within the 196 amino acids of the cytoplasmic domain,
ADAM13 contains at least 15 predicted phosphorylation sites by various kinases (Figure
3.1) (ELM software; Dinkel et al., 2012).

After mutating each of these sites and

replacing the wild type protein with the mutated forms in vivo, we focused on several
phosphorylation sites that appeared to be essential for ADAM13 activity in CNC
migration. These include sites that are putative targets of glycogen synthase kinase 3
(GSK3) and Polo-like kinase (Plk). GSK3 is a serine/threonine kinase that consists of two
isoforms, α and β. It is perhaps most well known as an inhibitor of the canonical Wnt
signaling pathway, in which it phosphorylates β-catenin to target it for proteosomal
degradation in the absence of a Wnt signal. There have also been a number of other
cellular substrates of GSK3 identified that influence processes such as apoptosis, cell
cycle, cell polarity, and migration (Doble and Woodgett, 2003; Sun et al., 2009). In some
cases these events are controlled by Wnt signaling, such as the GSK3-regulated
degradation of the Smad1 (Fuentealba et al., 2007), while for other substrates the
upstream events that regulate GSK3 are unknown. The canonical Wnt pathway has
demonstrated importance during CNC induction, but its role in CNC migration is less
clear (Stuhlmiller and Garcia-Castro, 2012). However GSK3 is likely to be important for
craniofacial development as the GSK3 knockout mice develop cleft palate (Liu et al.,
2007). Plk is also a serine/threonine kinase that consists of five family members, Plk1-5.
All five Plks are implicated in various stages of cell cycle progression, and there is
increasing evidence for Plk functions extending beyond cell proliferation, such as
mediating neuronal differentiation and synaptic homeostasis (reviewed in de Carcer et al.,

!

47!

2011). To our knowledge, the role of Plk in CNC migration has not been addressed,
however Plk1 is known to be overexpressed in numerous cancers where it participates in
cancer cell migration and invasion (Han et al., 2012; Rizki et al., 2007; Zhang et al.,
2013).
The following results presented in this chapter examining the activities of GSK3
and Plk in the CNC and their involvement in ADAM13 regulation were previously
published in (Abbruzzese et al., 2014). I was involved in performing the experiments for
Figures 3.2, 3.3, 3.4, 3.6, and 3.7, and other members of the Alfandari lab participated in
Figures 3.2, 3.3A-C, 3.5A, and 3.7C. A. Salicioni was was involved in figure 3.3C.

Section II: ADAM13 phosphorylation sites are critical during CNC migration!

To better understand how ADAM13 function is regulated, we identified several
putative phosphorylation sites within the cytoplasmic domain using protein prediction
software (ELM; (Dinkel et al., 2012). To ask whether phosphorylation at any of these
sites is functionally important for ADAM13 activity during CNC migration, we replaced
the specific residues with either an alanine to prevent phosphorylation or a negatively
charged aspartate to mimic constitutive phosphorylation. We chose targeted injection as
the most direct technique to test the ability of these variants to replace the function of
endogenous ADAM13 in the CNC (Figure 3.2A). In this technique, a single CNC
precursor cell is injected with RFP as a lineage tracer to follow migration in vivo
(McCusker et al., 2009). In these experiments, percentage inhibition represents the
percentage of embryos without CNC migration. Because cleavage patterns can vary in
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different batches of embryos, we used RFP alone in each experiment to determine the
targeting efficiency and normalized the results. In each experiment, the ability of the
mutant to rescue migration was compared with wild-type ADAM13. For this assay, we
knocked down both ADAM13 and ADAM19 using morpholinos (MOs), since we have
shown that the cytoplasmic domains of these ADAMs have overlapping functions and
can regulate Calpain8-a gene expression to stimulate migration (Cousin et al., 2011). Our
results show that replacing ADAM13 with non-phosphorylatable constructs for two of
the GSK3 sites (A13-Gsk/A) or the Plk site (A13-Plk/A) did not rescue CNC migration in
morphant embryos (Figure 3.2B). Conversely, the phosphomimetic for either of these
sites (A13-Gsk/D or A13-Plk/D, respectively) is able to significantly rescue migration.
This suggests that phosphorylation at the GSK3 and Plk sites is essential for ADAM13
function in the CNC.
The binding of Plk to its substrate often requires that the substrate first be
phosphorylated at the sequence Ser-(pSer/pThr)-(Pro/X). Once bound to its phosphoprimed substrate, Plk will phosphorylate it at a different locus (Elia et al., 2003).
ADAM13 contains three of these consensus motifs, two of which are also the putative
GSK3 target sites. Therefore we generated complementary amino acid substitutions that
would block phosphorylation at one site (GSK3 or Plk) while mimicking phosphorylation
at the other to determine whether the GSK3 and Plk phosphorylation sites are
functionally linked or independent. These data show that mimicking phosphorylation at
the GSK3 sites is not sufficient to rescue ADAM13 function when the Plk
phosphorylation site is blocked (A13-Gsk/D-Plk/A; Figure 3.2B). However, the
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phosphomimetic Plk site is capable of rescuing the non-phosphorylatable GSK3 sites
(A13-Gsk/A-Plk/D).
We then tested, first, whether the two kinases were present in the CNC and,
second, whether they could phosphorylate ADAM13. To answer the first question, we
performed a Western blot on CNC dissected at stage 17 using antibodies specific to either
kinase. Indeed, each antibody detected the predicted size band (Figure 3.3A),
demonstrating that both GSK3 and Plk proteins are present in the CNC during migration.
We then produced an antibody against a phosphorylated peptide corresponding to the Plk
site in ADAM13. The antibody was affinity purified against the phosphorylated peptide
and affinity depleted with the non-phosphorylated peptide. Human HEK293T cells were
transfected with either the wild-type ADAM13 or the non-phosphorylatable mutant A13Plk/A. We found that wild-type ADAM13 was clearly phosphorylated in these cells,
whereas the mutant was not (Figure 3.3B). In addition, treatment of the cells with either a
Plk inhibitor or a GSK3 inhibitor prevented this phosphorylation, showing that in
HEK293T cells, endogenous Plk did phosphorylate ADAM13. This further suggests that
in the absence of GSK3, Plk did not phosphorylate ADAM13. Interestingly, in these
cells, the main form of ADAM13 phosphorylated is shorter (∼65 kDa) than the mature
ADAM13 (M; 100 kDa), suggesting that this form may not contain the metalloprotease
domain (form D). This shorter form of ADAM13 is also the one phosphorylated in vitro
by purified GSK3 (Figure 3.3C). Phosphorylation was increased in the ADAM13 mutant
A13-Gsk/D, suggesting that the third GSK3 phosphorylation site (885T) of ADAM13 can
also be phosphorylated in vitro.
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Section III: GSK3 and Plk activity are required for ADAM13 function! in CNC migration
!
Our mutation analysis suggests that GSK3 and Polo-like kinases should be
required for CNC migration at least to phosphorylate ADAM13. Because these kinases
are critical in multiple biological processes, we next tested whether lowering their
activity in the CNC would cause a defect in migration without other major developmental
defects. In particular, GSK3 was shown to phosphorylate the transcription factor Twist to
modify its activity (Lander et al., 2013). A non-phosphorylatable form of Twist did not
bind to and inhibit Slug/ Snail2, suggesting that phosphorylation by GSK3 is critical for
normal Twist function during CNC development. To lower each kinase activity, we used
previously characterized dominant-negative constructs and tested their ability to interfere
with CNC migration without inhibiting CNC induction when injected at relatively low
doses. Our results show that 300 pg of the GSK3 dominant negative (GSK3-DN;
(Dominguez et al., 1995) injected at the eight-cell stage into a CNC precursor cell
perturbed CNC migration in 30% of the injected embryos (Figure 3.4B and C), whereas it
did not perturb the expression of Slug in premigratory CNC (Figure 3.4A). We also
performed grafts on embryos injected with the dominant-negative GSK3 that confirmed
that migration was inhibited in these embryos (Movie 3.1). We then coinjected either
wild type or the phosphomimetic forms of ADAM13 together with the GSK3-DN to test
their ability to rescue migration. We found that expressing both ADAM13-Gsk/D and Plk/D, but not the wild-type ADAM13, could rescue the loss of migration caused by
GSK3-DN (Figure 3.4B and C). This confirms that one of the key substrates of GSK3
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during CNC migration is ADAM13 and that phosphorylations at the GSK3 and Plk sites
are required for proper ADAM13 function in vivo.
We next tested the requirement of Plk in CNC induction and migration using low
doses of a dominant-negative construct, Plk-DN (Descombes and Nigg, 1998).
Decreasing Plk activity by injecting 80 pg of Plk-DN mRNA at the eight-cell stage led to
52% inhibition of CNC cell migration (Figure 3.5A and Movie 3.2). We then asked
whether this migration defect could be rescued by coexpressing the ADAM13
phosphomimetic variants. In contrast to GSK3-DN, which was rescued by both
phosphomimetics (Figure 3.4B), only the Plk-mimetic, A13-Plk/D, could restore
migration of the CNC when Plk activity was reduced (Figure 3.5A). This is consistent
with a model of successive phosphorylation of ADAM13 cytoplasmic domain by which
Plk functions downstream of GSK3. To confirm the effect of Plk-DN on migration, we
also performed in situ hybridization to detect the CNC markers Twist and Sox10 and
observed similar results to those obtained by fluorescence in the targeted injection assays.
We found that whereas CNC induction appeared unaffected by Plk-DN, there was a
defect in migration caused by decreasing Plk activity, and this could be rescued by
coexpressing ADAM13-Plk/D (Figure 3.5B and C). Taken together, these results suggest
that during CNC migration, ADAM13 is regulated by Plk and GSK3 phosphorylation and
that the Plk phosphorylation is absolutely required, whereas GSK3 phosphorylation can
be omitted if the Plk site is phosphorylated.
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Section IV: ADAM13 protease activity is not regulated by GSK3! or Plk phosphorylation

!To determine the effect of GSK3 and Plk phosphorylations on ADAM13
proteolytic activity, we tested the ability of the nonphosphorylatable mutants to cleave
substrates both in vitro and in vivo. When cotransfected with the protocadherin PAPC in
Cos-7 cells, both non-phosphorylatable ADAM13 variants Plk/A and Gsk/A are able to
shed the extracellular domain of PAPC from the cell surface as efficiently as wild-type
ADAM13, whereas the protease active site mutant ADAM13-E/A cannot (Figure 3.6A)
(Cousin et al., 2011). Similarly, the phosphodeficient variants are also able to undergo
autoproteolysis to shed their own ectodomain into the medium (Figure 3.6A) (Gaultier et
al., 2002). In addition, coexpressing Plk-DN or GSK3-DN does not prevent wild-type
ADAM13 from shedding PAPC (Figure3.7).
To confirm these results and examine ADAM13 protease activity in vivo, we used
the targeted injection assay to overexpress the phosphodeficient variants along with the
cell adhesion molecule cadherin-11 in the CNC. Overexpression of cadherin-11 prevents
CNC migration, and this can be rescued by coexpression of either ADAM13 or the
extracellular fragment of cadherin-11 (McCusker et al., 2009). Accordingly, whereas
cadherin-11 blocked migration in 40% of embryos, both the A13-Plk/A and -Gsk/A
variants could rescue migration as efficiently as wild-type ADAM13 (Figure 3.6B). The
results from these in vitro and in vivo assays indicate that phosphorylation of ADAM13
by GSK3 and Plk is not essential for the proteolytic cleavage of at least two of its
identified substrates, PAPC and cadherin-11.
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Section V: Plk controls the nuclear function of ADAM13

The cleaved cytoplasmic domain of ADAM13 (C13) must translocate to the
nucleus and increase Calpain8-a (Capn8) expression to promote CNC migration (Cousin
et al., 2011). Therefore we investigated whether phosphorylation by Plk is necessary to
stimulate the cleavage of C13 from the membrane-bound protease, its nuclear
translocation, or its activity in gene regulation. We first showed that the cytoplasmic
domain of ADAM13-Plk/A is cleaved in embryos, indicating that intramembrane
processing by γ-secretase is not dependent on phosphorylation by Plk (Figure 3.8A). We
then generated the alanine substitutions at the GSK3 and Plk sites in a construct
containing C13 fused to green fluorescent protein (GFP-C13) to observe their subcellular
localization. When transfected into Cos-7 cells, we found that, similar to wild-type GFPC13, both variants containing the non-phosphorylatable alanine substitutions, GFP-C13Plk/A and GFP-C13-Gsk/A, accumulate in the nucleus (Figure 3.8B). Thus the
requirements for nuclear translocation of C13 do not rely on phosphorylation at the
GSK3 or Plk sites. To test whether these cytoplasmic domain phosphomutants are
functional in the CNC, we performed a targeted injection assay to replace endogenous
ADAM13 with the version of ADAM13 missing its cytoplasmic domain (ADAM13Δcyto) complemented with the different GFP-C13 variants. Similar to the behavior of
full-length ADAM13, we found that only C13-Plk/D could rescue CNC migration as well
as wild type, with no significant rescue when phosphorylation was abolished (C13-Plk/A,
Figure 3.8C). This confirms that Plk phosphorylation is needed for the function of C13,
independent of its extracellular functions such as proteolytic activity.
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Finally, we asked whether the role of Plk phosphorylation is to regulate the
transcriptional activity of C13. We showed in Chapter II of this thesis that in embryos
lacking ADAM13 cytoplasmic domain, restoring the levels of Capn8 expression is
sufficient to rescue CNC migration (Cousin et al., 2011). This rescue is only possible if
ADAM13 metalloprotease activity is also present. Therefore we tested whether
expressing Capn8 mRNA could rescue the loss of migration in embryos expressing nonphosphorylatable ADAM13 with the two morpholinos against ADAM13 and 19 at the
eight-cell stage. Capn8 expression was unable to rescue CNC migration when coexpressed with A13-Gsk/A. However, we observed partial but significant recovery when
Capn8 was coexpressed with the A13-Plk/A mutant, which is consistent with the level of
recovery obtained when coexpressed with ADAM13-Δcyto (Figure 3.8C and D) (Cousin
et al., 2011). These results suggest that phosphorylation of ADAM13 by Plk is important
for its ability to regulate Capn8 transcript levels.

Section VI: Chapter III Discussion

We established in Chapter II that the cytoplasmic domain plays a central role in
the pro-migratory activity of ADAM13, as it controls both the level of ADAM13 protein
present in the CNC and the transcriptional activity in these cells (Alfandari et al., 2001;
Cousin et al., 2011). In this chapter, we show that one of these controls is mediated by a
phosphorylation cascade involving GSK3 and Polo-like kinase. We further demonstrate
that these phosphorylations are essential for the nuclear function of ADAM13 in the
CNC. Our results suggest a model in which ADAM13 is successively phosphorylated in
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vivo, first by GSK3 to phosphoprime for Plk, and second by Plk at the critical residue
T833 (Figure 3.9).
ADAM phosphorylation has been shown to regulate either proteolytic activity or
subcellular localization of the protease (Diaz-Rodriguez et al., 2002; Izumi et al., 1998;
Soond et al., 2005). Recently ADAM17 phosphorylation by Polo-like kinase 2 was
shown to regulate the shedding of its substrate in mammalian cells (Schwarz et al., 2014).
In contrast, we showed here that ADAM13 proteolytic activity is not affected by its
phosphorylation, as the non-phosphorylatable mutants can cleave PAPC in vitro and can
rescue the overexpression of cadherin-11 in vivo. Given that GSK3 and Plk are also
known to mark substrates for degradation (Descombes and Nigg, 1998; Kim et al., 2009;
Moshe et al., 2004; Schmidt et al., 2005), it is significant to note that the level of protein
expressed is not reduced in the non-phosphorylatable mutant, and the maturation and
subcellular localization is indistinguishable from the wild-type protein (Figure 3.8A and
B). Furthermore, we show here that the non-phosphorylatable cytoplasmic domain as a
GFP fusion expressed together with the extracellular and transmembrane domains of
ADAM13 (with intact proteolytic activity) does not rescue CNC migration, whereas the
wild-type cytoplasmic domain does. This indicates that the effects of phosphorylation on
ADAM13 are restricted to the independent activity of the cytoplasmic domain, possibly
its activity in the nucleus.
Further evidence that phosphorylation is required for the nuclear activity of C13 is
provided by the fact that increasing the levels of Calpain-8a expression, a critical target
gene of C13, can rescue migration of CNC expressing phospho-deficient ADAM13Plk/A. The level of rescue was comparable to what was previously observed with a
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mutant of ADAM13 lacking the entire cytoplasmic domain (Cousin et al., 2011). On the
other hand, Calpain-8a expression had no effect when coinjected with the mutant for the
GSK3 sites. This suggests that GSK3 phosphorylation of ADAM13 is important not only
to create Plk binding sites, but is potentially also needed for events downstream or
parallel to Calpain8-a transcription.
Since it is still unknown how C13 modulates gene expression, we can only
speculate at this point as to why phosphorylation is necessary for this process. As you
will see in Chapter VI, we have identified several transcription factors that are expressed
in the CNC that bind to ADAM13. Thus, one hypothesis is that C13 can regulate
transcription by acting as a coactivator, and that phosphorylation of C13 mediates this
interaction. This hypothesis is explored further in Chapter VI. Another possibility is that
C13 is involved in the nuclear transport of a transcription factor or cofactor that is critical
for Capn8-a expression. The cytoplasmic domain of human ADAM10, which was also
shown to be cleaved from the membrane-bound protease and capable of translocating to
the nucleus, is thought to participate in the nuclear trafficking of HIV-1 to promote HIV
replication as well as transport of the androgen receptor to contribute to progression of
prostate cancer (Arima et al., 2007; Friedrich et al., 2011; Tousseyn et al., 2009).
Although we do not observe a defect in the nuclear translocation of the phospho-deficient
ADAM13 ctyoplasmic domain, it is conceivable that phosphorylation mediates the
binding of C13 to a critical protein in the cytoplasm that requires C13 to reach the
nucleus.
Of significance, the work presented in this chapter also highlights novel roles for
GSK3 and Plk in the CNC. GSK3 is a well-known inhibitor of the canonical Wnt
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pathway, where it phosphorylates β-catenin to induce its degradation. Both canonical and
noncanonical Wnt have been shown to play roles in CNC induction and migration. In
particular, Wnt signaling is essential for the induction of CNC (Abu-Elmagd et al., 2006;
Garcia-Castro et al., 2002), but evidence suggests that it needs to be turned off during
migration. Activating the Wnt pathway by either stimulating with Wnt-1 or inhibiting
GSK3 with LiCl blocks trunk neural crest cell migration (de Melker et al., 2004),
whereas genetic knockout of GSK3 in mice leads to cleft palate, a defect generally due to
CNC cell migration defects (Liu et al., 2007). In Xenopus, GSK3 phosphorylation of
Twist modifies its activity, promotes its binding to Slug, and results in the inhibition of
Slug (Lander et al., 2013). Slug is one of the first transcription factors induced in the
CNC and is progressively turned off during migration. GSK3 phosphorylation of Twist
may help further inhibit the remaining Slug protein activity during migration. Our results
showing that when GSK3 activity is reduced, migration can be rescued by expressing the
ADAM13 phosphomimetic mutant, suggests that GSK3 activity could be involved in part
to activate one or more ADAMs required for neural crest cell migration.
Although Plk regulates multiple aspects of development through its control of cell
cycle progression, there is no evidence of its role in controlling cell migration in a
developmental context. On the other hand, Plk1 was previously shown to be important
for the invasion of breast cancer cells through a laminin-rich extracellular matrix by
phosphorylating the intermediate filament protein vimentin, which in turn regulates the
level of β1 integrin on the cell surface (Rizki et al., 2007). Implication of Plk in cancer
cell migration and invasion is growing and extending to multiple cancer types, but the
mechanism of action is not well understood, and in many studies, the increase in the
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number of cells invading could be the result of increases in cell proliferation due to Plk
overexpression. One interesting possibility is that at least part of Plk stimulation of cell
migration is via the phosphorylation of an ADAM in a mechanism similar to what we
observed for ADAM13.

Section VII: Chapter III Materials and Methods

Morpholinos and DNA constructs
Morpholino antisense oligonucleotides (GeneTools) against ADAM13 and ADAM19
were described previously (McCusker et al., 2009; Neuner et al., 2009). All of the
ADAM13 constructs used for the CNC migration assays contain seven silent mutations in
the morpholino-binding region so that it is resistant to the MO13. Phosphorylation
mutations were introduced by site-directed mutagenesis to replace the putative
phosphorylated residue with alanine or aspartate. The predicted GSK3 sites are serines
752 and 768, and the predicted Plk site is threonine 833. Dominant-negative GSK3,
containing the mutation K85R, has been characterized previously (Dominguez et al.,
1995) and was a generous gift from Isabel Dominguez (Boston University School of
Medicine). The dominant-negative Plk construct (encoding the two Polo box domains of
Plk1) was published previously (Ito et al., 2008) and was a gift from Rafael Fissore
(University of Massachusetts Amherst).
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Antibodies
The following antibodies were used: g821, goat polyclonal antibody to the ADAM13
cytoplasmic domain (Cousin et al., 2011); 6615F, rabbit polyclonal antibody to the
ADAM13 cytoplasmic domain (Alfandari et al., 1997); 4A7, mouse monoclonal to the
ADAM13 cytoplasmic domain; 7C9, mouse monoclonal to the ADAM13 cysteine-rich
domain (Gaultier et al., 2002); PAPC, mouse monoclonal to the extracellular domain
(Chen and Gumbiner, 2006), 8C8, monoclonal antibody to β1 integrin (Gawantka et al.,
1992); anti-Plk, mouse monoclonal to Plk1 (Invitrogen); and anti-GSK3, mouse
monoclonal to GSK3 α/β (LifeSpan BioSciences). P-A13, the antibody to phosphorylated
ADAM13 (833T, Plk site), was generated by immunizing two rabbits (ProSci) with a
phosphorylated peptide linked to KLH (EZBiolab). Phosphospecific antibodies were
affinity purified on the phosphorylated peptide and immunodepleted using the nonphosphorylated peptide.

Injections
Capped mRNA were synthesized for all constructs except GSK3-DN using SP6 RNA
polymerase on DNA linearized with NotI as described earlier (Cousin et al., 2000).
GSK3-DN was linearized with SacI and transcribed with T7 RNA polymerase. For the
CNC targeted injection assays, embryos were injected at the eight-cell stage into either
the left or right dorsal-animal blastomere (CNC precursor) with 200 pg of RFP or GFP
mRNA as a lineage tracer. Morpholinos to ADAM13 and 19 (2MO, 1 ng each) were
injected either alone or in combination with 80 pg of mRNA encoding wild-type
ADAM13 or the various phosphomutants. 2MO plus ADAM13-Plk/A or A13-Gsk/A was
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rescued with 80 pg of calpain8-a mRNA. For the dominant negatives, 80 pg of Plk-DN
mRNA was injected alone or together with 80 pg of ADAM13 mRNA, and 300 pg of
GSK3-DN mRNA was injected alone or with 300 pg of ADAM13 mRNA. For the
overexpression of cadherin-11, 300 pg of cadherin-11 and 300 pg of ADAM13 were
used. Embryos were raised at 15°C until they reached tailbud stage (stages 24–27) and
were scored for inhibition of CNC migration by the absence of RFP-positive cells within
the migration pathways.
For in situ hybridizations, embryos were injected into one cell at the two-cell
stage with 200 pg of GFP mRNA plus 300 pg of the mRNAs for Plk-DN, GSK3-DN, or
ADAM13 variants. Embryos were sorted for RFP expression on the left or right side and
fixed at neurula or early tailbud stage (14 or 21, respectively). Whole-mount in situ
hybridizations were performed as described earlier (Harland, 1991).

Grafts
Embryos were injected in one cell at the two-cell stage and raised at 14°C. Embryos were
sorted for optimum lineage tracer expression (GFP or mRFP) at stage 15 (as soon as the
anterior neural folds are visible and raised). The vitelline envelopes of selected embryos
were removed, and embryos were placed in a dish of nontoxic modeling clay (Van Aken)
containing 1xMBS (88.0 mM NaCl, 1.0 mM KCl, 2.4 mM NaHCO3, 15.0 mM HEPES
[pH 7.6], 0.3 mM CaNO3-4H2O, 0.41 mM CaCl2-6H2O, 0.82 mM MgSO4) and 50 μg/ml
gentamycin. Embryo-sized cavities were formed in the Plasticine using a Pasteur pipette
whose tip had been melted into a glass ball. The embryos were placed in the cavities,
oriented according to experimenter’s grafting preference, and immobilized by pulling
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back some modeling clay around them. Once immobilized, the ectoderm covering the
CNC was peeled off, the CNCs were cut out using an eyelash knife and hair loop, and
grafted into host embryos whose CNCs were removed. Each CNC was grafted according
to its proper anteroposterior and dorsoventral orientation. The grafted embryos were left
to heal for 30 min in 1xMBS, with an embryo-sized coverslip pressed onto the dissected
region of the embryo to maintain the ectoderm flush with the CNC and mesoderm. The
embryos were then raised in a tissue culture dish coated with 1% agarose in 0.1xMBS
and 50 μg/ml gentamicin at 14°C overnight.

Cell culture and transfection
293T cells were obtained from the American Type Culture Collection (ATCC) and
transfected using X-tremeGENE HP according to manufacturer’s instructions (Roche).
For detection of phosphorylated ADAM13, cells expressing ADAM13 were treated
overnight with 0.2% dimethyl sulfoxide, 0.1 μM Plk inhibitor GW843682X (SigmaAldrich), or 1 μM GSK3 inhibitor AR-A014418 (Sigma-Aldrich). Cos-7 cells were
obtained from ATCC and transfected using Fugene-6 (Roche) according to
manufacturer’s instruction. For PAPC and ADAM13 shedding assays, cells were
incubated with medium containing 2% serum 24 hr after transfection, and conditioned
supernatants were collected at 48 hr. The shed extracellular domains were purified using
concanavalin-A–agarose beads (Vector Laboratories) overnight at 4°C, eluted in reducing
Laemmli buffer, and blotted using the PAPC or 7C9 antibodies.
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Immunoprecipitation and Western blots
Cells were extracted in RIPA buffer (Tris-buffered saline [TBS], 1% NP-40, 1%
deoxycholate, 0.1% SDS) with protease phosphatase inhibitor cocktail (Pierce).
Immunoprecipitation of ADAM13 was performed using a monoclonal antibody to the
cytoplasmic domain (4A7), bound to protein G–agarose (Pierce Biotechnology), for 2 hr
at 20°C. Immunoprecipitates (IPs) were washed three times with extraction buffer before
elution with Laemmli buffer. ADAM13 IPs were blotted using the phosphospecific
antibody at 0.1 μg/ml overnight at 4°C. Unless otherwise noted, Western blots were
performed on polyvinylidene fluoride membranes (Millipore) and blocked with 5%
nonfat dry milk in TBS with 0.1% Tween-20. All antibody incubations and washes were
also performed in TBS 0.1% Tween-20. Embryos for Western blots and
immunoprecipitations were extracted in 1× MBS, 1% Triton X-100, 5 mM EDTA, and
Halt Protease and Phosphatase inhibitor cocktail (ThermoScientific).

Kinase assays
For the in vitro phosphorylation, the 4A7 immunoprecipitates were washed in kinase
buffer (25 mM 4-(2-hydroxyethyl)-1-pipera-zineethanesulfonic acid, pH 7.2, 10 mM
MgCl, 10 mM MnCl, 22 1 mg/ml bovine serum albumin, 40 mM β-glycerophosphate, 5
mM p-nitrophenylphosphate, 10 μM aprotinin, and 10 μM leupeptin) and incubated with
active GSK3 (SignalChem) in the presence of 32P-ATP as previously described (Li et al.,
2011).
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Fluorescence microscopy
Cos-7 cells were transfected with the GFP-fusion proteins plus membrane-bound
mCherry to visualize the cell boundaries and placed on fibronectin-coated (10 μg/ml)
glass-bottom plates (MatTek). Photographs were taken using a Zeiss 200M inverted
microscope equipped with an Apotome and a 63× oil immersion lens to obtain optical
sections. For in vivo CNC migration assays, embryos were imaged using a Zeiss Stereo
Lumar-V12 fluorescence microscope.
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Figure 3.1: Amino acid analysis of the ADAM13 cytoplasmic domain. Using the ELM protein
prediction software, we analyzed the amino acid sequence of C13 to identify putative
phosphorylation sites and interaction domains. The lysine/arginine-rich (KR) region of C13 is
shown in red and the proline-rich (PR) region in blue. C13 contains a predicted nuclear
localization sequence (NLS, green) and multiple SH3 binding sites (pink). Residues predicted to
be phosphorylated are identified to the right of the protein with the corresponding kinase for each
site on the left. Ligands for predicted interaction motifs are also shown on the right. This figure has
not been published.
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FIGURE 3.2: Phosphorylation sites are required for ADAM13 function during CNC
migration. (A) Fluorescence images showing representative embryos for the injections of RFP
alone, the knockdown with 2MO, or the rescue with wild-type ADAM13. Arrows indicate the
position of the three migration segments (from left to right: hyoid, branchial, mandibular). (B)
Histogram of targeted injection assays testing the ability of ADAM13 phosphomutants to rescue
CNC migration in ADAM13/19-deficient embryos (2MO) from at least three independent
experiments. Values are percentages of embryos with no CNC migration, normalized to 2MO +
wild-type ADAM13. The error bars correspond to the SD. n, number of embryos scored for each
case. Statistical significance of rescue: *p < 0.05, **p < 0.01. The experiments described in this
figure were performed by both myself and H. Cousin. This figure was published in (Abbruzzese et al.,
2014).
!
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FIGURE 3.3: GSK3 and Plk can phosphorylate ADAM13. (A) Western blots for Plk1 (68
kDa) and GSK3β (47 kDa) on protein extract from!27 dissected CNC (CNC) or one total embryo
equivalent at the same stage as dissection (Tot St17). (B) Western blot showing phosphorylation
of ADAM13. The main forms of ADAM13 protein are represented at the top. The pro form (P)
contains the prodomain and is inactive, the mature form (M) is proteolytically active, and
cleavage of the metalloprotease domain results in a shorter form (D) that appears to be the
principal phosphorylated form of ADAM13. Nuclear Cherry (nCherry, negative control),
ADAM13 (A13), or the nonphosphorylatable mutant (A13-Plk/A) was expressed in HEK293T
cells. Cells expressing ADAM13 were treated overnight with dimethyl sulfoxide (DMSO), Plk
inhibitor (Plk Inh), or GSK3 inhibitor (Gsk Inh). All of the samples were first
immunoprecipitated with a monoclonal antibody to ADAM13 (mAb 4A7), followed by Western
blot using the phospho-ADAM13 antibody to the Plk phosphorylation site (P-A13) or the rabbit
polyclonal to the ADAM13 cytoplasmic domain 15F for the total ADAM13 protein (Tot). (C)
Autoradiograph of immunoprecipitated (IP) ADAM13 produced in HEK293T cells
phosphorylated by purified active GSK3. The experiment described in (B) was performed by D.
Alfandari and (C) by myself and A. Salicioni. This figure was published in (Abbruzzese et al., 2014).
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FIGURE 3.4: GSK3 activity is critical for ADAM13 in CNC cell migration. (A) In situ
hybridization using a probe to detect the CNC marker slug in neurula-stage embryos (st. 14),
showing that induction is not affected by GSK3-DN. Injected sides of each embryo are on the left
(asterisk). (B) Histogram representing the percentage of embryos with no CNC migration in a
targeted injection assay from at least five independent experiments. Values are normalized to
injection of RFP alone. Error bars are SD. n, number of embryos scored. *p < 0.01, ***p < 0.001.
(C) Fluorescence images showing typical result for each case in the targeted injection assay in B.
A defect in migration is scored by the absence of RFP-labeled cells within the migration pathway.
This figure was published in (Abbruzzese et al., 2014).
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FIGURE 3.5: ADAM13 requires Plk activity in the CNC. (A) Histogram showing the
percentage of embryos with inhibited CNC migration in a targeted injection assay. Values are
normalized to injection of GFP alone and are from at least three independent experiments. Error
bars are SD. n, number of embryos scored. *p < 0.05, **p < 0.01. (B) In situ hybridization
detecting both of the CNC markers Sox10 and Twist in early tailbud embryos (st. 21), showing
that migration, but not induction, is decreased by Plk-DN. Injected side of each embryo is on the
left. (C) Analysis of CNC migration from the in situ hybridizations in B, showing the percentage
of embryos for each case with severe, weak, or no defect in CNC migration on the injected side
compared with the noninjected side of each embryo. The experiment described in (A) was performed
by H. Cousin. This figure was published in (Abbruzzese et al., 2014).
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FIGURE 3.6: Phosphorylation of ADAM13 does not affect its proteolytic activity. (A)
Western blot from Cos-7 cells transfected with the protocadherin PAPC and various ADAM13
constructs. The glycoproteins purified from the conditioned media were probed with an antibody
to the extracellular domain of PAPC or with 7C9, a monoclonal antibody to the cysteine-rich
domain of ADAM13. E/A is a catalytically inactive variant of ADAM13. (B) The histogram
represents the percentage of embryos displaying no migration from targeted injection of cadherin11 mRNA alone or together with the ADAM13 variants. Values are normalized to RFP alone.
Error bars are SD. !n, number of embryos scored from at least three independent experiments. *p
< 0.05, **p < 0.01. This figure was published in (Abbruzzese et al., 2014).
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Figure 3.7: Blocking Plk or GSK3 activity does not affect PAPC shedding by ADAM13.
Western blot from Cos-7 cells transfected with the protocadherin PAPC and ADAM13 plus either
wild type kinases or their dominant negative forms (DN). The glycoproteins purified from the
conditioned media were probed with an antibody to the extracellular domain of PAPC. PAPC
and ADAM13 were detected in the cell extract with the PAPC antibody or 6615F, a polyclonal
rabbit antibody to the cytoplasmic domain of ADAM13. E/A is a catalytically inactive variant of
ADAM13. This figure has not been published.
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FIGURE 3.8: ADAM13-dependent regulation of calpain8 expression depends on ADAM13
phosphorylation. (A) ADAM13 was immunoprecipitated (IP) from 20 embryos using a goat
polyclonal antibody g821. Noninjected embryos (NI) at stage 18 (neurula) are compared with
sibling embryos injected with MO13 or MO13 plus MO-resistant mRNA encoding ADAM13Plk/A or wild type. ADAM13 protein was detected by Western blot using 6615F. The
polyvinylidene fluoride membrane was cut below 25 kDa and the two halves probed separately.
The cleaved cytoplasmic domain (Cyto) is observed at 17 kDa for both wild-type and Plk/A
ADAM13. Samples of the input for the IP were analyzed by Western blot with the 8C8 antibody
for β1 integrin as a loading control. (B) Fluorescence images showing the localization of GFPfusion proteins (green) expressed in Cos-7 cells along with membrane-bound mCherry (red). GFP
is observed uniformly throughout the cytoplasm and nucleus, whereas GFP-C13 and the
phosphodeficient mutants all accumulate strongly in the nucleus. (C, D) Analyses of targeted
injection assays displaying the loss of CNC migration as a percentage of embryos. (C) MO13 +
MO19 (2MO) was coinjected with mRNA encoding ADAM13 lacking its cytoplasmic domain
(ΔCyto) plus either GFP-C13 wild type or phosphomutants. Values are normalized to the rescue
with GFP-C13 wild type, and Student’s t tests were performed to compare values to 2MO +
ΔCyto. (D) 2MO was injected with ADAM13-Plk/A or ADAM13-Gsk/A mRNA alone or
together with Capn8 mRNA. Inhibitions are normalized to RFP, and Student’s t tests were
performed against 2MO. Error bars are SD from four or more independent experiments. n,
number of embryos scored. **p < 0.01, ***p < 0.005. The experiment described in (C) was performed
by H. Cousin. This figure was published in (Abbruzzese et al., 2014).
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FIGURE 3.9: Successive phosphorylation of ADAM13. Proposed model depicting successive
phosphorylation of ADAM13 by which GSK3 primes ADAM13 at two sites (S752 and S768;
step 1) for subsequent phosphorylation at a second site on ADAM13 (T833; step 2). NLS, nuclear
localization signal. The lysine/arginine-rich (KR) region of the cytoplasmic domain is shown in
red, and the proline-rich region is shown in blue. This figure was published in (Abbruzzese et al.,
2014).
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CHAPTER IV
ADAM13 IS REGULATED BY FRIZZLED-4 DURING CNC MIGRATION

Abstract
In this chapter, we investigate a new mechanism for the regulation of ADAM13
activity in the CNC. Here we show that the Wnt receptor Fz4 binds to the cysteine-rich
domain of ADAM13 and negatively regulates its proteolytic activity in vivo. Our studies
indicate that Fz4 associates with ADAM13 during its transport to the plasma membrane.
In addition, we demonstrate that the interaction with Fz4 controls the rate of ADAM13
processing, which affects the amount of active protease that reaches the surface as well as
the amount of cleaved cytoplasmic domain that is generated for signaling in the nucleus.
This work describes a novel mechanism for regulating ADAM activity by a
transmembrane protein that is normally involved in the Wnt signaling pathway.

Section I: Introduction

The work presented in this chapter was the result of a collaboration between our
lab and the lab of Dr. Herbert Steinbeisser at the University of Heidelberg. Dr.
Steinbeisser’s lab has previously studied the role of Frizzled-4 (Fz4) in the CNC.
Frizzleds are a family of seven-pass transmembrane proteins that serve as receptors on
the cell surface for Wnt ligands to activate the Wnt pathway. Wnt signaling can be
subdivided into two pathways that activate different intracellular effectors: the canonical
pathway, which activates β-catenin-mediated transcription, and the non-canonical or
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planar cell polarity (PCP) pathway, mediated through the intracellular protein
Dishevelled, that induces actin cytoskeleton remodeling (Gordon and Nusse, 2006). The
choice of pathway depends on the specific combination of Wnt ligand and Fz receptor
and can be further regulated by specific co-receptors and secreted modulators that
compete for Wnt ligand binding (Niehrs, 2012). !Both canonical and non-canonical
signaling are critical during numerous stages of embryo development. During CNC
development, the canonical pathway is essential for the specification of CNC cells, while
its role in migration is uncertain (Stuhlmiller and Garcia-Castro, 2012). The noncanonical pathway, however, is important for the formation of lamellipodia and filopodia
in CNC cells to enable and direct their migration in Xenopus (De Calisto et al., 2005;
Mayor and Theveneau, 2014).
Fz4 loss-of-function studies in Xenopus showed that it is required for normal
CNC migration (Gorny et al., 2013). In both human and Xenopus, two alternatively
spliced variants of Fz4 have been identified; a full length transmembrane form and a
shorter secreted form (Fz4-v1) that is generated by intron retention and contains the Nterminal portion of the extracellular domain but lacks the seven transmembrane and
cytoplasmic domains (Sagara et al., 2001; Swain et al., 2005). Secreted Fz4-v1 retains the
Wnt-binding cysteine-rich domain (CRD) and both the human and !Xenopus protein have
been shown to activate Wnt/β-catenin signaling under specific !conditions (Gorny et al.,
2013; Sagara et al., 2001; Swain et al., 2005). In addition, when expressed with noncanonical Wnts, such as Wnt11, Fz4-v1 can activate the PCP pathway (Gorny et al.,
2013). Using a morpholino that targets both variants of Fz4, it was found that CNC
migration could be restored by re-expression of Fz4-v1 alone (Gorny et al., 2013).
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Although gain-of-function experiments showed that Fz4-v1 can alter Wnt signaling in the
embryo, it isn’t known whether affecting the Wnt pathway is responsible for its effects on
CNC migration.
Fz4 has strong similarities to the Wnt modulators Secreted Frizzled Related
Proteins (SFRPs), which also possess a Fz-like CRD, and both types of proteins can have
agonist and antagonist effects on the Wnt pathway depending on their doses (Gorny et al.,
2013; Mii and Taira, 2009; Uren et al., 2000). !SFRPs have a clear role in binding to Wnt
ligands and affecting their ability to interact with Fz receptors, yet they also exhibit
promiscuity in their binding partners and interact with a number of non-Wnt related
proteins (reviewed in Bovolenta et al., 2008). Notably, they have been shown to interact
with several proteases and modify their proteolytic activity. In Xenopus, the SFRP
othologue Sizzled binds to Tolloid-like metalloproteases and inhibits the processing of
both Chordin and procollagen-C (Lee et al., 2006; Muraoka et al., 2006), while in
mammals, the SFRP2/Tolloid protease interaction enhances collagen processing
(Kobayashi et al, 2009). In addition, mouse SFRP1 and 2 bind and inhibit ADAM10 in
the retina and this is important for maintaining proper levels of Notch signaling (Esteve et
al., 2011). In the absence of SFRP1 and 2, ADAM10 is hyperactivated leading to
increased processing and activation of Notch signaling, ultimately causing defects in
retinal neurogenesis. Thus, given the similarities between SFRPs and the !secreted Fz4
variant, we investigated whether Fz4-v1 could modulate the activity of ADAM13 in !the
CNC. T
! he results presented in this chapter were originally published in (Abbruzzese et
al., 2015). I was involved in performing the experiments for Figures 4.1A and C, 4.2, 4.4,
4.5A-B and 4.6D, 4.6C, and 4.7B. Experiments for following figures involved other
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members of the Alfandari lab or by the Steinbeisser lab: Figures 4.1B and D, 4.2, 4.3,
4.5C, 4.6A-B, 4.7A and C.

Section II: ADAM13 cysteine-rich domain binds to Fz4!

SFRP1/2 have been shown to interact with and inhibit ADAM10 proteolytic
activity (Esteve et al., 2011). Therefore, we tested whether such an interaction existed
between Fz4 and ADAM13. Indeed, ADAM13 and Fz4-v1, as well as the full length Fz4
receptor, co-precipitate when transfected into HEK293T cells (Figure 4.1A). In addition
to the disintegrin and metalloprotease domains, ADAMs also contain a cysteine-rich
domain, an EGF-like domain, and a transmembrane and cytoplasmic domain (see Figure
4.1B). To identify which of these domains is responsible for binding to Fz4, we tested
variants of ADAM13 that express either individual or combinations of domains. We used
Fz4-v1 in these experiments because both proteins seem to have a similar binding, and
the potential surface contact in Fz4-v1 is smaller. In these experiments, we found that the
cysteine-rich domain of ADAM13 is sufficient to promote Fz4-v1 interaction, whereas
the disintegrin domain is not (Figure 4.1B). Interestingly, this domain of ADAM13 is
also responsible for interacting with the second heparin-binding domain of fibronectin
(Gaultier et al., 2002) and is thought to control proteolytic specificity (Smith et al., 2002).
Whereas the functional analyses, showing that Fz4/Fz4-v1 combined knockdown
inhibits CNC cell migration, strongly suggest that these proteins are present in the CNC
(Gorny et al., 2013), the published expression pattern reported for Fz4 and Fz4-v1 (Shi
and Boucaut, 2000) do not closely match neural crest cells, suggesting that Fz4 and Fz4-
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v1 could act on the CNC from adjacent tissues (for example, the placodes). To confirm
that mRNA of either Fz4 or Fz4-v1 is present, we performed quantitative real-time PCR
with dissected CNC explants using primers designed to selectively amplify each form.
The result shows that both Fz4 and Fz4-v1 are, indeed, expressed in the CNC, but their
mRNAs are not restricted to these cells, confirming the in situ hybridization (ISH)
pattern. When compared with the Zinc finger protein SNAI2 (also known as and hereafter
referred to as Slug), a typical CNC marker, the overall expression levels of Fz4 and Fz4v1 in whole embryos at stage 17 are very similar and represent between 2% (Fz4-v1) and
4% (Slug, Fz4) of GAPDH expression (Figure 4.1C). At the same stage, Slug is
expressed in the CNC at 57% of the GAPDH level, making it very obvious by ISH.
However, Fz4 and Fz4-v1 are expressed at 5% and 2% of GAPDH, respectively, a level
similar to the global expression in the embryo. We also performed double ISH using a
Fz4-receptor-specific full-length probe and a short locked nucleic acid (LNA)-probe
specifically recognizing Fz4-v1 but not Fz4 (Gorny et al., 2013) to distinguish between
the two Fz4 splice variants (Figure 4.1D, blue) and the neural crest markers Sox10 and
Twist (both red). With this technique it is clear that Fz4-v1 is present in the CNC at both
stage 20 and stage 24, whereas Fz4 appears to be expressed in placodes as well as in the
extreme tips of the CNC segments (Figure 4.1D, arrowheads). Together these data show
that ADAM13, Fz4 and Fz4-v1 are all expressed in the CNC, and that ADAM13 and
Fz4-v1 expression patterns clearly overlap.
To determine whether ADAM13 colocalizes with either form of Fz4, we Cterminally tagged ADAM13 with GFP, and Fz4 or Fz4-v1 with RFP, and co-expressed
these constructs in Xenopus CNC and cell lines (Figures 4.2 and 4.3). In the CNC, Fz4 is
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detected in two main compartments, vesicles and the plasma membrane associated with
the fibronectin substrate (Figure 4.2; Movie 4.1). ADAM13 protein is detected in all
membranes but enriched in vesicles as well as in cellular protrusions that are in contact
with the fibronectin substrate. ADAM13 colocalizes with Fz4 in a subset of vesicles
(Figure 4.2 upper and middle rows, arrowheads) and at the membrane that is in contact
with the substrate (Figure 4.2 middle row, arrows). The localization of Fz4-v1 is clearly
distinct, surrounding the nucleus in a pattern resembling the endoplasmic reticulum. In
time-lapse movies at the level of the substrate, Fz4-v1 appears to be closely associated
with ADAM13 in some membrane protrusions (Figure 4.2 lower row, boxed areas, and
Movie 4.2). Thus, the subcellular localization of ADAM13, Fz4 and Fz4-v1 is compatible
with a potential interaction of these proteins in migrating CNC cells.
In the Xenopus fibroblast cell line (XTC), we used sub-cellular markers for the
lysosome (Lysotracker), endoplasmic reticulum (ER-tracker), and Golgi complex (WGA)
to identify the compartment in which ADAM13 colocalizes with Fz4 and Fz4-v1. Fz4
expression was found in both the endoplasmic reticulum and lysosomes (Figure 4.3), but
was hardly detected in the Golgi complex (Figure 4.3). ADAM13 was associated with all
three markers but appeared to only colocalize with Fz4 in the ER in these cells (Figure
4.3). The vesicles in which ADAM13 and Fz4 colocalized did not stain with any of the
markers tested, suggesting that they were neither Golgi nor lysosomal in origin. The
staining obtained for Fz4-v1 was much more obvious and appeared to be restricted to the
ER where it perfectly colocalized with ADAM13 (Figure 4.3). Again, in WGA-positive
vesicles ADAM13 appeared to be mostly free of Fz4-v1 suggesting that the proteins do
not transit together to the cell surface in XTC cells (Figure 4.3). Unfortunately, these
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markers could not be used in a CNC explant, as they all bind very strongly to the yolkrich platelets (data not shown). A similar distribution of ADAM13-GFP, Fz4-RFP and
Fz4-v1-RFP was found in transfected human osteosarcoma (U2OS) cells, when using
antibodies against calnexin and GM130 to identify the ER and Golgi respectively (data
not shown).

Section III: Fz4 inhibits ADAM13 proteolytic activity and migration of CNC cells!

Having established that all three mRNAs are expressed in the CNC and that, upon
expression of fluorescent forms of the protein, they are expressed in overlapping
compartments of the CNC, we next tested whether the interaction between Fz4 and
ADAM13 affects the proteolytic activity of the latter. We tested the ability of Fz4 and
Fz4-v1 to inhibit ADAM13 cleavage of the paraxial protocadherin (PAPC) (Figure 4.4A,
Shed PAPC) and found full-length Fz4 more efficient (~100% inhibition) than secreted
Fz4-v1 (~50% inhibition). However, neither form effectively prevented self-shedding of
ADAM13 (Figure 4.4A, Shed A13). To test whether Fz4 simply prevented the interaction
of ADAM13 with PAPC, we performed co-immunoprecipitation of PAPC with
ADAM13 in the presence or absence of Fz4. The result shows that presence of Fz4 or
Fz4-v1 does not prevent binding of ADAM13 to PAPC, and suggests that Fz4 and Fz4v1 inhibit ADAM13 activity using a different mechanism (Figure 4.4B).
Because ADAM13 proteolytic activity is essential for CNC cell migration, we
hypothesized that overexpression of Fz4 should interfere with this process if both
proteins interact in vivo. Indeed, targeted overexpression of Fz4 or Fz4-v1 inhibited CNC
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cell migration (Figure 4.5A and B). To test whether Fz4 overexpression acts by inhibiting
ADAM13 protease activity we attempted to rescue CNC cell migration by
overexpressing either ADAM13 or the extracellular cleavage fragment of cadherin-11
(EC1-3). Interestingly, whereas ADAM13 and EC1-3 were capable of partially rescuing
both forms of Fz4 overexpressed, the rescue of full-length Fz4 was much more efficient
in our assay than that of the secreted Fz4-v1 (Figure 4.5A and B).
To test whether secreted Fz4-v1 inhibits migration in a cell autonomous manner
we grafted CNC expressing Fz4-v1 into wild type embryos, as well as wild type CNC
into Fz4-v1-expressing embryos (Figure 4.5C). Our results show that CNC cell migration
is only inhibited when Fz4-v1 is expressed by the CNC. Similarly, we found that mixing
cells that express Fz4-v1 with those that express ADAM13 and PAPC did not inhibit
PAPC shedding, suggesting that the secreted Fz4-v1 is unable to inhibit ADAM13
proteolytic activity on adjacent cells (Figure 4.5D). This result, taken together with the
data showing colocalization of ADAM13 with Fz4 and Fz4-v1 in mostly internal
compartments (Figure 4.2 and Figure 4.3), and the co-immunoprecipitation with the proform of ADAM13 (Figure 4.1B), suggests that the functional interaction is occurring
during the transit of ADAM13 to the cell surface. Another possibility is that PAPC is
already cleaved before both proteins (ADAM13 and PAPC) reach the surface.

Section IV: Loss of Fz4 inhibits CNC cell migration and increases ADAM13 processing!

Our results suggest that both forms of Fz4 can interact with ADAM13 and inhibit
its proteolytic activity. To test whether this is important in vivo, we performed loss-offunction experiments by knocking down Fz4 (and Fz4-v1). As previously reported
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(Gorny et al., 2013), Fz4 morpholino (MOFz4) inhibits CNC cell migration both in
grafting experiments (Figure 4.6A and B, and Movie 4.3) and targeted injection (Figure
4.6C). In targeted injections we found that we could not rescue CNC cell migration by
overexpressing ADAM13 in embryos lacking Fz4 (Figure 4.6C). In embryos, decrease of
Fz4 or Fz4-v1 (the morpholino does not distinguish between the two) results in a
decrease of the mature form of ADAM13 and an increase in the ADAM13 cytoplasmic
domain during CNC cell migration (Figure 4.7A, stage 24). We have previously shown
that the cleavage of the cytoplasmic domain by γ-secretase is preceded by an initial selfcleavage of ADAM13 within its cysteine-rich domain (Cousin et al., 2011). Our results
here suggest that, in the absence of Fz4 or Fz4-v1, ADAM13 self-processing is increased,
resulting in the decrease in the surface form of ADAM13 and a corresponding increase in
the cytoplasmic fragment. In gain-of-function experiments, when Fz4 or Fz4-v1 are
overexpressed in the embryo, we observed a reduction in the cleaved cytoplasmic
fragment of ADAM13 at stage 19 (Figure 4.7B). This reduction persists at stage 30 only
for the overexpression of Fz4-v1. In the case of Fz4, decrease of the mature ADAM13 is
observed together with that of the cytoplasmic fragment; however, this was not the case
when Fz4-v1 was overexpressed.
To confirm the role of endogenous Fz4 in ADAM13 longevity or stability, we
injected ADAM13-GFP together with membrane-bound mCherry (mb-Cherry) in
embryos, and visualized the GFP and mCherry signals in dissected CNC explants (Figure
4.7C). Whereas mb-Cherry was unaffected by Fz4 knockdown, we found that ADAM13GFP was drastically reduced following Fz4 knockdown. Given the finite amount of
mRNA encoding ADAM13-GFP, it is understandable that the results are more obvious
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than those observed for endogenous ADAM13, whose mRNA is constantly produced.
Taken together, these data support the model by which one of the roles of Fz4 or Fz4-v1
during CNC cell migration is to regulate the levels of both the active ADAM13 protease
at the surface as well as the production of cytoplasmic signaling fragment.

Section V: Chapter IV Discussion

ADAM13 and Fz4 are both essential for CNC cell migration. In the previous
chapters we demonstrated that ADAM13 has a dual role in the CNC where it controls
migration both by cleaving cadherin-11 in order to release an extracellular fragment, and
by sending its own cytoplasmic domain into the nucleus to regulate gene expression
(Cousin et al., 2011; McCusker et al., 2009). Thus, there are at least two functional forms
of ADAM13, the active protease at the cell surface (100 kDa) and the cytoplasmic
fragment within the nucleus (17 kDa). Although we know that both forms are essential, it
remains unclear how and when the cytoplasmic fragment is generated. We know that
cleavage by γ-secretase releases the cytoplasmic domain from the membrane and that this
follows an initial cleavage within the cysteine-rich domain by ADAM13 itself (Cousin et
al., 2011). In this chapter, we show that loss of Fz4 appears to increase the rate or induce
precocious processing of ADAM13, generating increased levels of the cytoplasmic
fragment with less mature protein reaching or remaining at the surface, whereas
overexpression reduces this processing. In cell culture, transfected Fz4 associates
preferentially with the pro-form of ADAM13, and appears to colocalize with ADAM13
in the ER, vesicles and at the plasma membrane. These observations suggest that Fz4
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regulates ADAM13 processing. This regulation involves a physical interaction of
ADAM13 with Fz4 through the cysteine-rich domain of ADAM13 during transit and at
the cell surface. Although this domain is also involved in binding ADAM13 substrate
(e.g. fibronectin) (Gaultier et al., 2002), we show that binding of ADAM13 to Fz4 does
not compete for binding to one of its substrates PAPC, suggesting that the proteolytic
inhibition is not due to competitive binding with the substrate.
Given that ADAM13 also binds to secreted Fz4 (Fz4-v1), this suggests that
interaction of the two proteins involves the extracellular domain of Fz4 (common to both
splicing variants). However, our results indicate that full-length Fz4 protein is more
effective at inhibiting ADAM13 self-processing and proteolytic activity than secreted
Fz4-v1. To which extent and how the cytoplasmic domain or the seven transmembrane
domains of Fz proteins are involved in the regulation of ADAM processing and activity
should be addressed in future studies. Even though Fz4 is most efficient at inhibiting
ADAM13 activity, it also reduces the ADAM13 protein level. This may explain why this
form of overexpression is rescued most efficiently following the expression of additional
ADAM13 or the cadherin-11 EC1-3 fragment. However, Fz4-v1 overexpression has little
effect on mature ADAM13 levels but does substantially reduce the processing of the
ADAM13 cytoplasmic domain. The results obtained for Fz4 knockdown, showing an
increase in the cytoplasmic fragment of ADAM13, suggest that the main form associated
with ADAM13 in the CNC is the secreted variant Fz4-v1, at least at stage 24. This would
also be consistent with the Fz4-v1 expression pattern and the fact that Fz4-v1 can rescue
CNC cell migration in Fz4 morphant embryos. The expression pattern of Fz4 shows that
it increases at the edges of the migration path towards the end of their progression. This
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increase could block ADAM13 proteolytic activity so that cadherins and other celladhesion molecules can accumulate in order to promote the integration of the CNC into
the target tissue. This process might be coordinated by expression of Fz4, which would
directly inhibit the activity of ADAM13, reduce ADAM13 protein levels and, also
indirectly, shut down ADAM13 by decreasing the activity of GSK3, a kinase required for
the nuclear function of ADAM13 (Abbruzzese et al., 2014).
Our results show that loss of Fz4 produces premature cleavage of the cytoplasmic
domain of ADAM13, together with a reduction of the mature metalloprotease at the cell
surface. In addition, loss of Fz4 inhibits CNC cell migration. Our targeted injections
suggest that ADAM13 cannot rescue CNC cell migration in embryos that lack Fz4. This
suggests that Fz4 is involved in several other roles within the CNC that remain to be
investigated. One possibility is that Fz4 KD could also affect other ADAMs, such as
ADAM9 and ADAM19 and their respective targets, and, therefore, cause part of the
phenotype that is not rescued by ADAM13. It should be noted that Fz4-v1 can also
inhibit cleavage of cadherin-11 by ADAM9 in vitro (see Appendix I, Figure A1).
Therefore, more detailed analyses of the phenotypes will be required to understand the
complete molecular pathway that depends on Fz4 during CNC cell migration.
Recently, it has been shown that furin-mediated maturation of ADAM17 and its
trafficking to the cell surface requires binding of another seven-pass transmembrane
protein, iRhom2 (also known as Rhbdf2) (Adrain et al., 2012). In addition, tetraspanin18,
another multi-spanning transmembrane protein, prevents cadherin-6B degradation prior
to neural crest cell migration in the chick embryo (Fairchild and Gammill, 2013), a
degradation that is performed by two ADAM proteins (ADAM10 and ADAM19)
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expressed in the neural crest (Schiffmacher et al., 2014). Thus, it is possible that
regulation by multiple transmembrane-containing proteins is a common feature of
ADAM metalloproteases.

Section VI: Chapter IV Materials and methods

!Antibodies!
The following antibodies were used: g821, goat polyclonal antibody against the
ADAM13 cytoplasmic domain affinity purified using ADAM13 peptide corresponding to
amino acids 821–914 (Cousin et al., 2011); g877, goat polyclonal antibody against the
ADAM13 cytoplasmic domain affinity purified using ADAM13 peptide corresponding to
amino acids 877–914; 6615F, rabbit polyclonal antibody against the ADAM13
cytoplasmic domain (Alfandari et al., 1997); 4A7, mouse monoclonal against the
ADAM13 cytoplasmic domain; 7C9, mouse monoclonal against the ADAM13 cysteinerich domain (Gaultier et al., 2002); PAPC, mouse monoclonal against the extracellular
domain (Chen and Gumbiner, 2006); 8C8, monoclonal antibody against β1 integrin
(Gawantka et al., 1992); 9E10, mouse anti-Myc monoclonal (ATCC). Rabbit polyclonal
antibodies against Fz4-v1 were obtained by immunizing two rabbits with a peptide
(STNAQLTRRPYSYA conjugated to LPH) specifically recognizing the v1 transcript.
The antibodies were affinity purified with the peptide before use.

Morpholinos and DNA constructs
Morpholino antisense oligonucleotides (Gene Tools) against Fz4/Fz4-v1 and ADAM13

!

86!

have been described previously (Cousin et al., 2011; Gorny et al., 2013). pCS2-Fz4/Fz4v1 with and without Myc-tag were linearized with NotI (Fermentas) and in vitro
transcribed using Sp6 RNA Polymerase (Ambion) (Gorny et al., 2013). Fz4-RFP was
made by cloning RFP-Flag-tag downstream of Fz4 between the EcoRI and XbaI sites
previously used to introduce the Myc-tag. ADAM13 and cadherin-11 constructs have
been previously described (Alfandari et al., 2001; Gaultier et al., 2002; McCusker et al.,
2009). ADAM13-GFP was made by replacing the Myc-tag of ADAM13-MT (Alfandari
et al., 2001) with GFP from the pCS2mt-UGP cut at Cla1 and Not1 (generous gift from
Mike Klymkowsky, University of Colorado, Boulder, CO).

Embryo injections and manipulations
Xenopus laevis embryos were obtained, and cultured as described previously (Gorny et
al., 2013). For Fz4 loss-of-function grafts, 250 pg of GFP mRNA was injected alone or
together with 18.75 ng of MOFz4 into one cell at the 2-cell stage. For gain-of-function
grafts, 334 ng of GFP mRNA was injected alone of together with 666 ng of Fz4-v1
mRNA into one cell at the 2-cell stage. Fluorescently labeled CNC cells were grafted into
non-injected host embryos at stage 15, prior to migration. For targeted injections,
embryos were injected into a single CNC precursor cell (dorsal-animal blastomere) at the
8-cell stage. For gain-of-function, 200 pg RFP was injected alone or with 100 pg Fz4 or
300 pg of Fz4-v1 mRNA, plus 300 pg ADAM13 or EC1-3 mRNA. In the loss-offunction targeted injections, 200 pg RFP mRNA, 10 ng MOFz4, and 300 pg ADAM13
mRNA were used. All embryos were raised at 15°C until tail-bud stage (stage 24–27)
when they were scored for inhibition of CNC cell migration by the absence of GFP- or
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RFP-positive cells within the migration pathways. To examine ADAM13 protein levels
in Fz4-knockdown or -overexpressing embryos, 25 ng MOFz4 or 10 ng MO13 was
injected at the 1-cell stage, or 300 ng RFP, Fz4 or Fz4-v1 mRNA was injected into both
dorsal cells at the 4-cell stage. Embryos were raised at 15°C and frozen at various stages
for later processing. To observe ADAM13-GFP fluorescence in CNC explants, embryos
were injected at the 2-cell stage with 200 pg ADAM13-GFP and 200 pg membranebound mCherry (mbCherry) mRNA, and 12.5 ng MOFz4.

Real-time PCR
Non-injected embryos were raised at 15°C until stage 17, at which point CNC cells were
dissected from ten embryos. Total RNA was extracted from ten CNC or three sibling
embryos at the same stage (High Pure RNA Tissue kit, Roche). PolyA mRNA was
purified on oligo-dT cellulose (Qiagen) and cDNA was synthesized using qScript cDNA
kit (Quanta), both according to manufacturer’s instruction. Fz4 and Fz4-v1 primers were
tested for specificity. Primer sequences are as follows are listed in Table 4.1.

Double in situ hybridization
!For double in situ hybridization (double ISH), Digoxigenin (DIG)- and Fluoresceinlabeled antisense RNA probes were synthesized using the respective RNA polymerases
and Labeling Mix from Roche according to manufacturer’s instructions. Double ISH was
carried out as described for normal ISH (Gorny et al., 2013) with the following
modifications. Embryos were hybridized simultaneously by using the DIG- and the
Fluorescein-labeled antisense probes. First, the DIG-probe was detected and stained in
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blue as described. When the desired staining was achieved, the reaction was stopped by
washing in PBS, 0.1% Tween-20 and embryos were refixed for 1 hr at room temperature
(RT), followed by 1 hr EDTA (5 mM in PBS) treatment at 60°C and six 10-min washes
at RT in PBS, 0.1% Tween-20. Blocking and second antibody reactions were carried out
as described for the DIG-probe but by using an anti-Fluorescein antibody (Roche). After
washing, the Fluorescein-labeled probe was visualized using the FastRed tablets (Sigma)
according to the manual. Pictures were taken with an Olympus SZX12 stereomicroscope
(with U-RFL-T UV-light) using a CC12 camera and software analySIS (Soft Imaging
Systems).

Cell culture and transfection
Co-immunoprecipitation experiments were performed in HEK293T obtained from ATCC
and transfected with XtremeGENE HP (Roche) according to manufacturer’s instructions.
Total cellular protein was extracted in TBS containing 1% Triton X-100, 5 mM EDTA,
1x Halt Protease and Phosphatase Inhibitor Cocktail (Thermo Scientific) and
immunoprecipitated for either ADAM13 or Fz4. PAPC shedding and cadherin-11
cleavage assays were performed in COS-7 and HEK293T cells (ATCC). For PAPC
shedding, COS-7 cells were incubated with medium containing 2% serum 24 hr after
transfection, and conditioned supernatants were collected at 48 hr. The cellular proteins
were extracted in reducing Laemmli buffer and blotted for ADAM13, Fz4 or PAPC. The
shed extracellular domains were purified using concanavalin-A–agarose beads (Vector)
overnight at 4°C, eluted in reducing Laemmli buffer and blotted using antibodies against
PAPC or 7C9. To test the cleavage of PAPC in trans, HEK293T cells were transfected
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with ADAM13 and PAPC, or either RFP or Fz4-v1. At 24 hr after transfection, cells were
resuspended in medium containing 2% serum, and the ADAM13 plus PAPC cells were
mixed with the cells expressing RFP or Fz4-v1. At 48 hr, the conditioned supernatants
were collected and purified for shed PAPC or ADAM13 as described above.

Fluorescence
CNC explants from embryos injected with the various mRNAs (ADAM13- GFP, Fz4RFP, Fz4-v1-RFP, mbCherry) were dissected and placed on a glass-bottomed dish
(Matek Corp) coated with gelatin (1 mg/ml) followed by fibronectin (20 mg/ml). Low
magnification photographs (Fig. 5) were obtained using an Axiovert200M fluorescence
microscope (Zeiss) with a 20x objective, 5 hr after dissection of the explants. Highmagnification photographs (Fig. 2) were obtained using a Nikon spinning disc confocal
with a 60x objective. To identify subcellular compartments, Xenopus XTC cells were
transfected with the various fluorescent constructs, plated on fibronectin-coated (10
mg/ml) glass-bottomed dishes (In Vitro Scientific) and incubated for 30 min in 1xMBS
with ER-tracker (blue), Lyso-tracker (blue) or WGA (blue), all from Molecular probes.
Cells were rinsed once with 1xMBS and once with complete XTC medium (67% L15,
10% FBS, 2 mM L-Glutamine, pen/strep, sodium pyruvate). Photographs were taken
using a Zeiss 200M inverted microscope equipped with an Apotome and a 63x oilimmersion lens to obtain optical sections. For in vivo CNC cell migration assays,
embryos were imaged using a Zeiss Stereo Lumar fluorescent stereoscope.

!

90!

!

Figure 4.1: ADAM13 binds to Fz4 and Fz4-v1. (A) Co-immunoprecipitation (IP) experiments
of Fz4 and Fz4-v1 with ADAM13. HEK293T cells were transfected with the various constructs
cloned into the pCS2+ vector alone or in combination. ADAM13 was IP using the cytoplasmic
domain antibody g821, and Myc-tagged (mt) Fz4 constructs were detected with mAb 9E10. Fz4mt and Fz4-v1-mt co-precipitate with ADAM13 only when both proteins are co- transfected.
Bands observed in lanes 2 and 3 of the total extract blotted with ADAM13 are non-specific. (B)
Schematic diagram of mature ADAM13 including the metalloprotease (M), disintegrin (D),
cysteine-rich (C), EGF repeat (E) and the cytoplasmic (Cy) domain. In co-IP experiments using a
rabbit polyclonal antibody to the Fz4-v1 protein, all ADAM13-mt constructs containing the
cysteine-rich domain were co-precipitated, while the disintegrin domain alone was not (D). (C)
Real-time PCR on dissected CNC and stage-matched whole embryos (Total), detecting the level
of Slug, Fz4, or Fz4-v1 expression, represented as a percentage of GAPDH expression. The
average cycle threshold (CT) values in the CNC were as follows (Slug 24.7, Fz4 28.3, Fz4-v1
29.7, GAPDH 23.9). No CT was seen for water or no RT control. Error bars represent the SD. (D)
Double in situ hybridization using short probes recognizing Fz4 or Fz4-v1 (blue) as well as
probes recognizing the two CNC markers Sox10 and Twist (both red). The arrowheads point to
the tip of the CNC segment. Scale bar: 500 mm. In situ hybridization for ADAM13 is presented
as a reference marker (A13). The experiments described in (B) were performed by I.Kleino and in (D) by
L. Kaufmann. This figure was published in (Abbruzzese et al., 2015).
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Figure 4.2: Fz4 colocalizes with ADAM13 in CNC cells. ADAM13-GFP, Fz4- RFP and Fz4-v1
RFP were expressed in CNC explants placed on fibronectin substrate. The fluorescence was
detected using a spinning disc confocal acquiring every 2 seconds for one minute. Frames from
each movie were extracted and annotated. ADAM13-GFP colocalizes with Fz4-RFP in vesicles
(boxed areas and arrowhead) 10 mm from the fibronectin substrate (upper panel). At the plasma
membrane in contact with the substrate, ADAM13-GFP colocalizes with Fz4-RFP in both
vesicles (arrowheads) and at the membrane (arrow, middle panel). ADAM13-GFP is detected in
close association with Fz4-v1 in membrane protrusions in direct contact with the fibronectin
substrate (boxed areas, lower panel). This experiment was performed by myself and D. Alfandari. This
figure was published in (Abbruzzese et al., 2015).
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Figure 4.3: Expression of ADAM13-GFP, Fz4-RFP and Fz4-v1-RFP in XTC cells using
optical sections by structured illumination. Markers (in blue) for the lysosome (Lysotracker),
endoplasmic reticulum (ER-tracker), Golgi (WGA) are also presented. This experiment was
performed by D. Alfandari. This was a supplementary figure published in (Abbruzzese et al., 2015).
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Figure 4.4: Fz4 inhibits ADAM13 proteolytic activity. (A) Western blot showing the cleavage
of the proto-cadherin PAPC by ADAM13. The medium from transfected cells was collected and
glycoproteins purified using concanavalin-A-agarose beads (ConA). The extracellular fragment
of PAPC (60 kDa) is present when ADAM13 is co-transfected (lane 1) but absent when the
protease dead ADAM13-E/A is used (lane 2). Co-transfection of Fz4-v1 decreases PAPC
cleavage by about 50%, whereras Fz4 completely inhibits the cleavage (compare lanes 1, 3 and
4). Neither form inhibits ADAM13 self-shedding. (B) Co-immunoprecipitation of ADAM13 and
PAPC. ADAM13 was co-transfected either with PAPC, Fz4-mt or Fz4-v1-mt alone, or in various
combinations. ADAM13 was immunoprecipitated (IP) with g877 antibody and associated PAPC
and Fz4 or Fz4-v1 were detected by western blot. Fz4 and Fz4-v1 do not compete for the binding
of PAPC to ADAM13 (compare lanes 1 with 3, 4 and 6). This figure was published in (Abbruzzese et
al., 2015).
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Figure 4.5: Overexpression of Fz4 inhibits CNC cell migration. (A,B) Histogram representing
the percentage of embryos with no fluorescent CNC cells in the migration pathway following
targeted injection at the 8-cell stage in one dorsal animal blastomere (% inhibition of CNC cell
migration). Values are normalized to injection of RFP alone. (A) Injection of Fz4 inhibits
migration and can be rescued by either ADAM13 or the cadherin-11 extracellular fragment EC13. Student’s t-test was performed to compare % inhibition to Fz4 alone. (B) Similarly, injection
of Fz4-v1 inhibits migration, and can be partially rescued with ADAM13, the extracellular
domain of cadherin-11 (EC1-3) and ADAM13 lacking the cytoplasmic domain (Δcyto). Student
t-tests were used to compare values to Fz4-v1. (C) Fluorescently labeled CNC cells were grafted
to determine whether the inhibition of CNC cell migration was cell autonomous. CNC cells
overexpressing Fz4-v1 do not migrate. Wild type CNC cells grafted into embryos overexpressing
Fz4-v1 in the pathway migrated similar to control. (D) Western blot from HEK293T cells
transfected with ADAM13, or the non-proteolytic mutant of ADAM13 (E/A) and PAPC. These
cells were mixed with cells transfected with Fz4-v1 or RFP and incubated together for 24 hr. The
conditioned supernatant, which contains Fz4-v1, does not inhibit ADAM13 cleavage of PAPC.
*P<0.05, ***P<0.001. n: number of embryos scored from three or more independent
experiments. Error bars represent SD. ns, not significant. The grafts described in (C) were performed
by H. Cousin. This figure was published in (Abbruzzese et al., 2015).
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Figure 4.6: Loss of Fz4 inhibits CNC cell migration. (A) Representative embryos grafted with
fluorescent CNC cells from control embryos (GFP) or embryos injected with the Fz4 morpholino
(MO Fz4). Scale bar: 500 µm (B) Histogram representing the percentage of embryos without
CNC cell migration following the grafts. (C) Histogram representing the percentage of embryos
without CNC cell migration following targeted injection. Loss of Fz4 inhibits CNC cell migration
and is not significantly rescued by the overexpression of ADAM13. n: total number of embryos.
Asterisks represent statistical significance obtained by using student’s t-test. ***P<0.001, ns: not
significant. At least three independent experiments were performed. Error bars represent SD. The
grafts in part (A) and (B) were performed by H. Cousin. This figure was published in (Abbruzzese et al.,
2015).
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Figure 4.7: Loss of Fz4 affects ADAM13 processing. (A) Western blot of ADAM13 at various
stages of embryo development (stage 19 to 30). Embryos were injected with the Fz4 morpholino
(+) or the ADAM13 morpholino (MO13, last lane) to visualize the specific bands. In control
embryos the pro-form (P, 120 kDa), the mature form (M, 100 kDa) and the cytoplasmic domain
(Cyto, 17 kDa) are visible, whereas these are absent in MO13 embryos. There is no difference of
processing at stage 19. At stage 24, the mature form of ADAM13 decreases while the
cytoplasmic domain increases in MOFz4 injected embryos (red line). At stage 30 the decrease of
the mature form is still obvious, whereas there is no visible difference for the cytoplasmic domain
fragment. The b1 integrin subunit was used as a loading control. (B) Western blot for ADAM13
in embryos injected with RFP, Fz4 or Fz4-v1 mRNA. Embryos injected with the morpholino to
ADAM13 (MO13) serve as a control for the antibody specificity. At stage 19 embryos expressing
Fz4 or Fz4-v1 show less ADAM13 cytoplasmic domain fragments (Cyto, 47% and 23%,
respectively). At this stage Fz4 also reduces the mature form of ADAM13 (M, 58%), whereas
Fz4-v1 does not. At stage 30, Fz4-v1 injected embryos have almost no cytoplasmic domain
fragment, whereas the mature form is not affected. (C) Representative example of dissected CNC
expressing ADAM13-GFP and mb-Cherry (total of eight explants for each condition). ADAM13
GFP is clearly present in control CNC, whereas it is undetectable in CNC injected with MO Fz4.
The morpholino has no effect on mb-Cherry expression. The experiments in part (A) and (C) were
performed by D. Alfandari. This figure was published in (Abbruzzese et al., 2015).
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Table 4.1: Chapter IV real time quantitative PCR primers. Sequences of primers used to
quantify Fz4 and Fz4-v1 expression in the CNC.
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CHAPTER V
ADAM13 PROCESSING OF CADHERIN-11 IS ESSENTIAL FOR CNC
MIGRATION
Abstract
While the previous chapters have focused on either the intracellular signaling
activity of ADAM13, or mechanisms for regulating the protein, this chapter investigates
the extracellular role of ADAM13. The lab has previously shown that in the CNC,
ADAM13 cleaves the cell adhesion molecule cadherin-11. Interestingly, this cleavage
generates a shed extracellular fragment of cadherin-11 (EC1-3) that possesses promigratory activity via an unknown mechanism. In this chapter, we confirm that cleavage
of cadherin-11 to generate EC1-3 is indeed essential to promote cell migration, and we
further investigate the mechanism by which EC1-3 functions. Since EC1-3 retained the
homophilic binding site that normally enables cadherin-mediated cell-cell adhesion, a
prominent question that stood out was whether EC1-3 interacts with full-length cadherin11 to disrupt its adhesive activity, or another receptor to activate a promigratory signaling
pathway. Here we show that while the integral cadherin-11 requires its homophilic
binding site to promote CNC migration in vivo, the EC1-3 fragment does not. Our results
indicate that EC1-3 does not act as a competitive inhibitor of cadherin-11 adhesion but
instead stimulates migration through a different receptor on the surface. The identity of
this receptor remains unknown, but potential partners of EC1-3 in the CNC will be
discussed further in Chapter VI.
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Section I: Introduction

The CNC undergoes two phases of migration: an initial cohesive phase where the
cells migrate collectively as a group of cells, followed by a transition into single cell
migration to reach their final destinations (Alfandari et al., 2003; Alfandari et al., 2010;
Sadaghiani and Thiebaud, 1987). This requires a dynamic regulation of cell adhesion,
which occurs mainly through the expression and activity of cadherins. Cadherins are
calcium-dependent transmembrane proteins that contain an adhesive homophilic binding
site in the extracellular domain, allowing two cadherins of the same type to form a tether
between two cells. The intracellular domain of the classical cadherins also contains
binding sites for p120-catenin and forms a connection to the cytoskeleton through direct
interactions with β-catenin, which links to actin through α-catenin.
In Xenopus, the classical cadherins N-cadherin and cadherin-11 are both
expressed in the CNC (Hadeball et al., 1998; Theveneau et al., 2010; Vallin et al., 1998).
Multiple studies have demonstrated that the mesenchymal cadherin-11 is required for
proper CNC cell migration and that its levels have to be tightly regulated. Either
depletion or overexpression of cadherin-11 is sufficient to block CNC migration in vivo
(Borchers et al., 2001; Kashef et al., 2009; McCusker et al., 2009). One aspect of
cadherin-11 function in the CNC is likely maintaining cell-cell adhesion, although this
has not yet been clearly demonstrated. Evidence for this role comes from studies showing
that replacing the endogenous cadherin-11 with a mutant lacking the adhesive site blocks
cell migration, while overexpressing this non-adhesive form in the CNC also inhibits
migration, in which case it is presumed to be acting as a dominant negative of cadherin-
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11-mediated cell-cell adhesion (Becker et al., 2013). It is clear, however that cadherin-11
function in the CNC extends beyond regulating cell-cell adhesion. Several unexpected
roles include promoting protrusion formation through its cytoplasmic domain via an
interaction with the guanine nucleotide exchange factor GEF-Trio, as well as controlling
proliferation rates through binding and sequestering β-catenin to suppress the Wnt
pathway (Borchers et al., 2001; Kashef et al., 2009; Koehler et al., 2013; McCusker et al.,
2009). In addition, Dr. Kashef’s lab recently showed that cadherin-11 plays a role in
mediating cell-cell contacts during contact inhibition of locomotion (CIL; (Becker et al.,
2013), a mechanism that is important for the directional migration of CNC cells
(Carmona-Fontaine et al., 2008). During CIL, cell-cell contacts are initiated by cadherins,
which then modify RhoA/Rac1 activity through the non-canonical Wnt/PCP pathway
(Becker et al., 2013; Carmona-Fontaine et al., 2008; Theveneau et al., 2010). This in turn
affects the polarization of the cytoskeleton and leads to a change of migration direction
after the collision. The process allows collectively migrating cells to define a cell-free
edge at which most of the protrusive activity is concentrated. This enables the leading
cells to persistently migrate ventrally away from the group and into their designated
pathways, after which the trailing cells will follow the leader cells (Figure 5.1).
Importantly, loss of cadherin-11 in the CNC or overexpression of the homophilic
binding-deficient variant causes defects in CIL, suggesting that the extracellular function
of cadherin-11 is essential for CIL (Becker et al., 2013; Kashef et al., 2009).
One method for the regulation of cadherin-11 levels or activity in the CNC is by
ADAM13-mediated processing of the extracellular domain (McCusker et al., 2009). In
this study, it was shown that the inhibition of migration due to overexpressing cadherin-
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11 in the CNC could be relieved by co-expressing ADAM13 (McCusker et al., 2009).
Cadherin-11 contains five extracellular repeats (EC1-5), which have immunoglobulinlike folds separated by flexible linkers, followed by the transmembrane and cytoplasmic
domains. The membrane-distal EC1 contains the adhesive site, consisting of two
conserved tryptophan residues and the QAV motif. Based on predicted molecular
weights, it was estimated that ADAM13 cleavage of cadherin-11 occurs between EC3
and EC4 and would therefore eliminate the homophilic binding site from the
transmembrane stump. Thus, a likely hypothesis for how cadherin-11 processing
promoted migration was simply that it directly reduced cell-cell adhesion by removing
the cadherin-11 adhesive domain. However, the story became more interesting when it
was discovered that in the absence of cadherin-11 cleavage (either by overexpression of
cadherin-11 or the knockdown of ADAMs in the CNC), cell migration could be restored
by expressing an artificial cleavage fragment of cadherin-11 (EC1-3) (McCusker et al.,
2009). This suggested that after EC1-3 was shed from the surface, it retained biological
function and could go on to promote cell migration, indicating a more complex model
than simply eliminating the adhesive ability of cadherin-11.
Several possibilities for the mechanism of action of EC1-3 were proposed
(depicted in Figure 5.2) including a competitive inhibition model whereby EC1-3, which
retains the homophilic binding site, binds to a full-length cadherin-11 molecule to prevent
it from participating in cell-cell adhesion (McCusker et al., 2009). Alternatively, EC1-3
could be binding to another receptor on the cell surface to activate a signaling pathway
that would stimulate cell migration. The aim of the project presented in this chapter is to
distinguish between these two models by mutating the adhesive site in EC1-3 to
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determine if homophilic binding is required for its pro-migratory activity. In addition, we
collaborated with Dr. Kashef’s lab to investigate whether the role of cadherin-11 in CIL
was mediated by shed EC1-3 fragment, or if this activity was restricted to the full-length
protein. The results presented in the following sections are from a manuscript that is
currently in revision at Developmental Biology (Abbruzzese et al., in revision). I
performed all of the experiments in this chapter, with the exception of Figure 5.6, which
was performed and analyzed by a member of the Kashef lab.

Section II: Cadherin-11 cleavage is required for CNC migration

We have previously shown that cleavage of cadherin-11 by ADAM13 stimulates
CNC migration. ADAM13 cleaves cadherin-11 in vitro and in vivo. In the CNC,
overexpression of cadherin-11 blocks migration, and this can be rescued by increasing
the levels of ADAM13 or by expressing an artificial extracellular cleavage fragment of
cadherin-11 (EC1-3), which is normally generated by ADAM13. Furthermore, the triple
knockdown of ADAM9, 13 and 19 can also be rescued by expressing EC1-3 (McCusker
et al., 2009), suggesting that cleavage is important to generate an active soluble cadherin11 fragment. However, attempts to prevent cleavage by mutating the predicted cleavage
site in the linker region between extracellular repeats 3 and 4 were unsuccessful (data not
shown). Based on the hypothesis that cleavage specificity was structural rather than
sequence-specific, we used an alternative strategy of misaligning the protease active site
of ADAM13 and the putative extracellular cadherin-11 cleavage site. Using protein
modeling, we predicted the extracellular repeats of cadherin-11 to be approximately 50 Å
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and an EGF-like repeat to be 30 Å. Thus, by inserting the ADAM13 EGF-like repeat
immediately N-terminal to the cadherin-11 transmembrane domain (C11-egf), the linker
region between EC3 and EC4 would presumably be raised by 30 Å relative to the plasma
membrane and the protease active site would then instead be in line with the globular
domain of EC4 (Figure 5.3A). When transfected into Cos-7 cells, wild-type cadherin-11
is cleaved by ADAM13 but not by the inactive ADAM13-E/A mutant (Figure 5.3B).
However, when C11-egf is co-expressed with ADAM13, cleavage does not occur, as
shown by the absence of the cleaved protein fragment that remains in the membrane
(Figure 5.3B).
Overexpression of cadherin-11 inhibits CNC cell migration due to both increase
in cell adhesion and association with β-catenin (Borchers et al., 2001). To test if the C11egf construct was functional in the CNC, we first performed a targeted injection in which
a single CNC precursor (dorsal animal blastomere) is injected at the 8-cell stage with a
lineage tracer, red fluorescent protein (RFP), to follow the migration of CNC cells
(Abbruzzese et al., 2014; Cousin et al., 2011; Cousin et al., 2012). At the tailbud stage,
embryos are scored for the presence of fluorescent cells in the CNC migration pathways,
and for each condition the percentage of embryos without migration is normalized to the
injection of RFP alone (% inhibition of CNC migration). Overexpression of either wild
type cadherin-11 or C11-egf inhibits migration in 38% and 40% of embryos, respectively
(Figure 5.4A and B). The inhibition observed for C11-egf suggests that the protein is still
functional as it can block CNC cell migration as well as the wild-type protein. While
migration defects due to overexpression of wild-type cadherin-11 can be rescued by coexpressing ADAM13, overexpression of the non-cleavable C11-egf could not be rescued
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by ADAM13 (Figure 5.4A and B). We then designed a new variant of ADAM13 that
contains one extra copy of its EGF-like domain (A13-egf), so that the extracellular
domains of C11-egf and A13-egf are each raised from the membrane by a similar
distance. With this construct, we do observe a significant rescue of migration when
expressed with C11-egf in the CNC, suggesting that A13-egf is able to cleave C11-egf.
Next we sought to determine if cleavage of cadherin-11 is essential for CNC cell
migration by replacing the endogenous cadherin-11 with the non-cleavable C11-egf. In a
targeted injection assay, we injected a morpholino against cadherin-11 (MO11) to prevent
translation of the endogenous protein, which blocked migration in 40% of the embryos
(Figure 5.4C and D), consistent with previous results (Kashef et al., 2009). CNC
migration is significantly restored by co-injecting MO11 with mRNA encoding a
morpholino-resistant cadherin-11. However, expression of C11-egf in the MO11
background leads to migration defects similar to MO11 alone (Figure 5.4C). Taken
together, these results demonstrate that cleavage of cadherin-11 by ADAM13 is essential
for its function during CNC cell migration.

Section III: Increase of ADAM13 expression leads to higher CNC invasiveness and
blocks repulsive response in single colliding CNC cells

As cadherin-11 mediated cell-cell adhesion promotes CIL and is important for the
directional migration of CNC in vivo (Becker et al., 2013), we hypothesized that
ADAM13 might play a role in CIL. To test this hypothesis, we performed explant
confrontation assays in vitro (Becker et al., 2013; Carmona-Fontaine et al., 2008). In wild
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type explants, CIL prevents the mutual invasion of CNC cells (Carmona-Fontaine et al.,
2008). By confronting explants injected with two different lineage tracers (RFP and
GFP), it is possible to quantify the degree of overlap of the two explants (overlapping
index, OI, defined as the quotient of the explant overlapping area (yellow) and the
normalized area of one explant (red or green) at the time point of highest invasion Δt
(Becker et al., 2013). Inhibition of CIL increases the invasiveness of the explants
resulting in an increase of the OI.
Fluorescently labeled wild-type CNC explants show characteristic CIL with a
small OI (10.4%, Figure 5.5A, G; Movie 5.1). Interestingly both ADAM13 KD (Figure
5.5B, OI=11.4%) and cadherin-11 overexpression (Figure 5.5C, OI=11%) were not
significantly different from the wild-type CNC (Movies 5.2 and 5.3). In contrast,
overexpression of ADAM13 (Figure 5.5D, OI=24%) or the cadherin-11 cleavage
fragment EC1-3 (Figure 5.5E, OI=28.5%) showed significantly higher invasion
suggesting that CIL was inhibited in these explants (Movies 5.4 and 5.5). We then tested
whether this inhibition of CIL depends on the presence of a functional homophilic
binding site on the EC1-3 fragment. The homophilic interaction occurs by a “β-strand
swapping” mechanism where the two amino-terminal tryptophan residues from each
cadherin-11 molecule extend into the large hydrophobic QAV pockets of the partner
molecule (Patel et al., 2006). Mutating the two tryptophan residues to alanine and
replacing the alanine of the QAV motif with methionine (QMV) is sufficient to disrupt
these interactions (Tamura et al., 1998). In the confrontation assay, expression of the nonadhesive mutant of EC1-3 (na-EC1-3) in one of the explants did not increase cell
invasion (Figure 5.5F and Movie 5.6, OI of 11.3%).
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To confirm our results in single CNC cells we used a collision analysis assay
(Becker et al., 2013). Wild-type CNC cells change direction after a collision with another
CNC cell as demonstrated by relative velocity analyses (Figure 5.6A, original vector in
red). Although depletion of ADAM13 (Figure 5.6B) or overexpression of cadherin-11
(Figure 5.6C) leads to formation of larger and longer lasting CNC cell clusters in vitro,
single cells show typical CIL response and change of migration direction after the
collision. In contrast, collisions of two CNC cells overexpressing either ADAM13 or
EC1-3 lead to minimal change of direction upon contact (Figure 5.6D and E,
respectively). Again, this suggests that increased ADAM13 expression or expression of
the cleavage fragment of cadherin-11 interferes with CIL in single CNC cells. Expression
of the non-adhesive fragment na-EC1-3, however, did not perturb single cell repulsion
(Figure 5.6F).
Taken together, these results demonstrate that ADAM13 can modulate CIL.
Given that the proteolytic fragment of cadherin-11 (EC1-3) produces the same effect as
ADAM13 overexpression it is likely that ADAM13 decreases CIL by cleaving cadherin11 and producing the EC1-3 fragment. The presence of the homophilic site on the EC1-3
is critical, suggesting that it may act as a competitive inhibitor for cadherin-11-mediated
cell-cell adhesion during CIL. Interestingly, the loss of ADAM13 function leads to
normal CIL in vitro indicating that migration defects due to higher levels of cadherin-11
or loss of ADAM13 in vivo are not due to a defect in CIL.

!

107!

Section IV: EC1-3 promotes CNC migration independently of the homophilic binding
site

The previous results suggest that EC1-3 can act as a competitive inhibitor of
cadherin-11 in CIL and that this function requires the homophilic binding site. We next
tested if the same site was also critical to promote CNC migration in vivo. Using the
targeted injection assay, we first investigated which EC repeats of the shed cadherin-11
fragment are required to promote CNC migration. Thus, we generated truncations of
EC1-3 that included either only EC1, or EC1 and EC2 (EC1-2). We found that EC1 alone
was not sufficient to rescue CNC migration defects that are due to overexpression of
cadherin-11 (23.7% inhibition compared to 33.5% inhibition for overexpression of
cadherin-11 alone; Figure 5.7). However, EC1-2 was able to rescue the migration defects
similar to EC1-3 (4.4% and -0.2% inhibition, respectively; Figure 5.7). It is important to
note that a negative inhibition number for EC1-3 shows that the protein tested can not
only rescue the overexpression of full-length cadherin-11 but also actually increase CNC
migration, something that was also seen previously (McCusker et al., 2009).
We then asked whether homophilic interactions of cadherin-11 are required to
promote CNC cell migration. Our results show that in embryos overexpressing cadherin11 in the CNC (33.8% inhibition), migration can be significantly recovered by coexpressing either wild type EC1-3 (9.3% inhibition) or the non-adhesive mutant, na-EC13 (12% inhibition; Figure 5.8A and B). This was also true for the overexpression of C11egf, where the inhibition of CNC migration was restored to 4.9% with co-expression of
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EC1-3, and 1.4% with na-EC1-3, compared to 32.3% inhibition for overexpression of
C11-egf alone (Figure 5.8 A and B).
We then used the non-cleavable cadherin-11 (C11-egf) to test if the homophilic
binding site was required both in the transmembrane and the extracellular fragment. For
this we used the morpholino to cadherin-11 with various combinations of the rescue
mRNA. As seen previously, C11-egf cannot rescue CNC migration by itself but can
when co-injected with the EC1-3 (Figure 5.8C and D). Surprisingly, this rescue is also
achieved by the na-EC1-3 showing that the homophilic binding site is not required once
cadherin-11 is cleaved. In contrast, the same mutation present on the full-length cadherin11 (na-C11) renders the protein incapable of rescuing migration whether the EC1-3 is
provided or not (Figure 5.8C and D).
Taken together these results show that cadherin-11-mediated cell-cell adhesion
supported by the homophilic binding site is essential for CNC migration in vivo.
However, once cleaved by ADAM13, the extracellular fragment of cadherin-11 does not
rely on homophilic binding for its activity. Additionally, our results suggest that the
target receptor of EC1-3 is not cadherin-11 or at least not the classical binding site.

Section V: Chapter V Discussion

Increased levels of cadherin-11 are implicated in both natural and disease-related
cell migration and invasion. For example it plays a critical role in trophoblast cell
invasion during implantation (Getsios and MacCalman, 2003; Peng et al., 2015) as well
as during cancer cell migration and invasive metastasis (Huang et al., 2010). On the
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extracellular side, cleavage of the extracellular domain of cadherin-11 by ADAM13
promotes CNC cell migration via an unknown mechanism (McCusker et al., 2009). In
this chapter, we investigated the domains of cadherin-11 that are critical for its function
when inserted into the plasma membrane or after shedding by ADAM13 to provide new
insight about the mechanism by which the extracellular fragment of cadherin-11 can
promote cellular migration, a role that is likely conserved in other invasive cells.
It was originally proposed that cleavage of cadherin-11 by ADAM13 could
promote migration in multiple ways. First, by removing the homophilic domain (EC1)
from the plasma membrane it should decrease cell-cell adhesion. Second, the released
EC1-3 fragment could also act as a competitive inhibitor, binding to intact cadherin-11
and further decreasing the cell-cell adhesion. Finally, the released EC1-3 could bind to a
signaling receptor on the surface of CNC to promote cell migration. Here, we engineered
a non-cleavable form of cadherin-11 in addition to mutating the homophilic site
exclusively on the transmembrane or the shed form of cadherin-11, to test these various
possibilities.
By replacing endogenous cadherin-11 with the non-cleavable cadherin-11 (C11egf) we demonstrated that cleavage is absolutely essential for CNC migration.
Furthermore, expressing the EC1-3 together with the non-cleavable cadherin-11 fully
rescued migration even when the homophilic binding site was mutated (na-EC1-3),
demonstrating that once shed, the cadherin-11 fragment promotes migration by a
mechanism independent of homophilic competition. On the other hand, exchanging the
endogenous cadherin-11 with full-length cadherin-11 containing a mutated homophilic
domain did not rescue migration even in the presence of a wild type EC1-3, clearly
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demonstrating the absolute requirement of the homophilic binding on the integral
cadherin-11 form. While this confirms previous results showing that non-adhesive
cadherin-11 could not substitute for the endogenous protein (Becker et al., 2013), our
results further define which form (integral) requires the homophilic binding domain.
The results presented in this chapter point to a model in which the EC1-3 binds to
an unknown receptor at the surface of the CNC to promote cell migration. Other
cadherins have also been shown to be cleaved and promote cell migration. For example,
ADAM10 cleaves N-cadherin and promotes glioblastoma cell migration (Kohutek et al.,
2009). In addition the cleavage of N-cadherin releases a pool of β-catenin from the
membrane to the cytoplasm increasing β-catenin downstream target genes (Reiss et al.,
2005). Furthermore, cleavage of E-cadherin by ADAM15 produces an extracellular
fragment that binds to the EGF receptor Her2 and Her3 and can promote signaling
throught the Erk pathway (Najy et al., 2008). In squamous cell carcinoma the E-cadherin
extracellular fragment binding to EGF- and IGF1- receptors, stimulates both MAPK and
AKT pathway promoting cell migration and invasion (Brouxhon et al., 2014). Thus, it
seems that shed cadherin fragments are widely used to promote cell migration and
invasion in both natural (neural crest) and pathological (cancer) processes, although the
role of the homophilic binding site was not tested in these studies. Further work will be
required to define the signaling pathway stimulated by the cadherin-11 extracellular
fragment in the CNC in vivo.
Cadherin-11 has also been shown to mediate contact inhibition of locomotion
(CIL) during CNC migration (Becker et al., 2013). Together with N-cadherin, cadherin11 engagment at the surface of CNC prevents cell invasion and promotes a change in
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direction when two neural crest cells interact. Our results show that ADAM13 activity
can reduce CIL. Given that the cleavage product of cadherin-11 by ADAM13 (EC1-3)
also decreases CIL, it is likely that the observed decrease of CIL by ADAM13 is due to
ADAM13 cleavage of cadherin-11. Obviously we cannot eliminate the possibility that
ADAM13 overexpression also affects other cell adhesion molecules that could account
for the inhibition of CIL. In particular N-cadherin has been shown to play an essential
role in CIL (Theveneau et al., 2010) and Xenopus ADAM13 can cleave N-cadherin in
vitro (unpublished observation). It is also possible that ADAM13-induced decrease of
CIL is due to a protease independent function, for example a role of the adhesive
disintegrin and cysteine-rich domains or the cytoplasmic domain, but this is less likely
given the ability of EC1-3 to produce the same phenotype. Our results also suggest that
the cleaved EC1-3 fragment can indeed act as a homophilic competitor for the integral
cadherin-11. The fact that the homophilic site on EC1-3 is important to interfere with CIL
suggests that CIL is not the mechanism that allows EC1-3 to promote CNC migration in
vivo. In addition, our result showing that knockdown of ADAM13 does not affect CIL in
vitro suggests that the integral cadherin-11, rather than the cleavage fragment, is involved
in this process. On the other hand, our result also suggests that when CIL needs to be
reduced, for example to invade tissues that may express cadherin-11, ADAM13 can
perform this function rapidly. Given that the proteolytic activity of ADAM13 is inhibited
by Fz4 in the CNC (Abbruzzese et al., 2015), as shown in Chapter IV, this protein could
act as a switch to control cadherin-11 cleavage at various phases of CNC development
and as such finely tune the intensity of CIL.
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Section VI: Chapter V Materials and Methods

Morpholinos and DNA constructs
ADAM13 morpholino antisense oligonucleotide (MO13) and morpholino against
cadherin-11 (MO11) were designed as previously characterized (Kashef et al., 2009;
McCusker et al., 2009) and purchased from Gene Tools, LLC. Full-length ADAM13
(A13), protease-dead ADAM13-E/A, full-length cadherin-11 (C11), EC1-3-myc,
GAP43-mcherry and GAP43-GFP were published previously (Alfandari et al., 2001;
Kashef et al., 2009; McCusker et al., 2009). The 5’ untranslated region of cadherin-11
that is recognized by MO11 is not present in the cadherin-11 construct in pCS2+. In
addition, four silent mutations were made downstream of the ATG to further prevent
binding of MO11. C11-egf was engineered by introduction of a SacI site in the C11
construct immediately upstream of the transmembrane domain (QuikChange) and
inserting the EGF-like domain of Xenopus ADAM13 (51 amino acids), amplified with
the primers 5’-CTG AAC CCC AAT CCC TTA ACT GTG TTT CTA AAT GTA ATG
G-3’ and 5’-GCT CCA GTA CTG AGT CCA GCA GTG ACA CCT ACA GGG AGG
T-3’. A13-egf (containing two copies of the EGF-like domain) was made by inserting an
AscI followed by a SacI site immediately upstream of the transmembrane domain, and
then inserting the amplified EGF-like domain of ADAM13 into the AscI and SacI sites
using the primers 5’-AGG CGC GCC TTG TGT TTC TAA ATG TAA TGG-3’ and 5’CGA GCT CAG TGA CAC CTA CAG GGA GGT-3’. The non-adhesive cadherin-11
(na-C11) and EC1-3 (na-EC1-3) each contain point mutations at W55A and W57A (W2
and W4 after prodomain removal), and A130M of the QAV motif to disrupt the
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homophilic binding site as previously reported (Tamura et al., 1998). EC1 and EC1-2
were made by introducing stop codons immediately upstream of EC2 (after F159) with
the primers: 5’-CCC GGA GTT CTA ATT GCA TGA AAA CTA CCA CGC AAA TGT
G-3’ and 5’-TTT CAT GCA ATT AGA ACT CCG GGG GAT TAT CAT TTA TGT C3’, or upstream of EC3 (after F268) with primers: 5’-ACC AAA GTT TTA ACC ACA
AAG TGC GTA CCC CAT GTC TGT G-3’ and 5’-CAC TTT GTG GTT AAA ACT
TTG GTG GAT TGT CAT TGA CAT C-3’.

Cell culture and protein detection
Cos-7 cells (ATCC) were transfected according to manufacturer’s instructions (FuGENE
HD, Roche). After 48 hrs total cellular proteins were extracted with 1X TBS, 1% Triton
X-100, 5 mM EDTA, 1X Halt Protease and Phosphatase Inhibitor Cocktail (Thermo
Scientific). Glycoproteins were purified from the cell extract using agarose bound
Concavilin A (ConA) beads (Vector Labs) overnight at 4°C and eluted in reducing
Laemmli. Cadherin-11 was detected by Western blot using the mouse monoclonal
antibody 1B4 (McCusker et al., 2009), and ADAM13 using the rabbit polyclonal
antibody 6615F (Alfandari et al., 1997).

Embryo manipulation
Handling of Xenopus laevis embryos and CNC explants were performed as described
previously (Kashef et al., 2009). All constructs were transcribed in vitro into mRNA
according to manufacturer’s description (Ambion Inc.). In vivo CNC migration assays by
targeted injection of a fluorescent lineage tracer were performed as previously published
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(Abbruzzese et al., 2014; Abbruzzese et al., 2015Abbruzzese, 2015 #30; Cousin et al.,
2011; Cousin et al., 2012). Eight-cell stage embryos were injected into the D1 blastomere
with 333 pg of RFP-flag mRNA, plus 333 pg of all cadherin-11 constructs for
overexpression assays. In knockdown experiments, 200 pg of RFP-flag mRNA and 5 ng
of MO11 was used alone or together with 80 pg of cadherin-11 constructs. All embryos
were raised at 15°C until they reached tailbud stage and were scored for CNC migration
by the presence of RFP-labeled cells in the migration pathways. Embryos were imaged
using a Nikon fluorescent dissecting microscope or a Zeiss Stereo Lumar fluorescent
stereoscope. For the confrontation and collision assays, 1 ng of mRNA or 2 ng of MO13
was injected into the D1 blastomere of eight-cell stage embryos.

Confrontation and collision assays
CIL assays were performed as described (Becker et al., 2013; Carmona-Fontaine et al.,
2008). For the collision assay, CNC cells were dissociated for three minutes with 0.3 mM
EGTA in Danilchiks buffer (lacking CaCl2) as described previously (Becker et al., 2013).
Live cell images were taken with Axio Observer.Z1 spinning disc confocal microscope
with 10x plan apochromate NA 0.45 air objective using AxioVision 4.8.2 software
(Zeiss).
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Figure 5.1: Contact inhibition of locomotion (CIL) directs the migration of CNC cells.
During CIL, contact between two cells causes a collapse of protrusion at the site of contact and a
subsequent change in the direction of migration away from the collision (a). In the CNC, cells
begin migrating collectively as a group into the pharyngeal arches (b). The trailing cells that are
within the mass of the group encounter contacts with other CNC cells on all sides, preventing
stable protrusions from forming, and thus cannot persistently migrate in a direction away from the
group (c). The leader cells at the front of the stream have no contacts with other CNC cells at
their ventral edge, and are able to maintain stable protrusions that allow them to migrate ventrally
(d). The CNC cells do not exhibit CIL with the underlying mesoderm, potentially due to
differential cadherin expression, and are able to migrate efficiently on top of this cell population.
This figure was originally published in (Carmona-Fontaine et al., 2008). !
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Figure 5.2: Potential models for the role of cadherin-11 cleavage by ADAM13. Cadherin-11
(red) binds to ADAM13 (blue) on the surface of CNC cells. Intracellularly, cadherin-11 also
binds to p120 catenin and links to the actin cytoskeleton via an interaction with β-catenin. After
ectodomain cleavage by ADAM13, cadherin-11 maintains this interaction with β-catenin.
Several mechanisms have been proposed for how cleavage of cadherin-11 by ADAM13 promotes
CNC migration. First, the removal of the adhesive site on cadherin-11 after cleavage could
alleviate cell-cell adhesion by preventing it from binding to other cadherin-11 molecules (1).
Second, the soluble fragment generated from the cleavage containing extracellular repeats 1-3
(EC1-3) could bind to an intact cadherin-11 to occupy its adhesive site, and thereby reduce cellcell adhesion (2). And finally, EC1-3 could bind to an unknown receptor to activate a
promigratory signaling pathway (3). This figure was originally published in (McCusker et al., 2009).
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Figure 5.3: Generating a non-cleavable cadherin-11. (A) Model of non-cleavable C11-egf
design. Each EC repeat in cadherin-11 (red) is roughly 50 Å, which was measured in Pymol using
a homology model (Swiss-Model) that I made of the cadherin-11 structure. Cadherin-11 is
predicted to be cleaved by ADAM13 (blue) in the linker region between EC3 and EC4 (blue
arrow). The structure of an EGF-like repeat was measured in Pymol as 29 Å, slightly over half of
the length of an EC repeat. The EGF-like repeat from ADAM13 (cyan) was cloned and inserted
near the juxtamembrane region of cadherin-11 (C11-egf) to raise the extracellular domain from
the surface and misalign the cadherin-11 linker with the ADAM13 active site. (B) Western blot
from showing cleavage of C11 by ADAM13 but not by the inactive ADAM13-E/A containing a
mutation in the active site. Glycoproteins were purified from transfected Cos-7 cells with ConAagarose beads and detected using the antibody 1B4 to the cadherin-11 cytoplasmic domain.
Cleavage is observed by the presence of a shorter membrane-bound C11 fragment at 65 kD
(arrowhead). This cleavage fragment is absent when C11-egf is co-transfected with ADAM13.
ADAM13 was detected using the antibody to the ADAM13 cytoplasmic domain 6615F. The 120
kDa Pro-form and the 100 kDa mature form are shown. This figure has not been published.
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Figure 5.4: Targeted injection assays testing non-cleavable C11-egf in CNC migration in
vivo. (A, C) Histograms represent the percentage of embryos with no CNC migration, normalized
to injection of RFP alone, for the overexpression of C11 or C11-egf with A13 or A13-egf (A) or
the replacement of endogenous C11 with wildtype or non-cleavable C11-egf (C). Representative
images of embryos in (A) are shown in (B), and images of embryos in (C) are shown in (D), with
arrowheads pointing to RFP-labeled cells that successfully migrated into the branchial and hyoid
arches. n: number of embryos scored from three or more independent experiments. Error bars
represent SD. Student’s t-test was performed to determine statistical significance. ***p<0.005.
Scale bar, 500 µm. This figure has not been published.
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Figure 5.5: Increase of Adam13 expression leads to higher CNC invasiveness in vitro.
Confrontation assay. Left column: Confronted explants at time point t=0. Right column:
Confronted CNC explants at time point of highest invasion Δt. Confrontations of wildtype
explants with (A) wildtype CNC explants, (B) explants of Adam13-depleted CNC (MO13) or (C)
CNC explants overexpressing C11 show only small overlapping explant borders with low
invasiveness. In contrast, yellow overlapping area increases significantly in confrontations with
CNC cells overexpressing (D) Adam13 or (E) cleavage product EC1-3. (F) Overexpression of the
non-adhesive extracellular fragment na-EC1-3 in CNC explants leads to small overlap when
confronted with wild-type explants. Average Overlapping Index (OI) is given in (G) with n =
number of confrontations. wt: wildtype. Error bar shows standard error. (***) Significance to
wildtype vs. wildtype with p<0.005 after student’s t-test. Scale bar, 50 µm. Data analysis for this
figure was performed using MatLab by S.F. Becker. This figure has not been published.

!

120!

Figure 5.6: Increase of Adam13 expression blocks the repulsive response in colliding single
CNC cells in vitro. Collision assay. First three columns: Single CNC cells before (t-Δt), during
(t) and after (t+Δt) mutual contact. Yellow and white vectors give change of cell location. Fourth
column: Relative velocity vectors with initial velocity vector (red, n = 10 collisions). Mutual
collisions of (A) wildtype CNC cells, (B) Adam13-depleted CNC cells (MO13) and (C) CNC
cells overexpressing C11 lead to repulsive response of the cells and CIL. In contrast, CNC cells
overexpressing (D) Adam13 or (E) the cleavage product EC1-3 show no change of direction. (F)
Repulsive response and CIL are observed in collisions in single CNC cells overexpressing the
non-adhesive fragment na-EC1-3. Scale bar, 50 µm. The experiments described in this figure and
corresponding data analysis were performed by S.F. Becker. This figure has not been published.
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Figure 5.7: Cadherin-11 extracellular repeats 1 and 2 are sufficient to stimulate CNC
migration in vivo. (A) Histogram representing the percentage of embryos with no migration due
to the overexpression of C11, normalized to RFP. Rescue of migration requires co-expression of
the artificial C11 cleavage fragment containing at least extracellular repeats 1 and 2 (EC1-2),
while EC1 alone is not sufficient. (B) Representative images of embryos in (A) are shown with
arrowheads pointing to RFP-labeled cells that successfully migrated into the branchial and hyoid
arches. n: number of embryos scored from three independent experiments. Error bars represent
SD. A student’s t-test was performed for significance to C11 overexpression. *<0.05, ***<0.005.
Scale bar, 500 µm. This figure has not been published.
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Figure 5.8: EC1-3 does not promote migration in vivo through the homophilic site. (A-D)
Targeted injection assays to measure CNC migration with histograms showing the percentage of
embryos with inhibited migration normalized to RFP (A, C) and representative images of each
condition with arrowheads pointing to RFP-positive cells within the branchial and hyoid arches
(B, D). na-EC1-3 rescues the overexpression of C11 or C11-egf as well as EC1-3 (A, B), and also
rescues migration when expressed along with MO11 and C11-egf (C, D). Full-length na-C11
cannot rescue migration when expressed with MO11, and cannot be rescued by wildtype EC1-3
in the MO11 background (C, D). n: number of embryos scored from at least three independent
experiments. Error bars represent SD and a student’s t-test was performed to determine statistical
significance. **<0.01, ***<0.005. Scale bar, 500 µm. This figure has not been published.
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CHAPTER VI
DISCUSSION: EXPLORING THE MORE GLOBAL IMPACTS OF ADAM13
MULTIFUNCTIONALITY
Forward
The main goal of this thesis was to better understand the mechanisms of how
ADAM13 controls CNC cell migration. In the process, we unveiled several novel
features of ADAM13 activity and regulation. In this chapter, I will provide a summary of
these findings and how they fit together in the context of cell migration in the first
section. Here I will also discuss the broader impacts that our work will have on the study
of ADAM proteins. In Section II, I will present several interesting questions that have
come out these studies and preliminary work that we have done to try to answer these
questions.
!
Section I: Summary and global implications of work presented in this thesis

ADAM13 performs diverse activities in the CNC
In this thesis, I have covered several stories all related to the role of ADAM13 in
the CNC. The function of ADAMs in various cell types has been described in the
literature at length concerning its extracellular activity as a master regulator of
ectodomain shedding on the cell surface. An unprecedented finding presented in this
thesis is that the ADAM proteins also possess the ability to participate in regulation of
gene expression. Thus, these multifaceted proteins are able to control critical events both
on the cell surface and intracellularly to promote CNC cell migration.
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Figure 6.1 shows a model of the various aspects of ADAM13 function and
regulation in CNC cells that have been revealed from the studies described in this thesis.
In this model, we depict a dual role of ADAM13, with essential activities both on the
extracellular and the intracellular side of the cell. First, on the cell surface, we know from
previous work that ADAM13 cleaves the extracellular domain of cadherin-11 to release a
soluble fragment (EC1-3) that goes on to stimulate cell migration. ADAM9 also has the
ability to cleave cadherin-11. By generating a non-cleavable variant of cadherin-11, we
have now been able to confirm that this shedding event is necessary for migration. In
addition, removing the homophilic binding site in the shed cadherin-11 fragment revealed
that this site is not required for its activity and that it is likely stimulating migration by
interacting with another cell surface receptor other than full-length cadherin-11 (Figure
6.1-4). The identity of this receptor is unknown, however there are ongoing experiments
by other members of our lab to identify EC1-3 binding partners and preliminary results
suggests that EC1-3 may be acting by stimulation of Akt signaling via growth factor
receptors. In addition to shedding cadherin-11, we have also performed experiments that
indicate a possible role for ADAM13 in degrading the extracellular matrix in order to
clear a pathway for CNC to migrate through the embryo. This data was not discussed in
this thesis but was published in (Cousin et al., 2012) (see Appendix for reprint).
On the intracellular side, we discovered that the cytoplasmic domain of ADAM13
(C13) is cleaved off from the membrane-bound protease by γ-secretase and translocates
to the nucleus (Figure 6.1-1). Our data suggests that this intramembrane processing
follows an initial ectodomain shedding where ADAM13 cleaves itself within the
cysteine-rich domain. A striking finding from this work is that once in the nucleus, C13
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modulates the expression of multiple genes, with at least one of its target genes, the
cytoplasmic protease Calpain8, being an essential player in CNC migration. Although
we have not yet identified the substrates of Calpain8 in the CNC, this finding provided
the first evidence that a Calpain family member has a role in CNC migration. Another
interesting result from this study was that the cytoplasmic domain of another ADAM in
the CNC, ADAM19, which resides in the endoplasmic reticulum (ER), is also capable of
regulating Calpain8 expression. This provided an explanation for the redundancy
observed for ADAM13 and ADAM19, since the lab has shown that ADAM19 appears to
have different substrate preferences and is incapable of cleaving cadherin-11 (McCusker
et al., 2009).
The final two additions that this thesis has contributed to the model describe
mechanisms by which ADAM13 is regulated. First, we showed that an important prerequisite for C13 nuclear function is that this domain is phosphorylated by the kinases
GSK3 and Plk (Figure 6.1-2). Whether certain stimuli signal these kinases to
phosphorylate ADAM13 is not yet known, but it is clear that they are necessary for the
activity of C13. This was also the first demonstration that either kinase is required for
CNC migration. Finally, the work presented here has uncovered the ability of a Wnt
ligand receptor, Fz4, and its secreted splice variant Fz4-v1 to control the rate of
ADAM13 processing and maturation (Figure 6.1-3). This regulation appears to happen
during the transit of the two proteins to the cell surface. Importantly, Fz4 likely controls
both the extracellular and intracellular activities of ADAM13, since it prevents hyperactivation of the protease on the cell surface and in turn prevents premature processing
and accumulation of the cytoplasmic signaling domain. Fz4-v1 had already been
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identified as a necessary protein in CNC migration (Gorny et al., 2013), however this was
the first study to shed light on a mechanism of action.
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Figure 6.1: Model of ADAM13 activities in the CNC. Model depicting the four main findings
from the work presented in this thesis. (1) In Chapter II we showed that the cytoplasmic domain
of ADAM13 (blue) is cleaved off from the membrane-bound protease by γ-secretase. The
cytoplasmic domain then translocates to the nucleus to upregualte Calpain8-a expression (Cpn8,
red), which is an essential molecule for CNC migration. (2) In Chapter III, we demonstrated that
GSK3 and Plk successively phosphorylate ADAM13 and this appears to be required for the
nuclear activity of the cytoplasmic domain. (3) Chapter III revealed a novel role the Wnt receptor
Fz4 (purple) and its secreted splice variant Fz4-v1 in regulating ADAM13 activity. These two
proteins interact during their transit to the surface and Fz4 controls the rate of ADAM13
maturation and cytoplasmic domain cleavage. (4) Finally, the results from Chapter IV show that
cleavage within the ectodomain of cadherin-11 (green) by ADAM13 is essential for CNC
migration, and this generates a soluble fragment of cadherin-11 (EC1-3) that does not require its
homophilic binding site in order to stimulate CNC migration. Thus, rather than binding to other
intact cadherin-11 molecules to prevent cell-cell adhesion, we hypothesize that it functions by
binding to a different, unknown receptor in the CNC to activate a promigratory signaling cascade.
This figure has not been published.
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The cytoplasmic domain contributes substantially to the overall function of ADAMs
Cytoplasmic tails of ADAMs have largely been viewed as a means of inside-out
regulation of the extracellular protease via its interaction partners or post-translational
modifications. For example, ADAM17 cytoplasmic domain binds to thioredoxin-1 and
negatively regulates ADAM17 ability to shed the EGF receptor ligand (Aragao et al.,
2012). In addition, ADAM17 phosphorylation by Polo-like kinase 2 was shown to
control the shedding of its substrate in mammalian cells (Schwarz et al., 2014). It is
certain that proteolytic activity is one of the paramount features of ADAMs and tight
regulation over the shedding of surface molecules is critical for countless biological
processes. Many ADAMs have overlapping expression patterns and often substrate
preferences, but can also make specific selections from a diverse array of substrates in
different cell types. Thus it is an obvious priority to understand how the shedding
activities of each ADAM are uniquely regulated in different cells. However, given the
results presented in this thesis that identify essential and independent functions of the
ADAM cytoplasmic tail, we argue that this new feature of the protein should not be
overlooked in the study of ADAM function in normal and disease cells.
Our studies have demonstrated a distinct nuclear function of the ADAM
cytoplasmic domain, which is necessary to stimulate cell migration in the CNC via
modulating gene expression. In addition, other labs have also now found new roles for
this domain in ADAMs showing that it can perform significant functions that are separate
from regulating the protease domain. After an initial ectodomain shedding by ADAM15,
ADAM10 is then processed by γ-secretase to generate a cytoplasmic fragment that
translocates to the nucleus (Friedrich et al., 2011). This fragment has been shown to
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participate in the nuclear trafficking of HIV-1 to enable replication of the virus, as well as
nuclear entry of the androgen receptor to enhance the progression of prostate cancer
(Arima et al., 2007; Endsley et al., 2014; Friedrich et al., 2011). Additionally,
intracellular binding partners of ADAMs have been identified that mediate activities
independent from the protease. In human hepatic stellate cells, the cytoplasmic tail of
ADAM12 binds to integrin-linked kinase (ILK), which mediates a functional interaction
between ILK and β1-integrin to activate Akt and phosphoinositide 3-kinase (PI3K)
pathways and subsequently promote cell adhesion and survival (Leyme et al., 2012).
Thus, while there are indeed clear examples where the cytoplasmic domain plays a key
role in the extracellular function of ADAMs by either directly modifying its catalytic
activity or by trafficking the protein to the correct subcellular compartment (Cao et al.,
2001a), we propose that it controls a more diverse set of functions within the cell to
contribute to both physiological and pathophysiological development.

Implications of our findings on the study of ADAMs in development and disease
ADAMs have been linked to many disease and pathological conditions, such as
cancer, heart disease, diabetes, and Alzheimer’s, which is in part due to their primary
contribution to shedding critical membrane proteins (reviewed in Edwards et al., 2008).
Many of the principal substrates of ADAMs lead to disease states when dysregulated and
therefore governing their levels and function at the surface is a paramount task.
Importantly, ADAM gain- and loss-of-function phenotypes often mimic those observed
for aberrant expression or activation/inhibition of its substrates. However, the work
presented in this thesis suggests that the dysregulated shedding of substrates may not be
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the whole story as to why ADAM alterations cause disease. Our studies indicate that the
ability of the cytoplasmic domain to participate in gene regulation may be a general
feature among ADAMs, since we observed in Chapter II that this ability is conserved in
several ADAMs from frog, marsupial and mice (Cousin et al., 2011). Therefore, an
interesting question that arises is whether this nuclear function contributes to the
involvement of ADAMs in different developmental and disease processes. It also brings
into question the analysis of ADAM function using dominant negative constructs, which
lack catalytic activity but still possess a potentially active cytoplasmic domain, as well as
the study of non-proteolytic ADAMs.
Of the 21 ADAM family members described in humans, only 13 of these are
proteolytically active based on the presence of a conserved Zn++-binding active site motif
(HEXGHXXGXXHD) (Edwards et al., 2008). This leaves 8 human ADAMs that lack
protease activity. However, knockout studies in mice have shown that some of these
ADAMs still have important roles in development (reviewed in Edwards et al., 2008).
The most obvious evidence for this is the knockout of the catalytically inactive ADAM22
in mice, who suffer from hypomeylination of peripheral nerves and severe ataxia, and
ultimately die within two weeks of birth (Sagane et al., 2005). The mechanism by which
non-proteolytic ADAMs contribute to development is unknown, but it is tempting to
speculate that it could be attributed in part to activity of the cytoplasmic domain.
In Chapter II, we demonstrated that at least one of the target genes of ADAM13,
Calpain8-a, performs an essential function in the CNC. It is interesting to note that many
of the other target genes identified in the microarray have significant implications in
disease. For instance, platelet derived growth factor receptor (PDGFR) expression was
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increased by ADAM13 cytoplasmic domain, and this protein is linked to multiple types
of cancers and tumor progression (reviewed in Heldin, 2013). Thus, it is compelling to
ask whether increased amounts of ADAM cytoplasmic domain or different diseaseassociated isoforms cause gene expression changes that drive disease progression.
Three breast cancer-associated mutations in ADAM12 were recently identified.
Two extracellular mutations were found to affect protein folding and zymogen
maturation, whereas a third mutation resided in the cytoplasmic tail within a di-leucine
motif (Dyczynska et al., 2008; Sjoblom et al., 2006). This third mutation was investigated
and found to have no detrimental effects on maturation, localization, surface expression,
or proteolytic activity (Stautz et al., 2012b). From these results, the authors concluded
that it is unlikely to be a driving mutation in breast cancer. But since it is now clear that
ADAM cytosolic tails can perform more diverse functions than previously thought, it is
possible that these conclusions are limited by the authors’ analysis of only the traditional
ADAM functions. It would be interesting to further examine the relevance of this breast
cancer-associated mutation to gene expression changes within these cells, as well as its
effect on interaction partners of ADAM12 mediated through this domain.
Many ADAMs are produced in a variety of alternatively spliced forms, mostly
altering the cytoplasmic tail (Edwards et al., 2008). Four ADAM15 splice variants, which
differ only in their cytoplasmic domain lengths and sequences, are differentially
expressed in human mammary carcinomas compared to normal breast tissue. Notably,
two of these isoforms are associated with increased adhesion, migration and invasion of
cancer cells (Zhong et al., 2008), further underscoring the notion that different features
included in the cytoplasmic domain of ADAMs can significantly alter the function of the
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protein and affect disease outcomes. To conclude, we believe that the current approach to
studying ADAM function is constrained by the view of their capabilities within the cell,
and if the studies expanded their perspective to more thoroughly address the roles of the
non-catalytic domains, it would lead to a greater understanding of ADAM contribution to
both development and disease.

Section II: Looking ahead

Some interesting questions that arose from the findings of this thesis, among others,
include how the cytoplasmic domain regulates transcription, is ADAM13 controlled by
the Wnt pathway, how does Caplain8-a stimulate CNC migration, and what is the
receptor for soluble cadherin-11 after it is shed by ADAM13? In this section I will
address some of these questions and offer potential hypotheses based on the current
literature and preliminary data if available.

Is ADAM13 controlled by the Wnt pathway?
Multiple pieces of evidence both from this thesis and other studies suggest that
ADAM13 is involved in the Wnt pathway. From the work in this thesis, the most obvious
links are that ADAM13 processing and activity is regulated by an interaction with the
Wnt receptor Fz4, and that it is phosphorylated by GSK3, whose activity can be directly
regulated by Wnt signaling. Activation of the canonical Wnt pathway inhibits GSK3 to
relieve phosphorylation and degradation of β-catenin. Canonical Wnt signaling is
required for CNC induction (inhibited GSK3), but is presumed to be shut off during CNC
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migration (active GSK3) while non-canonical/PCP signaling is active (Mayor and
Theveneau, 2014; Stuhlmiller and Garcia-Castro, 2012). Thus, it is a possibility that Wnt
stimuli could regulate ADAM13 function by controlling the activity of GSK3. There do
exist, however, additional levels of control over GSK3 activity, including stimuli such as
insulin or the growth factors EGF and PDGF, which stimulate GSK3-inactivating kinases
(Brady et al., 1998; Cross et al., 1995; Saito et al., 1994). There appears to be multiple
pools of GSK3 within the cell, however, that are restricted to the individual signaling
pathways. For example, insulin signaling does not appear to affect GSK3 involved in the
Wnt pathway and vice versa (Ding et al., 2000; Yuan et al., 1999). This is most likely due
to the sequestration of GSK3 in the “destruction complex” consisting mainly of GSK-3,
β-catenin, axin, and adenomatous polyposis coli (APC), leading to insulation of the Wnt
pool of GSK3 from outside regulators (Doble and Woodgett, 2003). At present, we do
not know if a particular subset of GSK3 in the cell is responsible for ADAM13
phosphorylation or how activation of Wnt affects this process in the CNC, but these are
interesting questions for future studies.
We described in this thesis how Fz4 and its secreted splice variant Fz4-v1 bind to
and inhibit ADAM13 activity. It is unclear at the moment whether Fz4 binding to a Wnt
ligand increases, decreases or has no effect on its ability to inhibit ADAM13. Another
possibility is that this interaction affects the activity of Fz4 in the Wnt pathway.
However, it is also unclear whether binding of ADAM13 to Fz4 modifies its ability to
respond to Wnt and to signal. In the closely related species Xenopus tropicalis, loss of
ADAM13 results in a severe decrease in Wnt signaling during CNC cell induction (Wei
et al., 2010). This is attributed to the loss of cleavage of ephrinB, resulting in an abnormal
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accumulation and increased signaling that, in turn, decreases canonical Wnt signaling.
Other members of our lab have shown that in Xenopus laevis, although knockdown of
ADAM13 also increases the level of ephrinB protein, it has no effect on Wnt signaling
during gastrulation. In contrast, knockdown of the two paralogues ADAM13 and MDC13
does result in a substantial decrease in β-catenin levels (Advani and Alfandari,
unpublished). In this model, however, it is unclear whether this change is due to cleavage
of ephrinB or a more direct effect on the Wnt pathway. Our new results described in this
thesis show a direct interaction of ADAM13 with Fz receptors, suggesting a more direct
role of ADAM13 in regulating the Wnt pathway, a role that will require further
investigation.
How does the cytoplasmic domain regulate transcription?
!
One important question that still remains after the culmination of this thesis is
how the ADAM13 cytoplasmic domain controls gene expression. While we know that it
goes to nucleus and leads to an increase in the levels of Calpain8-a mRNA, we have not
yet determined the mechanism by which this occurs or whether it is actually increasing
the transcription rate or the mRNA processing or stability.
There are several pieces of evidence that suggest that C13 does not function as a
transcription factor. First, the number of genes in the CNC regulated by C13 was very
large and their change in expression level was relatively small in the presence or absence
of C13 (two-fold). Second, despite having a nuclear localization sequence, it does not
have any predicted DNA binding domains. Finally, when transfected into Xenopusderived tissue culture cells (XTC or S3 cells), C13 alone is unable to activate Capn8-a
expression even when fused to the VP16 activator domain. Thus, a more likely scenario
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is that C13 is able to modulate transcript levels via an interaction partner. One possibility
is that it binds to one or more proteins in the nucleus that control Capn8-a gene
expression and modifies their transcriptional activity. Of course, given the recent findings
regarding the importance of the ADAM10 cytodomain in trafficking proteins to the
nucleus (discussed above in section I), another possibility is that C13 mediates the transit
of critical Capn8-a-regulating components from the cytoplasm or the membrane to the
nucleus to activate or modify transcription.
Based on analysis of C13 using structure prediction software, as well as circular
dichroism experiments that I performed on a recombinant version of C13 protein
expressed and purified from bacteria (data not shown), the structure appears to
intrinsically disordered. Another group has also recently shown using limited trypsin
digestion and circular dichroism that a recombinant ADAM10 cytoplasmic domain is
also disordered (Deng et al., 2014). Their data also indicates that it adopts a more ordered
structure and mediates homodimerization of ADAM10 when this domain is attached to
the transmembrane domain. So it is possible that C13 becomes ordered when bound to an
interaction partner, although this does not lend any insight to predicting the functional
mechanism.
As an initial approach to understanding how C13 could function in gene
expression, we decided to take a closer look at the amino acid sequence of C13 as well as
the promoter of Capn8-a. Based on the hypothesis that C13 could be acting as cofactor in
Capn8-a transcription, this allowed us to identify candidate transcription factors that
could be interrogated for their ability to bind C13 and activate Capn8-a expression.
Capn8-a promoter analysis revealed 41 predicted transcription factor binding sites
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(JASPAR CORE database), of which 23 are expressed in the CNC (based on literature
and my own experimental evaluation) (Figure A2.1). Several of these also contain
favorable interaction domains, such as acidic regions and WW, SH3 or forkhead
domains, which are likely to bind to either the highly basic region of C13 or its putative
binding motifs that we identified using ELM protein prediction. I have now tested a
series of interesting candidates for their ability to bind to ADAM13 (Appendix II) either
in vitro or in vivo.
A few candidates of interest that bind ADAM13 and have known roles in CNC
development include Yin-Yang 1 (YY1) and FoxD3 (Figures A2.2-2.5). YY1 can
regulate gene expression by interacting with the polycomb complex or binding directly to
DNA to either activate or repress transcription, and it can also function as an RNAbinding protein to control its stability. Its function is modulated by multiple protein
binding partners. In the CNC, YY1 binds to the Slug enhancer and represses its
expression in the non-neural ectoderm (Morgan et al., 2004). FoxD3, a forkhead-related
transcriptional regulator, blocks CNC formation when overexpressed in Xenopus (Pohl
and Knochel, 2001). It functions as a transcriptional repressor by directly binding to the
corepressor Grg4 (Groucho-related gene 4) (Yaklichkin et al., 2007). This binding occurs
via an eh1/GEH Groucho interaction motif (consensus sequence FSIDNIL) that is present
in FoxD3 (FSIENII). C13 also contains a heptapeptide sequence (FTLRNIS) that is
similar to this eh1 motif and could thus potentially be altering the repressive behavior of
FoxD3 and Grg4 by interacting with one or both proteins in this complex.
In addition, our protein prediction analysis of C13 also revealed a binding motif
for the transcription factor Brca1. Interestingly, the putative interaction site is also one of
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the GSK3 phosphorylation sites in C13 and the binding is predicted to be dependent on
phosphorylation.

In

co-immunoprecipitation

experiment,

we

have

found

that

phosphorylation does indeed affect Brca1 binding to ADAM13, however, unexpectedly
we see that it is the non-phosphorylatable form that binds better to Brca1 (Figure A2.6).
Despite being opposite to the predicted result, this could indicate that a mechanism for
phosphorylation-dependent control of C13 in mediating Capn8-a transcription via Brca1.
Brca1 has not previously been investigated in the CNC, but we have now cloned a
portion of Xenopus laevis Brca1 to generate a !probe for in situ hybridization, and can
detect clear Brca1 !expression in migrating CNC (Figure A3.1). !Finally, we see that
knocking down Brca1 expression in! the CNC by morpholino injection strongly inhibits
CNC !migration (Figure A3.2). This suggests an important function for Brca1 in the CNC.
We have yet to determine, however, if this role involves ADAM13 and the regulation of
ADAM13 target genes.
Although we have now demonstrated clear interactions with multiple important
CNC transcription factors, we have not yet succeeded in showing that any of these
interactions are functional in regulating Capn8-a gene expression. I have cloned up to 2.5
kb of the Capn8-a promoter upstream of a luciferase reporter gene to test whether C13
plus the different factors can activate reporter expression via this promoter. While this
strategy has not yielded any positive results (data not shown), it could be potentially
limited by the use of only a portion of the promoter and not include more distal regions or
enhancers elements that may be required. In the future I would like to test the direct
binding of C13 and the different candidates to the promoter in vivo using chromatin
immunoprecipitation (ChIP). This can be performed both to detect binding to select
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sequences by ChIP-PCR, as well as to identify all loci that C13 is bound by ChIP-seq.
Lastly, we have performed several mass spectrometry experiments as a non-biased screen
to identify binding partners of ADAM13. One example of a candidate identified by mass
sepc is the transcription factor Arid3-a (also known as Dril1), which was also found
among the predeicted transcription factor binding sites in the Capn8-a promoter. We have
since cloned Arid3-a and confirmed by CoIP that it does indeed bind to ADAM13 (data
not shown). We are continuing to do these experiments to also look for proteins that
differentially bind to ADAM13 depending on its phosphorylation state. We will
investigate the mass spec candidates further in the future with the hope that it will aid in
the clarification of the nuclear functions of C13.

What is the receptor for EC1-3 in the CNC?
Finally, another mechanism that remains to be unraveled is how the shed
cadherin-11 fragment, EC1-3, stimulates CNC migration after it is released from the
surface by ADAM13. The results of this thesis indicate that EC1-3 is not simply acting as
a competitive inhibitor of cadherin-11-mediated cell-cell adhesion, and is instead acting
through an alternative mechanism. Protease-induced generation of soluble cadherins have
been identified in other systems previously and shown to carry out activities that can
affect cell processes such as cell adhesion, migration, proliferation and survival. Soluble
E-cadherin (sE-cad) has been reported in patients with breast cancer, viral infections,
organ failure and benign disease (reviewed in Grabowska and Day, 2012). For example,
in breast cancer cells, sE-cad can bind to and induce phosphorylation of the receptor
tyrosine kinases (RTK) Her2 and Her3, which then activate downstream ERK signaling
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and cell proliferation (Najy et al., 2008). In other conditions, sE-cad can promote antiapoptotic signals via the EGF receptor and activation of Akt and ERK signaling (Inge et
al., 2011). Furthermore, a soluble N-cadherin fragment can promote survival of vascular
smooth muscle cells by interacting with the fibroblast growth factor receptor (FGF-R)
and activating PI3 kinase and Akt (Lyon et al., 2009).
Thus, there are many possibilities for the pathway stimulated by EC1-3 to induce
CNC migration, but there is significant evidence pointing towards an RTK-mediated
mechanism. The findings of this thesis have prompted further investigation to identify
the receptor for EC1-3 on the surface of CNC cells and other members of our lab are
currently pursuing these studies in further detail. In brief, our lab has evidence that EC1-3
can indeed stimulate Akt phosphorylation in the CNC, and there is ongoing work to
determine if this occurs through a specific RTK on the CNC surface (Mathavan and
Alfandari, unpublished).

Section III: Concluding remarks

This thesis has provided an in depth account of the many actions performed by
ADAM13 to enable CNC motility. Perhaps most significantly, we have produced a new
model of ADAM function in the cell that relies on both extracellular and intracellular
activities, demonstrating that it has a more diverse repertoire of tasks than previously
thought. Notably, our finding of a nuclear function for the ADAM cytoplasmic domain
has drawn many parallels to the groundbreaking discovery that the Notch receptor acts
not only as a transmembrane receptor, but is also processed by γ-secretase to generate a
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functionally active transcription factor. This insight has brought about a new
understanding of Notch-related disease and has even led to development of therapeutic
treatments, involving the use of γ-secretase inhibitors to block upregulation of Notch
target genes. Thus, I believe that pioneering this innovative approach to studying
ADAMs will transform the field and have far-reaching impacts on cell and
developmental biology.

!

140!

APPENDIX I
FZ4 INHIBITS MULTIPLE ADAMS
!
!

!

!

Figure A1: Secreted Fz4-v1 inhibits ADAM13 and ADAM9. Cadherin-11 was transfected into
Cos-7 cells together with either ADAM9 or ADAM13 with or without Fz4-v1. Glycoproteins
from the cellular extract were purified using concavilin-A-agarose beads and cadherin-11 was
detected by Western blot using the 1B4 monoclonal antibody to the cytoplasmic domain.
ADAM13 and ADAM9 both cleave cadherin-11 (cleaved fragment remaining in the membrane,
arrow), while their catalytically inactive forms (E/A) do not. Processing of cadherin-11 by both
ADAM13 and ADAM9 is inhibited by Fz4-v1, indicating that Fz4-v1 can act on multiple
ADAMs. This figure has not been published.
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APPENDIX II
DOES ADAM13 INTERACT WITH CNC TRANSCRIPTION FACTORS?

Figure A2.1: Calpain8-a promoter analysis. Analysis of 2.5 kb of the Xenopus laevis Calpain8a promoter sequence identified 41 predicted transcription factor (TF) binding sites (JASPAR
CORE). Of these, I found 23 to be expressed in the CNC (purple), based on either literature or
experimental analysis (western blot to detect protein or quantitative PCR to detect mRNA). The
promoter for the Calpain8-a homologue in zebrafish, mouse and human was also analyzed to
identify conserved predicted TF binding sites (orange). A subset of these TFs are also interesting
candidates for binding to C13 based on the presence of acidic regions (which could potentially
interact with the basic lysine/arginine-rich region of C13) or other motifs for which predicted
interaction sites exist in C13. This figure has not been published.
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Figure A2.2: ADAM13 interacts with multiple transcription factors. A-B) Myc-tagged
transcription factors FoxD3-mt (A) and Sox9-mt (B) were injected into 1-cell stage embryos
either alone or together with morpholino to ADAM13 (MO13) or the GFP fusion of the
ADAM13 cytoplasmic domain (C13). Proteins were extracted from 20 embryos/case at stage 17
and ADAM13 or C13 was immunoprecipitated (IP) from the extract using the goat polyclonal
antibody to the ADAM13 cytoplasmic domain. Myc-tagged protein was detected by Western blot
with the 9E10 monoclonal antibody and ADAM13 detected in IP samples with the rabbit
polyclonal 6615F to the cytoplasmic domain. ADAM13 binds to FoxD3 but not to Sox9. UI: uninjected. (C) YY1 was transfected into HEK293T cells alone or together with ADAM13 or GFPC13. YY1 or ADAM13 were immunoprecipitated from the cellular extract and each protein was
detected by Western blot using 6615F or an antibody to YY1. Both full length ADAM13 and C13
bind to YY1. The experiments described in part (C) were performed by D. Alfandari. This figure has not
been published.
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Figure A2.3: ADAM13 does not bind competitively to FoxD3 or Grg4 in Xenopus S3 cells.
Myc-tagged Grg4 and FoxD3 were transfected alone or together into Xenopus S3 cells.
Endogenous ADAM13 was immunoprecipitated (IP) with the goat polyclonal antibody to
ADAM13 cytoplasmic domain (g877, purified on a peptide corresponding to amino acids 877914 of C13). The myc-tagged transcription factors were detected in the IP and total cellular
extract (Input) by Western blot with the monoclonal 9E10 antibody and ADAM13 was detected
with the rabbit polyclonal 6615F antibody to the cytoplasmic domain. Both Grg4 and FoxD3 bind
to endogenous ADAM13 and this is not affected when both transcription factors are present,
indicating that the two proteins bind to different regions of ADAM13. This figure has not been
published.
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Figure A2.4: Plk-DN decreases binding of ADAM13 to FoxD3, but not Grg4 in S3 cells.
Myc-tagged Grg4 and FoxD3 were transfected into Xenopus S3 cells alone or together with either
the wild type or dominant negative form of GSK or Plk. Endogenous ADAM13 was
immunoprecipitated (IP) with the goat polyclonal antibody to ADAM13 cytoplasmic domain
(g886, purified on a peptide corresponding to amino acids 886-914 of C13). The myc-tagged
transcription factors were detected in the IP and total cellular extract by Western blot with the
monoclonal 9E10 antibody and ADAM13 was detected with the rabbit polyclonal 6615F
antibody to the cytoplasmic domain. The presence of Plk-DN reduces the binding observed for
ADAM13 with FoxD3 but not Grg4. It should be noted, however, that this decrease in binding is
not observed for the Plk/A mutant of ADAM13, or if cells are treated with an inhibitor or Plk
(data not shown). Thus, it may be due to the two proteins competing for the same docking site on
ADAM13. This figure has not been published.
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Figure A2.5: Mutation of the putative eh1 motif in ADAM13 does not prevent binding to
FoxD3. Myc-tagged Grg4 and FoxD3 were transfected into Cos-7 cells with wild type ADAM13
or a variant lacking the putative eh1 motif (A13-eh1/7A, mutation of the sequence FTLRNIS to
seven alanines). The eh1 motif present in FoxD3 (FSIENII) is required for its binding interaction
with Grg4. ADAM13 was immunoprecipitated (IP) from the cellular extract using the goat
polyclonal antibody to the cytoplasmic domain (g821, purified on a peptide corresponding to
amino acids 821-914 of C13). The transcription factors were detected in the IP or total extract
(Input) using the monoclonal antibody to myc (9E10). In these cells, we observe binding of both
wild type and the eh1/7A mutant of ADAM13 with FoxD3. Note: This experiment was
performed using Cos-7 cells, rather than Xenopus S3, in order to test FoxD3 or Grg4 binding to
an ADAM13 mutant since these cells do not have endogenous ADAM13. However, in Cos-7 or
HEK293T cells, we do not observed coimmunoprecipitation of Grg4 with ADAM13, and only
see this with the endogenous ADAM13 in S3 cells. This could indicate that there is an additional
factor present in S3 cells that promotes binding of Grg4 and ADAM13. Furthermore, it remains
possible that the ADAM13 does indeed require this putative eh1 motif to bind to Grg4, however
it cannot currently be tested in these cell lines. This figure has not been published.
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Figure A2.6: Brca1 binds to ADAM13. Myc-tagged (mt) Brca1 was transfected into HEK293T
cells together with empty vector (pCS2+) or either wild type ADAM13 or the phosphorylation
mutants. ADAM13 was immunoprecipitated (IP) from the cellular extract using the monoclonal
antibody to the cytoplasmic domain (4A7), and Brca1-mt was detected in the IP samples or the
total cellular extract by Western blot with the 9E10 antibody against the myc tag. Brca1 is
predicted to bind to a phosphorylated GSK3 site, however, we observe that while Brca1 does
indeed bind to wild type ADAM13, it binds better to the non-phosphorylatable forms of
ADAM13 and not to the GSK3 phosphomimetic form. The western blots in this figure were
performed by K. Loughmann. This figure has not been published.
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APPENDIX III
IS BRCA1 REQUIRED FOR CNC MIGRATION?

Figure A3.1: Brca1 is expressed in migrating CNC. In situ hybridization using a probe to
detect Brca1 shows that it expressed in the CNC during migration (arrows pointing to the
pharyngeal arches), as well as other dorsal tissues including the eye, neural tube, and possibly the
somites or the intersomitic boundaries. K. Loughmann was also involved in performing the in situ
hybridization for this figure. This figure has not been published.
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Figure A3.2: Loss of Brca1 in the CNC inhibits migration. 200 pg of RFP mRNA was injected
alone or together with either 1 or 2 ng of morpholino to Brca1 (MOBrca1) into the dorsal animal
blastomere at the 8-cell stage. Embryos were scored at tailbud stage for the presence of RFPexpressing cells in the migration pathways. (A) Histogram representing the percentage of
embryos with no migration (% inhibition) normalized to injection of RFP alone. (B)
Representative images of embryos scored for each case. These results suggest that Brca1 has an
important role in the migration of CNC cells. This figure has not been published.
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APPENDIX IV
LIST OF SUPPLEMENTARY MOVIE FILES
From Chapter III:
Movie 3.1: In vivo CNC migration following grafting of cells with reduced GSK3
activity. The control (RFP) is to the left, while embryo grafted with CNC expressing the
dominant negative GSK3 is to the right. Images were acquired every 3 minutes for 10
hrs. The described for this movie was performed by H. Cousin.
Movie 3.2: In vivo CNC migration following grafting of cells with reduced Plk
activity. The control (RFP) is to the left, while embryo grafted with CNC expressing the
dominant negative Plk is to the right. Images were acquired every 3 minutes for 10 hrs.
The experiment for this movie was performed by H. Cousin.

From Chapter IV:
Movie 4.1: ADAM13-GFP and Fz4-RFP localization in the CNC. Spinning disc
confocal time-lapse microscopy of CNC cells expressing ADAM13-GFP and Fz4-RFP.
Images were acquired every 2 seconds for 1 minute. The experiment for this movie was
performed by D. Alfandari and myself.

Movie 4.2: ADAM13-GFP and Fz4-v1-RFP localization in the CNC. Spinning disc
confocal time-lapse microscopy of CNC cells expressing ADAM13-GFP and Fz4-v1RFP. Images were acquired every 2 seconds for 1 minute. The experiment for this movie was
performed by D. Alfandari and myself.

Movie 4.3: In vivo migration of grafted Fz4-deficient CNC. Graft of cranial neural
crest cells expressing GFP alone (left) or with the morpholino to Fz4 (right) into wildtype embryos. Images were acquired every 3 minutes for 10 hours. The experiment for this
movie was performed by H. Cousin.

From Chapter V:
Movie 5.1: Confronting GAP43-GFP-labeled wildtype CNC explant with GAP43mCherry-labeled wildtype CNC explant leads to low overlapping (yellow). Images
captured every three minutes over a period of several hours as indicated in the movie and
taken with AxioObserver.Z1 spinning disc confocal microscope using a 10x plan
apochromate NA 0.45 air objective. Scale bar: 50 μm.
Movie 5.2. Confronting GAP43-GFP-labeled wildtype CNC explant with GAP43mCherry-labeled CNC explant co-injected with ADAM13 morpholino (MO13) leads
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to low overlapping (yellow). Images captured every three minutes over a period of
several hours as indicated in the movie and taken with Axio Observer.Z1 spinning disc
confocal microscope using a 10x plan apochromate NA 0.45 air objective. Scale bar: 50
μm.
Movie 5.3. Confronting GAP43-GFP-labeled wildtype CNC explant with GAP43mcherry-labeled CNC explant overexpressing full-length cadherin-11 (Cad-11) leads
to low overlapping (yellow). Images captured every three minutes over a period of
several hours as indicated in the movie and taken with Axio Observer.Z1 spinning disc
confocal microscope using a 10x plan apochromate NA 0.45 air objective. Scale bar: 50
μm.
Movie 5.4. Confronting GAP43-GFP-labeled wildtype CNC explant with GAP43mcherry-labeled CNC explant overexpressing Adam13 leads to increased
overlapping (yellow). Images captured every three minutes over a period of several
hours as indicated in the movie and taken with Axio Observer.Z1 spinning disc confocal
microscope using a 10x plan apochromate NA 0.45 air objective. Scale bar: 50 μm.
Movie 5.5. Confronting GAP43-GFP-labeled wildtype CNC explant with GAP43mcherry-labeled CNC explant overexpressing the shed extracellular fragment EC13 leads to increased overlapping (yellow). Images captured every three minutes over a
period of several hours as indicated in the movie and taken with Axio Observer.Z1
spinning disc confocal microscope using a 10x plan apochromate NA 0.45 air objective.
Scale bar: 50 μm.
Movie 5.6. Confronting GAP43-GFP-labeled wildtype CNC explant with GAP43mcherry-labeled CNC explant overexpressing a non-adhesive extracellular fragment
na-EC1-3 leads to low overlapping (yellow). Images captured every three minutes over
a period of several hours as indicated in the movie and taken with Axio Observer.Z1
spinning disc confocal microscope using a 10x plan apochromate NA 0.45 air objective.
Scale bar: 50 μm. The experiment for this movie was performed by S.F. Becker.
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SUMMARY

ADAMs are transmembrane metalloproteases that
control cell behavior by cleaving both cell adhesion
and signaling molecules. The cytoplasmic domain of
ADAMs can regulate the proteolytic activity by controlling the subcellular localization and/or the activation of
the protease domain. Here, we show that the cytoplasmic domain of ADAM13 is cleaved and translocates into the nucleus. Preventing this translocation
renders the protein incapable of promoting cranial
neural crest (CNC) cell migration in vivo, without
affecting its proteolytic activity. In addition, the cytoplasmic domain of ADAM13 regulates the expression
of multiple genes in CNC, including the protease
Calpain8-a. Restoring the expression of Calpain8-a is
sufficient to rescue CNC migration in the absence of
the ADAM13 cytoplasmic domain. This study shows
that the cytoplasmic domain of ADAM metalloproteases can perform essential functions in the nucleus
of cells and may contribute substantially to the overall
function of the protein.

INTRODUCTION
ADAMs are cell surface metalloproteases that contain a disintegrin domain (Alfandari et al., 2009; Blobel, 2005; Wolfsberg et al.,
1995). They are key players in many biological processes and
control cell adhesion and cell signaling. Their role in cell signaling
is linked to their ability to cleave molecules either to turn on
a signal, e.g., by cleaving growth factor precursors (EGF,
TNF-a) or receptors (Notch), or to turn off signals by cleaving
ligand/receptor complexes (e.g., ephrins) (Alfandari et al.,
2009). ADAM proteins have also been shown to regulate cell
adhesion by cleaving N- and E-cadherin to promote epithelial
to mesenchymal transition (EMT). In addition to reducing adhesion of these cells, cleavage of N- and E-cadherins by
ADAM10 releases b-catenin, which translocates into the nucleus
and activates gene transcription, further facilitating EMT (Maretzky et al., 2009; Reiss et al., 2005).
We have previously shown, using both a dominant-negative
(DN) and Morpholino knockdown (KD) approaches, that
ADAM13 plays a critical role in CNC cell migration (Alfandari

et al., 2001; McCusker et al., 2009). In vertebrates, CNC are
responsible for the formation of the face during embryogenesis.
We have previously shown that ADAM13, in collaboration with
other meltrins (ADAM9 and ADAM19), controls CNC cell migration by cleaving the extracellular domain of Cadherin-11
(McCusker et al., 2009). We have also shown that while its
proteolytic activity is critical for ADAM13 function, the
cytoplasmic domain of the protein is also important for regulating
its function through its interaction with an SH3-containing cytoplasmic adaptor protein PACSIN2 (Cousin et al., 2000). In
Xenopus tropicalis, ADAM13 is involved in CNC induction by
cleaving ephrin B ligands and upregulating the canonical Wnt
signaling pathway (Wei et al., 2010).
ADAM cytoplasmic domains are poorly conserved both
between the various ADAMs and also between orthologs in
different species. The ADAM13 cytoplasmic domain, like many
other ADAMs, contains proline-rich (PR) repeats that function
as SH3 binding sites. In addition, the juxta-membrane region
of the cytoplasmic domain is rich in lysine and arginine (KR).
ADAM cytoplasmic domains have been shown to regulate the
ADAM protein functions either through phosphorylation or by
controlling their subcellular localization (Cao et al., 2001a; Howard et al., 1999; Izumi et al., 1998; Janes et al., 2009; Maretzky
et al., 2009; Stautz et al., 2010; Xu and Derynck, 2010). Recently,
ADAM10 was shown to be cleaved by gamma-secretase,
releasing the cytoplasmic domain from the plasma membrane.
Using inhibitors of nuclear export they were able to detect the
ADAM10 cytoplasmic domain in the nucleus of transfected
293T cells associated with nuclear speckle, which could be
regions of active transcription (Tousseyn et al., 2009).
Here, we show that the ADAM13 cytoplasmic domain is
cleaved in vivo during embryogenesis and translocates into the
nucleus. This translocation is critical for the function of
ADAM13 during CNC cell migration and affects the expression
of multiple genes within these cells. One of these genes
Calpain8-a can rescue CNC migration in embryos lacking the
ADAM13 cytoplasmic domain. We also show that in Xenopus
the cytoplasmic domain of ADAM19 can substitute for the
ADAM13 cytoplasmic domain. Using GFP-fusions of the cytoplasmic domains of ADAMs in multiple species we show that
the cytoplasmic domains of Caenorhabditis meltrin (adm-2),
zebrafish ADAM13, and opossum ADAM13 can compensate
for the loss of the Xenopus ADAM13 cytoplasmic domain, while
mouse ADAM33 cannot. These results show that the function of
ADAM cytoplasmic domain in the nucleus has been conserved
during evolution.
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RESULTS
ADAM13 and ADAM19 Cooperate to Promote Cranial
Neural Crest Cell Migration
We have previously shown that three ADAM proteins play a role
during Xenopus CNC migration. ADAM9 and ADAM13 both
cleave Cadherin-11, while ADAM19 does not (McCusker et al.,
2009). We have also shown that ADAM19 is important for the
expression of CNC-specific genes including sox8 and slug (Neuner et al., 2009). To determine whether ADAM13 and 19 could
compensate for each other in CNC migration, we performed
single and double KD using Morpholino oligonucleotides (MO)
that prevent the translation of the endogenous protein
(McCusker et al., 2009; Neuner et al., 2009). CNC cells from morphant embryos were dissected before migration and grafted into
host embryos and the migration of grafted cells was followed
using the green fluorescent protein (GFP) as a lineage tracer (Figure 1). While single ADAM13 or ADAM19 KD prevents CNC
migration in less than 20% of the embryos, the double KD inhibits
migration in more than 80% of the embryos. CNC migration was
rescued by either ADAM13 or 19 but not the protease inactive
mutants (E/A) or a mutant lacking the cytoplasmic domain
(DCyto), suggesting that both the proteolytic activity and the
cytoplasmic domain are essential.
To determine if the effect on CNC migration was due to defect
in CNC induction we tested the expression of several CNC
markers in embryos lacking the ADAM13 protein. Our results
show that in the absence of detectable ADAM13 protein, all of
the CNC markers tested (snail2a, snail, slugb, sox8, sox9,
sox10, twist1) were expressed at the right place and the right
level (see Figure S1 available online). These results show that
in Xenopus laevis, ADAM13 KD affects CNC migration in the
absence of any effect on CNC induction.
These results show that ADAM13 and ADAM19 can compensate for each other even though their role in CNC migration
during normal embryo development is distinct. They also show
that the cytoplasmic domain of ADAM13 is essential for CNC
migration. We next investigated how the cytoplasmic domain
of ADAM13 could control cell migration.
The ADAM13 Cytoplasmic Domain Is Cleaved
by Gamma-Secretase and Translocates into the Nucleus
The ADAM13 extracellular domain is cleaved by autoproteolysis
in the cysteine-rich domain, releasing the active metalloprotease
from the cell surface (Gaultier et al., 2002) (Figure 2A). Ectodomain shedding of transmembrane proteins is often followed by
a cleavage by gamma-secretase (GS) that releases the
cytoplasmic domain (Hass et al., 2009). To investigate if a similar
processing occurs for ADAM13, we transfected Cos-7 and 293T
cells with the various ADAM13 constructs. After transfections,
the cytoplasmic and nuclear fractions were separated and
analyzed for the presence of the cytoplasmic fragment using
an antibody directed against this domain (6615F) (Alfandari
et al., 1997). When ADAM13 is transfected into 293T cells,
a 17 kDa fragment is detected in the nuclear extract (Figure 2B,
arrowhead). This is also the case following transfection with
a fusion protein containing the cytoplasmic domain of ADAM13
fused to GFP (GFP-C13) but not with GFP alone. To determine
if the same cleavage also occurs in vivo, we analyzed protein

Figure 1. ADAM13 and 19 Cooperate during CNC Migration
(A) Schematic representation of the grafts. Donor embryos are injected in one
cell at the 2-cell stage with GFP, or combinations of GFP, MO against ADAM13
and 19 and mRNA encoding various ADAM constructs. At stage 15, CNC are
dissected and grafted into host embryos. CNC migration is visualized using
a fluorescent microscope.
(B) Fluorescence photographs of representative grafted embryos at stage 24.
A positive migration is only counted if cells have progressed ventrally in one or
more of the posterior arches.
(C) Histogram representing the analysis of CNC migration in at least three independent experiments. The error bars correspond to the standard deviation
(SD). n: number of embryos.
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extract from either control embryos or embryos injected with
MO13. As seen in transfected cells, the ADAM13 antibody
recognizes a 17 kDa fragment present in control embryos but
absent in morphant embryos (Figure 2C). To test if GS is responsible for the cleavage of ADAM13 we treated Cos-7 cells with two
pharmacological inhibitors of GS. Indeed, both ILCHO (McLendon et al., 2000) and DAPT (Hemming et al., 2008) prevented
the accumulation of the ADAM13 cytoplasmic domain in the
nuclear fractions (Figure 2D). GS are known to cleave proteins
just distal to the transmembrane domain, which for ADAM13
would release a fragment of 21 kDa. Our results showing that
the fragment is approximately of 17 kDa and that the GFP-C13
fusion protein is also cleaved, although never associated with
the plasma membrane, suggest that subsequent cleavage by
a different enzyme may occur following the initial gamma-secretase cleavage. The absence of the 17 kDa fragment in cells
treated with the GS inhibitors suggests that this first step is critical. Using immunofluorescence, the cytoplasmic domain of
endogenous ADAM13 was also detected in the nucleus of
Xenopus S3 cells in foci that stained less intensely for DAPI suggesting that the DNA in this region is euchromatic and potentially
transcriptionally active (Figure S2).
The nuclear localization depends on the KR subdomain while
the PR subdomain directs a GFP-fusion protein to membrane
ruffles and actin stress fibers (Figure 2E). This is consistent
with a predicted bipartite nuclear localization signal in the KR
region (Hulo et al., 2008), and suggests that, as shown for
ADAM12, the cytoplasmic domain of ADAM13 may interact
with proteins of the cytoskeleton (Cao et al., 2001a). The nuclear
localization of GFP-C13 was also visible when the protein was
expressed in Xenopus embryos (Figure S2C).
To assess the contribution of nuclear localization to the function of the ADAM13 protein, we introduced a nuclear export
signal (NES), based on the net-NES prediction software
(la Cour et al., 2004), by adding one leucine at position 877 in
the PR domain of both ADAM13 (ADAM13-NES) and GFP-C13.
To test if the NES was functional we expressed GFP-C13NES
in XTC cells and detected its localization in live cells. Depending
on the cell, GFP-C13NES was either entirely cytoplasmic (Figure 2E) or was present in both the nucleus and the cytoplasm
of XTC cells (data not shown), suggesting that the NES is functional but that it does not prevent the translocation into the
nucleus.
Translocation of the Cytoplasmic Domain Is Critical
for ADAM13 Function during CNC Cell Migration
To investigate the role of the cytoplasmic domain of ADAM13
in vivo, we injected embryos with MO13 alone or together with
MO19. The injections were performed at the 8 to 16-cell stage
in a single cell that contributes to the CNC, and GFP or RFP
was used as a lineage tracer to follow the ability of cells to
migrate in vivo (McCusker et al., 2009) (Figure 3). Injection of
MO13 inhibited CNC migration in 30% of the embryos, while
the coinjection of MO13 and MO19 inhibited migration in 79%
of the embryos. As seen for the grafts, injection of RNA encoding
ADAM13, but not DCyto, rescued CNC migration. This technique
presents two main advantages over the graft. First, it allows the
injection and analysis of a greater number of embryos enabling
us to test multiple proteins and mutants. Second, since the

embryos do not have to be dissected, the migration pathways
between the epidermis and the mesoderm remain intact, which
could potentially explain why the targeted injection of MO13
inhibits CNC migration more efficiently than in the grafts. For
these reasons, we used the targeted injection for the remainder
of this study.
We then performed complementation experiments by coinjecting DCyto together with GFP-C13 in the morphant embryos,
and this combination rescued migration as efficiently as
ADAM13 (Figure 3B). Neither the single point mutant of
ADAM13 containing a NES (A13-NES), nor GFP-C13 alone,
was capable of rescuing migration. While mutations in the cytoplasmic domain affected the ability of ADAM13 to promote CNC
migration they did not affect the proteolytic activity, as shown by
the ability to cleave the protocadherin PAPC (Figure 3C). The
abnormal migration in ADAM13 KD was confirmed using in situ
hybridization with twist to detect the position of CNC after migration (Figure S3).
Taken together, these results show that both the proteolytic
activity and the cytoplasmic domain of ADAM13 are essential
for CNC migration in vivo. They also show that the cytoplasmic
domain does not need to be attached to the extracellular domain
or to the plasma membrane, but only needs to translocate and
remain in the nucleus (absence of rescue by ADAM13-NES) to
perform its critical function.
Since ADAM13 is capable of cleaving itself in the cysteine-rich
domain, we tested whether the autocatalysis of ADAM13 was
essential to generate the cleaved cytoplasmic domain. We injected the E/A-ADAM13, which is incapable of self-processing,
together with DCyto mRNA in morphant embryos. This combination did not rescue CNC migration (Figure 3E) suggesting that,
in vivo, the initial autocatalytic cleavage is required for the
secondary cleavage by GS.
The ADAM19 Cytoplasmic Domain Can Compensate
for ADAM13
To investigate if other ADAMs could compensate for the loss of
the ADAM13 cytoplasmic domain, we made GFP-fusions with
the cytoplasmic domains of Xenopus ADAM9, 10 and 19 which
all translocated into the nucleus of transfected XTC cells (Figure 3D). In complementation experiments, the cytoplasmic
domain of ADAM19 was able to rescue migration, while neither
the ADAM9 nor the ADAM10 cytoplasmic domains could (Figure 3E). Given that ADAM9 can cleave Cadherin-11 (McCusker
et al., 2009) and ADAM19 can compensate for the loss of the
ADAM13 cytoplasmic domain, the presence of both proteins in
the CNC may explain why the loss of ADAM13 only produces
defective migration in 30%–50% of the embryos, while the
double KD of ADAM13 and 19 inhibits migration in 80% of the
embryos.
The Functionality of the ADAM13 Cytoplasmic Domain
Is Evolutionarily Conserved
To test whether the function of the ADAM13 cytoplasmic domain
is evolutionarily conserved, we cloned the cytoplasmic domains
of the putative ADAM13 orthologs from worm (adm-2), zebrafish
(ADAM19a), marsupial (ADAM13), and mouse (ADAM33) in
frame with GFP. While the C. elegans (ceCm), zebrafish
(drC13), and the opossum (mdC13) constructs all translocated
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into the nucleus and rescued CNC migration, the mouse
(mmC33) construct did neither (Figures 3D and 3E). Using the
mouse constructs, the cytoplasmic domain of ADAM19 but not
ADAM12 was able to rescue CNC migration (Figure 3E). This
demonstrates that even within the meltrin subfamily, the cytoplasmic domains, which share proline-rich repeats and basic
residues, possess a relatively strict specificity in regulating cell
migration.

Figure 2. ADAM13 Cytoplasmic Domain Translocates to the Nucleus
(A) Schematic representation of ADAM13 proteolytic processing (left). The
Pro-domain is cleaved during transit to the cell surface (1). A second extracellular cleavage within the cysteine-rich domain has also been documented (2),
releasing the active protease. The cytoplasmic domain is cleaved by GS (3).
The GFP-fusion protein corresponding to the ADAM13 cytoplasmic domain
and the various mutants are represented (right).
(B) Western blot of ADAM13 cytoplasmic domain. 293T Cells were transfected
with GFP, GFP-C13, and wild-type ADAM13 (A13). Cells were fractionated to
generate a cytoplasmic (C) and a nuclear (N) fraction. Fractions were analyzed
by western blot using a polyclonal antibody to the cytoplasmic domain of
ADAM13 (arrowhead) (Alfandari et al., 1997). All membrane-bound fragments
of ADAM13 are found both in the cytoplasmic fraction (plasma membrane)
and in the nuclear fraction (ER attached to the nuclear membrane). The nuclear
protein PARP is found in the nuclear fraction, while GAPDH is in the cytoplasm.
(C) ADAM13 was immunoprecipitated from 10 embryos using a goat polyclonal
antibody. Noninjected embryos (NI) at stage 12 (gastrula) and stage 18 (neurula)

Role of the ADAM13 Cytoplasmic Domain
To understand the role of the cytoplasmic domain of ADAM13 in
the nucleus, we then tested if this domain could regulate gene
expression in the CNC. We dissected CNC from embryos injected with either a control MO (CMO), MO13 alone, or with
both MO13 and GFP-C13. Gene expression was assayed using
microarrays on independent triplicate experiments (Affimetrix,
BioMicro Center MIT core facility). The results of the overall analysis of gene expression show that the variation between experiments is greater than the variation between samples within each
experiment, suggesting that the level of gene expression in
outbred Xenopus populations is highly variable, and that the
analysis should be carried within each batch of sibling embryos
before comparing multiple experiments. These data have been
submitted in NCBI’s Gene Expression Omnibus (Edgar et al.,
2002) and are accessible through GEO series accession number
GSE21517.
We therefore used paired student t test (TM4 software suite
(Saeed et al., 2006)) to identify genes that were significantly
affected by the loss of ADAM13 (p < 0.01). A surprisingly large
number (40%) of genes were identified (matrix2). However within
these 6121 genes, only 172 were increased or decreased by
more than 40%, suggesting that ADAM13 is required for the
correct expression of a large number of genes, and that it serves
to modulate target gene expression rather than switch them on
or off.
We then performed another t test within this first set of genes
(6121) to identify those that were also significantly affected by
the presence of the ADAM13 cytoplasmic domain (p < 0.01),
and found that one third of these genes were (2096, matrix3).
We further consolidated the data by keeping only the genes
that were either reduced or increased with a minimum variation
of 40% (174 genes). Examples of genes affected by the
ADAM13 knockdown and the cytoplasmic domain rescue are
given in Figure 4A. These data show that the ADAM13 cytoplasmic domain can modulate the expression of multiple genes
in the CNC cells.
Calpain8-a Can Rescue Migration in CNC Lacking
the ADAM13 Cytoplasmic Domain
To identify genes regulated by the ADAM13 cytoplasmic domain
that are essential for CNC migration we performed quantitative
are compared with sibling embryos injected with MO13. The ADAM13 protein
was detected using 6615F.
(D) Cos-7 cells transfected with ADAM13 were treated for 4 hr with GS inhibitors
(+, ILCHO 50 mM or DAPT 10 mM).
(E) Localization of GFP-fusion proteins expressed in XTC cells. Hoechst was
used to detect the nuclei in cells transfected with GFP-C13NES.
See also Figure S2.
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Figure 3. ADAM13 Cytoplasmic Domain Is Critical for Cranial Neural Crest Cell Migration
(A) Lateral view of representative embryos injected with RFP and a control MO (CMO) or with MO13 (see also Figure S4). The white arrows point to the fluorescence observed in the three main CNC segments (from left to right, Mandibular Hyoid and Branchial).
(B) Histogram representing the percentage of embryos in which CNC migration was inhibited by either MO13 (black bars) or MO13 and MO19 (2MO, gray bars).
The numbers on the right indicate the number of embryos scored for each construct (schematic representation to the left). Statistical significance (at least three
independent experiments) was calculated using a Student’s t test p < 0.05. Significant rescue is indicated with an asterisk (*), and error bars are SD.
(C) Western Blot from Cos-7 cells transfected with various ADAM13 constructs and the protocadherin PAPC. The cell extract (Cell) and the glycoprotein purified
from the culture supernatant (Media) were probed with an antibody to the extracellular domain of PAPC. The cell extract was also probed with the 7C9, a monoclonal antibody to the cysteine-rich domain of ADAM13.
(D) Fluorescence images of live XTC cells transfected with GFP-fusion proteins corresponding to the various ADAM cytoplasmic domains. The ADAM number and
the species are indicated (xl; Xenopus laevis, dr; Danio rerio, mm; Mus musculus).
(E) Histogram representing the rescue experiments described in (A), using a complementation assay. The total number of embryos scored in at least three independent experiments is indicated on the right (N). Asterisk indicate significant rescue (p < 0.05), error bars are SD. The species name is indicated according to
standard nomenclature (ce; Caenorhadbitis elegans, md; Monodelphis domestica).

PCR on CNC with MO13 alone or MO13 plus GFP-C9, -C13,
or -C19 (Figure 4B). We expected that genes important for
CNC migration would be regulated by GFP-C13 and GFP-C19,
but not GFP-C9 since this construct does not rescue migration
(Figure 3). We found that Calpain8-a (Capn8-a) was the only gene
tested that fit the hypothesis. To test whether any of these genes
were important for CNC migration, we injected mRNA encoding
each of the candidates together with MO13 and DCyto in
complementation assays. Only Calpain8-a was able to rescue
CNC migration confirming that at least one gene regulated by
the ADAM13 cytoplasmic domain is required for CNC migration
(Figure 4C and 4D). The role of Calpain8-a in CNC migration was
confirmed using both a DN (Cao et al., 2001b) and a KD (MO to

prevent splicing). Using these two reagents in targeted injections, we found that CNC migration was inhibited by !40%
with the MO and !30% with the DN (Figure 4C). Together these
results demonstrate the importance of Calpain8-a in CNC migration and confirm that one of the essential roles of the ADAM13
cytoplasmic domain is to increase Calpain8-a expression.
DISCUSSION
Role of ADAM Cytoplasmic Domains
The cytoplasmic domains of ADAM10 (Tousseyn et al., 2009)
and ADAM13 are cleaved and translocate into the nucleus, suggesting that this may be a general feature of ADAMs. Our study
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Figure 4. The Cytoplasmic Domain of
ADAM13 Regulates Gene Expression
(A) Representative genes were selected from the
microarray data. The average fold change
between the control MO and MO13 (MO13) or
between MO13 and the rescue MO13 plus GFPC13 (MO13+C13) is represented as a Log2. Error
bars represent the SD. Four groups of genes are
presented. Xmc (Xenopus Marginal Coil), pafr
(Platelet-activating factor receptor), capn8-a (Calpain8-a), wnt3-A (Wingless-type MMTV integration site 3A), and pou50 (Pou-homeobox gene
50) are decreased in CNC injected with MO13
and are partially rescued by GFP-C13. nudc
(Nuclear distribution gene C), rad1 (Cell cycle
check point), and vamp8 (Vesicle-associated
membrane protein 8) are increased in CNC lacking
ADAM13, and rescued by GFP-C13. dusp18 (Dual
specificity Phosphatase 18) and mek-2 (Erk
Kinase) are increased in CNC with MO13, while
camK1 (Calcium/calmodulin-dependent protein
kinase 1) and dap (Death-associated protein
kinase 1) are decreased, with no significant effect
from GFP-C13.
(B) Histogram representation of quantitative PCR
data. Amplification was performed from cDNA isolated from CNC of embryos injected with either
MO13 or a combination of MO13, plus the cytoplasmic domains of ADAM9 (blue), ADAM13
(red), or ADAM19 (green). Values are represented
as the Log2 fold change compared with MO13
alone. Error bars correspond to the SD between
triplicates. (myt1: myelin transcription factor 1,
fst: follistatin, nubp1: nucleotide binding protein
1, inta6: Integrin alpha 6).
(C) Complementation assays with embryos injected with MO13 plus DCyto alone or with MMP13, Calpain8-a, or Xmc. CNC migration was also measured in
embryos injected with a MO to Calpain8-a or a DN Calpain8-a construct (Capn8-aC105S). The total number of embryos is given (n). Error bars correspond
to the SD. Statistical analysis was done using a Student’s t test. Asterisk represents p values <0.01, for (A) or <0.05 for (B). Representative examples are given
in (D).

shows that this translocation is essential for ADAM13 to increase
Calpain8-a expression and promote CNC migration. Calpains
have been linked to cell migration but their role is not entirely
solved. They may affect cell migration by cleaving components
of focal adhesions such as integrins, focal adhesion kinase and
talin at the trailing edge of the cell to control the release of the
cell membrane from the substrate (Franco and Huttenlocher,
2005). Other studies have shown that they can cleave b-catenin
to remove the GSK3 phosphorylation sites and generate a stable
form that can translocate into the nucleus and induce the expression of target genes including those involved in epithelium to
mesenchyme transition (Abe and Takeichi, 2007). The MO that
prevents Calpain8-a splicing will be useful to test the various
hypotheses and determine the exact contribution of this
protease during CNC migration.
Our results clearly show that while multiple ADAM cytoplasmic
domains can translocate into the nucleus, they have distinct and
specific functions that will need to be elucidated for each protein
and may contribute to the overall function of the protein, as well
as the robust effect of the DN constructs that have been used in
the past. These DNs, lacking the proteolytic activity, are often
more potent at producing a phenotype than the elimination of
the protein (Alfandari et al., 2001; Pan and Rubin, 1997). This
could be the result of overexpressing the cytoplasmic domain

both in cells that normally express the target ADAM and ectopically in cells that do not.
In physiological situation, it will be interesting to determine the
role of the cytoplasmic domain of nonproteolytic ADAMs. In
pathological conditions, it will be of interest to define mutations
in the cytoplasmic domain of ADAMs that are associated with
specific diseases and determine if these affect the cleavage,
translocation, or other activity of this domain in and out of the
nucleus.
Evolutionary Conservation of the ADAM13 Protein
Function
Here, we show that the single meltrin found in C. elegans, as well
as the orthologs of ADAM13 in fishes and marsupials but not in
eutherians (placental mammals), can functionally replace the
cytoplasmic domain of Xenopus ADAM13. In eutherians, the
most likely ortholog is ADAM33, but its cytoplasmic domain is
not conserved in either sequence identity (it is acidic rather
than basic) or function. In the mouse and human genomes there
is no better candidate, making it likely that the role of the
ADAM13 cytoplasmic domain has been lost. The duplication of
the single meltrin (c.e.adm-2) during evolution has generated
four distinct ADAMs in vertebrates (ADAM9, 12, 13/33, 19). Of
these, ADAM13 and ADAM19 maintained the original nuclear
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function in most vertebrates, while after the divergence between
marsupials and eutherians the function was lost in ADAM13/33.
This could have been facilitated by the ability of the ADAM19
cytoplasmic domain to assume ADAM13 role, decreasing the
selection pressure.
It will be interesting to identify the sequence that allows the
ADAM13 and 19 cytoplasmic domains to selectively activate
Calpain8-a and promote CNC migration. Clearly, the proline
repeats and basic amino acids are required but not sufficient
since ADAM9 and 12 possess both but are not capable of
rescuing cell migration.
Conclusions
ADAMs are multifunctional proteins that have been studied
extensively with regard to their proteolytic activities. While this
domain is clearly one of the most important of the protein, the
sum of all domains is required to control not only substrate specificity and subcellular localization, but also cell signaling.
EXPERIMENTAL PROCEDURES
Morpholinos
Morpholino antisense oligonucleotides (Genetool) against ADAM13 and
ADAM19 have been described previously (McCusker et al., 2009; Neuner
et al., 2009). Two control-morpholinos were used. One corresponds to
a randomly generated sequence of 25 mer and the other corresponds to a standard sequence (CCTCTTACCTCAGTTACAATTTATA). The morpholino antisense oligonucleotide to Calpain8-a (GAAAGTTATGAGACAACACCTGCTT)
was designed to prevent splicing. The realtime PCR primers were used to
amplify genomic DNA containing an intron, which was cloned and sequenced.
The efficiency was tested by realtime PCR from polyA-RNA purified from
embryos injected with 25, 12.5, and 6.25 ng of MO-capn. Eighty percent to
90% KD of calpain8-a mRNA was achieved using the lowest dose. A dose
of 1 ng at the 8-cell stage was chosen for the migration assay.
Antibodies
The following antibodies were used: 6615F: rabbit polyclonal antibody to the
ADAM13 cytoplasmic (Alfandari et al., 1997), gA13: goat polyclonal antibody
to the ADAM13 cytoplasmic, 7C9: mouse monoclonal to the ADAM13
cysteine-rich domain (Gaultier et al., 2002). PARP: mouse monoclonal C2-10
(BD, PharMingen). GAPDH: mouse monoclonal antibody 6C5 (Millipore).
PAPC: mouse monoclonal to the extracellular domain (Chen and Gumbiner,
2006).
Injections
Capped mRNA were synthesized using SP6 RNA polymerase on DNA linearized with NotI as described before (Cousin et al., 2000). For the CNC migration
assays, embryos were injected at the 16-cell stage in one dorsal animal blastomere with 1 ng of MO, 200 pg of RFP mRNA, and 80 pg of mRNA encoding
various constructs. For the graft assays, embryos were injected at the two cell
stage with 5 ng of MO, 300 pg of GFP mRNA, 400 pg of ADAM13 mRNA, or 200
pg of ADAM19 mRNA. Embryos were raised at 15! C until tail bud stage (St. 24–
28) at which time CNC migration was scored. The percentage of inhibition was
normalized to embryos injected with RFP or GFP alone.
For the gene expression analysis, embryos were injected at the one cell
stage with 10 ng of either a CMO, MO13, or MO13 plus 0.5 ng of GFP-C13.
Embryos were grown at 15! C for 48 hr until neurula stage (St. 15–17), at which
point CNC were dissected and immediately placed in a guanidium thioisocyanate solution to extract RNA. To control for the viability of the explants, four
CNC explants were placed on fibronectin and imaged by time-lapse microscopy using a Zeiss 200M inverted microscope and the openlab4 software (Improvision). CNC from each condition were capable of migrating in vitro. RNA
extraction was performed as previously described (Chomczynski and Sacchi,
1987). Total RNA was quantified by absorbance at 260 nm using a nanodrop
(Thermo Scientific).

RNA Amplification/Affymetrix Microarray
RNA were processed by the MIT core facility as described in the Supplemental
Experimental Methods.
Quantitative PCR
Quantitative PCR was performed as previously described (Neuner et al., 2009).
All primers were tested for efficiency. Primer sequences are given in Table S4.
cDNA was produced using polyA mRNA purified from 10 CNC explants
(QIAGEN) using direct cDNA kit (Quanta) according to manufacturer’s
instruction.
Cell Culture and Transfection
Cos-7 cells and 293T cells were obtained from ATCC and transfected using
Fugene-6 according to manufacturer’s instruction. Protein analysis was
done 48 hr after transfection. Cos-7 cells were trypsinized while 293T cells
were collected by pipetting into ice cold PBS. Nuclear and cytoplasmic fractions were isolated using the NE-PER kit (Pierce) following manufacturer’s
instruction. For PAPC shedding assay, cells were incubated with media containing 2% serum 24 hr after transfection and conditioned supernatants
were collected at 48 hr. The shed extracellular domain was purified using
Concanavalin-A-agarose (Vector), eluted in reducing Laemmli and blotted
using the PAPC monoclonal antibody (Chen and Gumbiner, 2006).
Fluorescence
Xenopus XTC cells were transfected using Fugene-HD following manufacturer’s instruction and placed on FN-coated glass bottom plates (Matek
Corp.). Cells were transfected with the GFP-fusion proteins, and were incubated with Hoechst (Invitrogen) to label nuclei. Photographs were taken using
a Zeiss 200M inverted microscope equipped with an Apotome and a 633
immersion lens to obtain optical sections. For in vivo CNC migration assays,
tailbud stage embryos were imaged using a Nikon fluorescent dissecting
microscope.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found online at doi:10.1016/j.devcel.
2010.12.009.
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GSK3 and Polo-like kinase regulate ADAM13
function during cranial neural crest cell migration
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ABSTRACT ADAMs are cell surface metalloproteases that control multiple biological processes by cleaving signaling and adhesion molecules. ADAM13 controls cranial neural crest
(CNC) cell migration both by cleaving cadherin-11 to release a promigratory extracellular
fragment and by controlling expression of multiple genes via its cytoplasmic domain. The latter activity is regulated by c-secretase cleavage and the translocation of the cytoplasmic domain into the nucleus. One of the genes regulated by ADAM13, the protease calpain8, is
essential for CNC migration. Although the nuclear function of ADAM13 is evolutionarily conserved, it is unclear whether the transcriptional regulation is also performed by other ADAMs
and how this process may be regulated. We show that ADAM13 function to promote CNC
migration is regulated by two phosphorylation events involving GSK3 and Polo-like kinase
(Plk). We further show that inhibition of either kinase blocks CNC migration and that the respective phosphomimetic forms of ADAM13 can rescue these inhibitions. However, these
phosphorylations are not required for ADAM13 proteolysis of its substrates, c-secretase
cleavage, or nuclear translocation of its cytoplasmic domain. Of significance, migration of the
CNC can be restored in the absence of Plk phosphorylation by expression of calpain-8a,
pointing to impaired nuclear activity of ADAM13.
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INTRODUCTION
Proteases of the family “a disintegrin and metalloprotease” (ADAM)
are transmembrane proteases that play crucial roles during development and disease progression. They are the major protease family involved in the shedding of membrane-bound proteins (cleavage
within the extracellular domain) and thus provide a means for rapidly modifying the level and function of proteins on the cell surface.
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Their shedding activity is central to the regulation of cell–cell and
cell–substratum adhesion, as well as critical signaling pathways such
as Notch, epidermal growth factor (EGF), Eph/ephrin, and Wnt. This
can control various cell processes, such as fate determination,
growth, survival, and migration (Alfandari et al., 2009).
We previously showed that in Xenopus laevis, the meltrin ADAMs
9, 13, and 19 all play important and partially overlapping roles in the
cranial neural crest (CNC; McCusker et al., 2009; Neuner et al.,
2009; Cousin et al., 2011, 2012). The CNC is a group of stem cells
that undergoes extensive migration in the embryo and gives rise to
the various craniofacial structures of all gnathostomes, including
bones, cartilage, and cranial ganglia (Santagati and Rijli, 2003). We
showed that ADAM13 plays a dual role in CNC migration. On the
cell surface, ADAM9 and ADAM13 are both capable of cleaving the
cell adhesion molecule cadherin-11 to release its adhesive extracellular domain to stimulate migration (McCusker et al., 2009). Intracellularly, the ADAM13 cytoplasmic domain possesses a surprising
ability to control gene expression when it is cleaved from the membrane-bound protease by G-secretase and shuttled to the nucleus.
The cytoplasmic domains of ADAM13 and 19 can both activate the
expression of the cytoplasmic protease calpain8-a, and this is required for CNC migration (Cousin et al., 2011). Nuclear translocation is also seen for the cytosolic tail of human ADAM10 and is believed to contribute to prostate cancer progression, suggesting that
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an independent function for the ADAM cytoplasmic domain separate from the metalloprotease activity may be a conserved feature
among ADAMs (Arima et al., 2007; Tousseyn et al., 2009). In addition to its role in regulating gene expression, the cytoplasmic domain of ADAM13 also regulates its own protein level (Alfandari
et al., 2001) and binds to the SH3-containing protein PACSIN2,
which appears to negatively regulate ADAM13 activity in vivo
(Cousin et al., 2000).
Phosphorylation of the cytoplasmic domain has been implicated
in regulating the function of several ADAMs, although these studies
mainly focused on the mechanism of controlling the proteolytic activity. For example, the ADAM9 cytoplasmic domain can bind to and
be phosphorylated by protein kinase C D (PKCD), and the activation
of PKC by phorbol ester stimulates ADAM9 shedding of HB-EGF
(Izumi et al., 1998). In addition, in response to either PKC activation
or growth factor stimulation, ADAM17 is phosphorylated by extracellular signal-regulated kinase (ERK), and this is required for efficient ectodomain shedding of the TrkA receptor tyrosine kinase by
ADAM17 (Diaz-Rodriguez et al., 2002; Soond et al., 2005). It is not
clear how these phosphorylation events regulate ADAM function
and whether they serve to directly modify the enzymatic activity of
the protease or mediate interactions with intracellular binding
partners.
ADAM13 contains multiple predicted kinase target sites within
the cytoplasmic domain, including Polo-like kinase (Plk) and glycogen synthase kinase 3 (GSK3). Plk is a well-conserved serine/
threonine kinase family containing five members (Plk1–5) that has
traditionally been studied for activities in cell cycle progression,
such as promoting spindle assembly and centrosome maturation
(Petronczki et al., 2008; Stuhlmiller and Garcia-Castro, 2012).
However, more recently, Plks have been noticed for nonproliferative functions, such as neuronal differentiation and synaptic homeostasis (de Carcer et al., 2011), as well as cell migration and
invasion of breast cancer cells (Rizki et al., 2007). GSK3, which includes the A and B isoforms, is also a serine/threonine kinase with
many cellular substrates and can affect diverse cell processes,
such as apoptosis, cell cycle, cell polarity, and migration (Doble
and Woodgett, 2003; Sun et al., 2009). It participates in multiple
signaling pathways, including canonical Wnt signaling, which is
known to play a role in the specification of the CNC (Stuhlmiller
and Garcia-Castro, 2012).
In this study, we identify novel roles for Plk and GSK3 in the CNC
and show that decreasing the activity of either kinase inhibits cell
migration in vivo. Our findings suggest that ADAM13 is an important substrate and is phosphorylated by GSK3 at two sites (serines
752 and 768) and by Plk at threonine 833. Kinase regulation at these
residues is not required to induce ectodomain shedding by ADAM13
but does appear to be important for the nuclear function of
ADAM13. In the absence of phosphorylation at the Plk site, CNC
cell migration can be recovered by increasing the transcript levels of
the critical target gene calpain8-a, indicating that phosphoregulation plays a significant role in the intracellular signaling activity of
ADAM13.

RESULTS
ADAM13 phosphorylation sites are critical during CNC
migration
To better understand how ADAM13 function is regulated, we identified several putative phosphorylation sites within the cytoplasmic
domain using protein prediction software (ELM; Dinkel et al., 2014).
To ask whether phosphorylation at any of these sites is functionally
important for ADAM13 activity during CNC migration, we replaced

FIGURE 1: Phosphorylation sites are required for ADAM13 function
during CNC migration. (A) Fluorescence images showing
representative embryos for the injections of RFP alone, the
knockdown with 2MO, or the rescue with wild-type ADAM13. Arrows
indicate the position of the three migration segments (from left to
right: hyoid, branchial, mandibular). (B) Histogram of targeted
injection assays testing the ability of ADAM13 phosphomutants to
rescue CNC migration in ADAM13/19-deficient embryos (2MO) from
at least three independent experiments. Values are percentages of
embryos with no CNC migration, normalized to 2MO + wild-type
ADAM13. The error bars correspond to the SD. n, number of embryos
scored for each case. Statistical significance of rescue: *p < 0.05,
**p < 0.01.

the specific residues with either an alanine to prevent phosphorylation or a negatively charged aspartate to mimic constitutive phosphorylation. We chose targeted injection as the most direct technique to test the ability of these variants to replace the function of
endogenous ADAM13 in the CNC (Figure 1A). In this technique, a
single CNC precursor cell is injected with red fluorescent protein
(RFP) as a lineage tracer to follow migration in vivo (McCusker et al.,
2009). In these experiments, percentage inhibition represents the
percentage of embryos without CNC migration rather than a decrease in migration length, which can be subjective. Because cleavage patterns can vary in different batches of embryos, we used RFP
alone in each experiment to determine the targeting efficiency and
normalized the results. In each experiment, the ability of the mutant
to rescue migration was compared with wild-type ADAM13. For this
assay, we knocked down both ADAM13 and ADAM19 using morpholino oligonucleotides (MOs), since we have shown that the cytoplasmic domains of these ADAMs have overlapping functions and
can regulate calpain8-a gene expression to stimulate migration
(Cousin et al., 2011). Our results show that replacing ADAM13 with
nonphosphorylatable constructs for the GSK3 (A13-Gsk/A) or the
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Plk sites (A13-Plk/A) did not rescue CNC migration in morphant embryos. Conversely, the phosphomimetic for either of these sites
(A13-Gsk/D or A13-Plk/D, respectively) is able to significantly rescue
migration (Figure 1B and Supplemental Figure S1). This suggests
that phosphorylation at the GSK3 and Plk sites is essential for
ADAM13 function in the CNC.
The binding of Plk to its substrate often requires that the substrate first be phosphorylated at the sequence Ser-(pSer/pThr)(Pro/X). Once bound to its phospho-primed substrate, Plk will phosphorylate it at a different locus (Elia et al., 2003). Of interest,
ADAM13 contains three of these consensus motifs, two of which are
also the putative GSK3 target sites. Therefore we generated complementary amino acid substitutions that would block phosphorylation at one site (GSK3 or Plk) while mimicking phosphorylation at the
other to determine whether the GSK3 and Plk phosphorylation sites
are functionally linked or independent. These data show that mimicking phosphorylation at the GSK3 sites is not sufficient to rescue
ADAM13 function when the Plk phosphorylation site is blocked
(A13-Gsk/D-Plk/A; Figure 1B). However, the phosphomimetic Plk
site is capable of rescuing the nonphosphorylatable GSK3 sites
(A13-Gsk/A-Plk/D).
To confirm the migration results, we also performed in situ
hybridization (ISH) on embryos injected with the two morpholinos
(MO13 and MO19 [2MO]) at the one-cell stage and further injected
at the eight-cell stage with the various ADAM13 constructs. Embryos
were sorted left and right before ISH using the fluorescent lineage
tracer coinjected with the rescue mRNA. We used a combination of
Sox10 and Twist probes to detect early- and late-migrating cells,
respectively. To our surprise, most of the embryos showed a relatively normal positioning of CNC (Supplemental Figure S2). We then
measured the length of CNC segments on both sides of each
embryo and scored the number of embryos in which the length varied by >20% on the side injected with mRNA compared with the
contralateral side with 2MO alone (Supplemental Figure S2; green,
increase in segment length; red, decrease in segment length). The
results obtained for A13-Plk/D (rescue), A13-Gsk/A (no rescue), and
A13-Gsk/D (rescue) were all consistent with the targeted injection
results, whereas the results using A13-Plk/A were not (equal number
of rescue and worsening of the phenotype).
To understand why the ISH results did not show the obvious
CNC positioning defect, we performed grafts with CNC lacking
ADAM13 and 19 and expressing the A13-Plk/A mutant. As seen for
the targeted injections, CNC migration was not observed in these
grafts (Supplemental Figure S3A). We then fixed the embryos and
performed ISH. The results show that even in these embryos in
which the grafted CNC did not migrate, the overall ISH pattern was
mostly normal (Supplemental Figure S3B). Collectively these results
show that ISH is not always a reliable method to measure cell migration (see Discussion) and that, when possible, analysis of lineage
tracer should be used.
We then tested, first, whether the two kinases were present in the
CNC and, second, whether they could phosphorylate ADAM13. To
answer the first question, we performed a Western blot on CNC dissected at stage 17 using antibodies specific to either kinase. Indeed,
each antibody detected the predicted size band (Figure 2A), demonstrating that both GSK3 and Plk proteins are present in the CNC
during migration. We then produced an antibody against a phosphorylated peptide corresponding to the Plk site in ADAM13. The
antibody was affinity purified against the phosphorylated peptide
and affinity depleted with the nonphosphorylated peptide. Human
HEK293T cells were transfected with either the wild-type ADAM13
or the nonphosphorylatable mutant A13-Plk/A. We found that wild-

FIGURE 2: GSK3 and Plk can phosphorylate ADAM13. (A) Western
blots for Plk1 (68 kDa) and GSK3B (47 kDa) on protein extract from
27 dissected CNC (CNC) or one total embryo equivalent at the same
stage as dissection (Tot St17). (B) Western blot showing
phosphorylation of ADAM13. The main forms of ADAM13 protein are
represented at the top. The pro form (P) contains the prodomain and
is inactive, the mature form (M) is proteolytically active, and cleavage
of the metalloprotease domain results in a shorter form (D) that
appears to be the principal phosphorylated form of ADAM13. Nuclear
Cherry (nCherry, negative control), ADAM13 (A13), or the
nonphosphorylatable mutant (A13-Plk/A) was expressed in HEK293T
cells. Cells expressing ADAM13 were treated overnight with dimethyl
sulfoxide (DMSO), Plk inhibitor (Plk Inh), or GSK3 inhibitor (Gsk Inh).
All of the samples were first immunoprecipitated with a monoclonal
antibody to ADAM13 (mAb 4A7), followed by Western blot using the
phospho-ADAM13 antibody to the Plk phosphorylation site (P-A13)
or the rabbit polyclonal to the ADAM13 cytoplasmic domain 15F for
the total ADAM13 protein (Tot). (C) Autoradiograph of immunoprecipitated ADAM13 produced in HEK293T cells phosphorylated
by purified active GSK3.

type ADAM13 was clearly phosphorylated in these cells, whereas
the mutant was not (Figure 2B). In addition, treatment of the cells
with either a Plk inhibitor or a GSK3 inhibitor prevented this phosphorylation, showing that in HEK293T cells, endogenous Plk did
phosphorylate ADAM13. This further suggests that in the absence
of GSK3, Plk did not phosphorylate ADAM13. Of interest, in these
cells, the main form of ADAM13 phosphorylated is shorter (^65 kDa)
than the mature ADAM13 (M; 100 kDa), suggesting that this form
may not contain the metalloprotease domain (form D). This shorter
form of ADAM13 is also the one phosphorylated in vitro by purified
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GSK3 (Figure 2C). Phosphorylation was increased in the ADAM13
mutant A13-Gsk/D, suggesting that the third GSK3 phosphorylation
site (885T) of ADAM13 can also be phosphorylated in vitro.

GSK3 and Plk activity are required for ADAM13 function
in CNC migration
Our mutation analysis suggests that GSK3 and Polo kinases should
be required for CNC migration at least to phosphorylate ADAM13.
Because these kinases are critical in multiple biological processes,
we next tested whether lowering their activity in the CNC would
cause a defect in migration without other major developmental defects. In particular, GSK3 was shown to phosphorylate the transcription factor Twist to modify its activity (Lander et al., 2013). A nonphosphorylatable form of Twist did not bind to and inhibit Slug/
Snail2, suggesting that phosphorylation by GSK3 is critical for normal Twist function during CNC development. To lower each kinase
activity, we used previously characterized dominant-negative constructs and tested their ability to interfere with CNC migration without inhibiting CNC induction when injected at relatively low doses.
Our results show that 300 pg of the GSK3 dominant negative (GSK3DN; Dominguez et al., 1995) injected at the eight-cell stage in a
CNC precursor perturbed CNC migration in 30% of the injected
embryos, whereas it did not perturb the expression of Slug in premigratory CNC (Figure 3). We also performed grafts on embryos injected with the dominant-negative GSK3 that confirmed that migration was inhibited in these embryos (Supplemental Movie S1). We
then coinjected either wild-type or the phosphomimetic forms of
ADAM13 together with the GSK3-DN to test their ability to rescue
migration. We found that expressing both ADAM13-Gsk/D and
-Plk/D, but not the wild-type ADAM13, could rescue the loss of migration caused by GSK3-DN (Figure 3, B and C). This confirms that
one of the key substrates of GSK3 during CNC migration is ADAM13
and that phosphorylations at the GSK3 and Plk sites are required for
proper ADAM13 function in vivo.
We next tested the requirement of Plk in CNC induction and
migration using low doses of a dominant-negative construct, PlkDN (Descombes and Nigg, 1998). Decreasing Plk activity by injecting 80 pg of Plk-DN mRNA at the eight-cell stage led to 52% inhibition of CNC cell migration (Figure 4A and Supplemental Movie S2).
We then asked whether this migration defect could be rescued by
coexpressing the ADAM13 phosphomimetic variants. In contrast to
GSK3-DN, which was rescued by both phosphomimetics (Figure
3B), only the Plk-mimetic, A13-Plk/D, could restore migration of the
CNC when Plk activity was reduced (Figure 4A). This is consistent
with a model of successive phosphorylation of ADAM13 cytoplasmic domain by which Plk functions downstream of GSK3. To confirm
the effect of Plk-DN on migration, we also performed in situ hybridization to detect the CNC markers Twist and Sox10 and observed
similar results to those obtained by fluorescence in the targeted injection assays. We found that whereas CNC induction appeared
unaffected by Plk-DN, there was a defect in migration caused by
decreasing Plk activity, and this could be rescued by coexpressing
ADAM13-Plk/D (Figure 4, B and C). Taken together, these results
suggest that during CNC migration, ADAM13 is regulated by Plk
and GSK3 phosphorylation and that the Plk phosphorylation is absolutely required, whereas GSK3 phosphorylation can be omitted if
the Plk site is phosphorylated.

ADAM13 protease activity is not regulated by GSK3
or Plk phosphorylation
To determine the effect of GSK3 and Plk phosphorylations on
ADAM13 proteolytic activity, we tested the ability of the nonphos-

FIGURE 3: GSK3 activity is critical for ADAM13 in CNC cell migration.
(A) In situ hybridization using a probe to detect the CNC marker slug
in neurula-stage embryos (st. 14), showing that induction is not
affected by GSK3-DN. Injected sides of each embryo are on the left
(asterisk). (B) Histogram representing the percentage of embryos with
no CNC migration in a targeted injection assay from at least five
independent experiments. Values are normalized to injection of RFP
alone. Error bars are SD. n, number of embryos scored. *p < 0.01,
***p < 0.001. (C) Fluorescence images showing typical result for each
case in the targeted injection assay in B. A defect in migration is
scored by the absence of RFP-labeled cells within the migration
pathway.

phorylatable mutants to cleave substrates both in vitro and in vivo.
When cotransfected with the protocadherin PAPC in Cos-7 cells,
both nonphosphorylatable ADAM13 variants Plk/A and Gsk/A are
able to shed the extracellular domain of PAPC from the cell surface
as efficiently as wild-type ADAM13, whereas the protease activesite mutant ADAM13-E/A cannot (Cousin et al., 2011; Figure 5A).
Similarly, the phosphodeficient variants are also able to undergo
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FIGURE 5: Phosphorylation of ADAM13 does not affect its
proteolytic activity. (A) Western blot from Cos-7 cells transfected with
the protocadherin PAPC and various ADAM13 constructs. The
glycoproteins purified from the conditioned media were probed with
an antibody to the extracellular domain of PAPC or with 7C9, a
monoclonal antibody to the cysteine-rich domain of ADAM13. E/A is a
catalytically inactive variant of ADAM13. (B) The histogram represents
the percentage of embryos displaying no migration from targeted
injection of cadherin-11 mRNA alone or together with the ADAM13
variants. Values are normalized to RFP alone. Error bars are SD.
n, number of embryos scored from at least three independent
experiments. *p < 0.05, **p < 0.01.
FIGURE 4: ADAM13 requires Plk activity in the CNC. (A) Histogram
showing the percentage of embryos with inhibited CNC migration in
a targeted injection assay. Values are normalized to injection of GFP
alone and are from at least three independent experiments. Error bars
are SD. n, number of embryos scored. *p < 0.05, **p < 0.01. (B) In situ
hybridization detecting both of the CNC markers Sox10 and Twist in
early tailbud embryos (st. 21), showing that migration, but not
induction, is decreased by Plk-DN. Injected side of each embryo is on
the left. (C) Analysis of CNC migration from the in situ hybridizations
in B, showing the percentage of embryos for each case with severe,
weak, or no defect in CNC migration on the injected side compared
with the noninjected side of each embryo.

autoproteolysis to shed their own ectodomain into the medium
(Gaultier et al., 2002; Figure 5A). In addition, coexpressing Plk-DN
or GSK3-DN does not prevent wild-type ADAM13 from shedding
PAPC (unpublished data).
To examine ADAM13 protease activity in vivo, we used the targeted injection assay to overexpress the phosphodeficient variants

along with the cell adhesion molecule cadherin-11 in the CNC.
Overexpression of cadherin-11 prevents CNC migration, and this
can be rescued by coexpression of either ADAM13 or the extracellular fragment of cadherin-11 (McCusker et al., 2009). Accordingly,
whereas cadherin-11 blocked migration in 40% of embryos, both
the A13-Plk/A and -Gsk/A variants could rescue migration as efficiently as wild-type ADAM13 (Figure 5B). The results from these in
vitro and in vivo assays indicate that phosphorylation of ADAM13 by
GSK3 and Plk is not essential for the proteolytic cleavage of at least
two of its identified substrates, PAPC and cadherin-11.

Plk controls the nuclear function of ADAM13
The cleaved cytoplasmic domain of ADAM13 (C13) must translocate to the nucleus and increase calpain8-a (Capn8) expression
to promote CNC migration (Cousin et al., 2011). Therefore we investigated whether phosphorylation by Plk is necessary to stimulate
the cleavage of C13 from the membrane-bound protease, its
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FIGURE 6: ADAM13-dependent regulation of calpain8 expression depends on ADAM13 phosphorylation. (A) ADAM13
was immunoprecipitated (IP) from 20 embryos using a goat polyclonal antibody g821. Noninjected embryos (NI) at
stage 18 (neurula) are compared with sibling embryos injected with MO13 or MO13 plus MO-resistant mRNA encoding
ADAM13-Plk/A or wild type. ADAM13 protein was detected by Western blot using 6615F. The polyvinylidene fluoride
membrane was cut below 25 kDa and the two halves probed separately. The cleaved cytoplasmic domain (Cyto) is
observed at 17 kDa for both wild-type and Plk/A ADAM13. Samples of the input for the IP were analyzed by Western
blot with the 8C8 antibody for B1 integrin as a loading control. (B) Fluorescence images showing the localization of
GFP-fusion proteins (green) expressed in Cos-7 cells along with membrane-bound mCherry (red). GFP is observed
uniformly throughout the cytoplasm and nucleus, whereas GFP-C13 and the phosphodeficient mutants all accumulate
strongly in the nucleus. (C, D) Analyses of targeted injection assays displaying the loss of CNC migration as a
percentage of embryos. (C) MO13 + MO19 (2MO) was coinjected with mRNA encoding ADAM13 lacking its
cytoplasmic domain ($Cyto) plus either GFP-C13 wild type or phosphomutants. Values are normalized to the rescue
with GFP-C13 wild type, and Student’s t tests were performed to compare values to 2MO + $Cyto. (D) 2MO was
injected with ADAM13-Plk/A or ADAM13-Gsk/A mRNA alone or together with Capn8 mRNA. Inhibitions are normalized
to RFP, and Student’s t tests were performed against 2MO. Error bars are SD from four or more independent
experiments. n, number of embryos scored. **p < 0.01, ***p < 0.005.

nuclear translocation, or its activity in gene regulation. We first
showed that the cytoplasmic domain of ADAM13-Plk/A is cleaved in
embryos, indicating that intramembrane processing by G-secretase
is not dependent on phosphorylation by Plk (Figure 6A). We then
generated the alanine substitutions at the GSK3 and Plk sites in a
construct containing C13 fused to green fluorescent protein (GFPC13) to observe their subcellular localization. When transfected into
Cos-7 cells, we found that, similar to wild-type GFP-C13, both
variants containing the nonphosphorylatable alanine substitutions,
GFP-C13-Plk/A and GFP-C13-Gsk/A, accumulate in the nucleus
(Figure 6B). Thus the requirements for nuclear translocation of C13
do not rely on phosphorylation at the GSK3 or Plk sites.

To test whether these cytoplasmic domain phosphomutants are
functional in the CNC, we performed a targeted injection assay to
replace endogenous ADAM13 with a version of ADAM13 missing
its cytoplasmic domain (ADAM13-$cyto) complemented with the
different GFP-C13 variants. Similar to the behavior of full-length
ADAM13, we found that only C13-Plk/D could rescue CNC migration
as well as wild type, with no significant rescue when phosphorylation
was abolished (C13-Plk/A). This confirms that Plk phosphorylation is
needed for the function of C13, independent of its extracellular
functions such as proteolytic activity.
Finally, we asked whether the role of Plk phosphorylation is
to regulate the transcriptional activity of C13. We showed that in
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Phosphorylation of ADAM13 does not regulate proteolytic
activity

FIGURE 7: Successive phosphorylation of ADAM13. Proposed model
depicting successive phosphorylation of ADAM13 by which GSK3
primes ADAM13 at two sites (S752 and S768; step 1) for subsequent
phosphorylation at a second site on ADAM13 (T833; step 2). NLS,
nuclear localization signal.

embryos lacking ADAM13 cytoplasmic domain, restoring the levels of Capn8 expression is sufficient to rescue CNC migration
(Cousin et al., 2011). This rescue is only possible if ADAM13 metalloprotease activity is also present. Therefore we tested whether
expressing Capn8 mRNA could rescue the loss of migration in embryos expressing nonphosphorylatable ADAM13 with the two
morpholinos against ADAM13 and 19 at the eight-cell stage.
Capn8 expression was unable to rescue CNC migration when coexpressed with A13-Gsk/A. However, we observed partial but significant recovery when Capn8 was coexpressed with the A13-Plk/A
mutant, which is consistent with the level of recovery obtained
when coexpressed with ADAM13-$cyto (Figure 6, C and D; Cousin
et al., 2011). These results suggest that phosphorylation of
ADAM13 by Plk is important for its ability to regulate Capn8 transcript levels.

DISCUSSION
ADAM13 plays a central role in regulating cranial neural crest
cell migration and induction in amphibian embryos (Alfandari
et al., 2001; Wei et al., 2010; Cousin et al., 2011, 2012). The cytoplasmic domain is critical, as it controls both the level of
ADAM13 protein present in the CNC and the transcriptional activity in these cells (Cousin et al., 2000; Cousin et al., 2011). Here
we show that one of these controls is mediated by a phosphorylation cascade involving GSK3 and Polo-like kinase. We further
demonstrate that these phosphorylations, although essential for
CNC migration, are not critical for ADAM13 cleavage of its extracellular substrates but are essential for the nuclear function of
ADAM13. Our results suggest a model in which ADAM13 is successively phosphorylated in vivo, first by GSK3 to phosphoprime for Plk, and second by Plk at the critical residue T833
(Figure 7).

ADAM phosphorylation has been shown to regulate either
proteolytic activity or subcellular localization (Izumi et al., 1998;
Diaz-Rodriguez et al., 2002; Soond et al., 2005). Recently ADAM17
phosphorylation by Polo-like kinase 2 was shown to regulate the
shedding of its substrate in mammalian cells (Schwarz et al., 2014).
In contrast, we show that ADAM13 proteolytic activity is not affected
by its phosphorylation (Figure 5). Of importance, the level of protein
expressed is not reduced in the nonphosphorylatable mutant, and
the maturation and subcellular localization is indistinguishable from
the wild-type protein (Figure 6, A and B).
To confirm that ADAM13 metalloprotease activity was unchanged in vivo, we tested the ability of nonphosphorylatable
ADAM13 to rescue migration of CNC overexpressing cadherin-11
(Figure 5B). We and others have shown that increased cadherin-11
expression inhibits CNC migration (Borchers et al., 2001; McCusker
et al., 2009) and that a corresponding increase of ADAM13 rescues
migration by cleaving the excess cadherin-11. Here we show that
the phosphodeficient ADAM13 can rescue cadherin-11 with the
same efficiency as wild-type ADAM13 (Figure 5B). Finally, coexpression of the nonphosphorylatable cytoplasmic domain as a GFP fusion together with the extracellular and transmembrane domains of
ADAM13 (with intact proteolytic activity) does not rescue CNC migration, whereas the wild-type cytoplasmic domain does (Figure
6C). This, together with the observation that the phosphorylated
form does not appear to contain the metalloprotease domain
(Figure 2B), confirms that these phosphorylations have no direct effect on the overall ADAM13 metalloprotease function and suggests
that they are strictly involved with the nuclear function of the cytoplasmic domain of ADAM13 (Cousin et al., 2011).

Phosphorylation of ADAM13 regulates its nuclear function
We previously identified a second and critical function for ADAM13
cytoplasmic domain. This function requires a sequence of events
including the cleavage of the domain by G-secretase and its translocation to the nucleus, where it regulates the expression of ^2000
genes (Cousin et al., 2011). Among those targets, calpain-8a, a calcium-activated cytoplasmic protease, was shown to play an essential role in the migration process and to be able to compensate for
the loss of the ADAM13 cytoplasmic domain (Cousin et al., 2011).
We show here that increasing the levels of calpain-8a expression can
rescue migration of CNC expressing ADAM13-Plk/A, the mutant for
the Plk phosphorylation site. The level of rescue was comparable to
what was previously observed with a mutant of ADAM13 lacking the
entire cytoplasmic domain (Cousin et al., 2011). This suggests that
the phosphorylation of ADAM13 by Plk is required to achieve the
proper level of calpain-8a expression. On the other hand, calpain-8a
expression had no effect by itself or when coinjected with the mutant for the GSK3 sites (Figure 6D; Cousin et al., 2011). This suggests that Gsk3 phosphorylation of ADAM13 is important not only
to create Plk-binding sites, but also for events downstream or parallel to calpain-8a transcription.
Calpain-8a is a cysteine protease, whose activity is tightly regulated by its level of RNA and subcellular localization and the concentration of calcium (Zanardelli et al., 2013). Of interest, phosphorylation of ADAM13 by Plk is predicted to create a binding site for
Forkhead association domain (FHA). Proteins that encode these domains, which were first identified in Forkhead transcription factors,
have a wide range of activities, including gene regulation and DNA
repair (Durocher et al., 2000; Hammet et al., 2003). For example,
FoxK2, a transcription factor that is expressed in the Xenopus CNC
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cells, contains one FHA domain (Pohl and Knochel, 2004). The analysis of the putative promoter region of calpain-8a in Xenopus laevis
and Xenopus tropicalis revealed several conserved sites for FoxK2
within 1000 base pairs of the transcription start. It will be of interest
to test whether ADAM13 binds to FoxK2 in vivo and whether this
interaction modulates gene expression and controls CNC migration. Using mass spectrometry analysis, we identified several proteins that bind to the cytoplasmic domain of ADAM13 and the
phosphomimetic A13-Plk/D but not to A13-Plk/A. Among these are
proteins involved in cytoskeletal dynamics, DNA repair, and protein
deacetylation. Additional work is required to sort out the relative
contribution of these proteins in regard to ADAM13 nonproteolytic
functions.
Another possibility is that calpain-8a is not localized or activated
properly in the CNC expressing the nonphosphorylatable mutant.
In that case, expression of more calpain-8a would compensate for
a lower overall activity. For example, another member of the family,
calpain-2, is required for proper convergent extension in the Xenopus gastrula and neurula (Zanardelli et al., 2013). Its activity is tightly
controlled by the noncanonical Wnt pathway. Wnt5a increases calpain-2 localization at the membrane, and this pathway is also known
to regulate calcium concentration via PLC/IP3 activation. Both
activities are regulated by Dishevelled, a protein that links the
Frizzled receptor to the various cytoplasmic effectors. Multiple
pieces of evidence suggest that ADAM13 is involved in the Wnt
pathway and could therefore affect calpain-8a activity. First, in
X. tropicalis, ADAM13 controls Wnt signaling by cleaving ephrinB1
and thus lowering the inhibition of the ephrin signaling on the Wnt
pathway (Wei et al., 2010). In X. laevis, ADAM13 binds and cleaves
cadherin-11 and PAPC, which are also known to regulate the Wnt
pathway (Jung et al., 2011; Kietzmann et al., 2012; Becker et al.,
2013; Koehler et al., 2013). In addition, we found that ADAM13
directly interacts with multiple Frizzled receptors (G. Abbruzzese,
A. Gorny, H. Cousin, I. Kleino, LT Kaufmann, H. Steinbeisser,
and D. Alfandari, unpublished data). The consequences of these
interactions with ADAM13 on Wnt signaling, as well as the contribution of the various phosphorylations, are not known, but it is possible that the noncanonical Wnt pathway, by regulating the local
calcium concentration, may regulate calpain-8a activity during CNC
migration.

ADAM knockdown does not overtly perturb CNC marker
position by ISH
Our results show that whereas the knockdown of ADAM13 and 19
clearly affects CNC migration when tested by targeted injections or
grafts (this study; McCusker et al., 2009; Cousin et al., 2011, 2012),
the position of CNC detected by ISH in morphant embryos appears
relatively unchanged (Supplemental Figure S2A). The central question is whether ADAM13 and 19 are essential for CNC migration, as
suggested by grafts and targeted injections, or are dispensable, as
suggested by ISH experiments. Related to this question is why ISH
is not able to detect the changes produced by the lack of ADAM13
and 19 that are so obvious in grafts. We and others previously
showed that cadherin-11 overexpression inhibits CNC migration,
but that in this case, CNC markers are turned off in the nonmigrating
cells (Borchers et al., 2001; McCusker et al., 2009). This is due at
least in part to the excess cadherin-11 cytoplasmic domain sequestering B-catenin at the membrane and preventing its signaling activity, including its activation of Twist expression (Borchers et al., 2001).
We also showed that the knockdown of ADAM13 results in an increase in cadherin-11 due to a lack of proteolysis (McCusker et al.,
2009). This suggests that CNC lacking ADAM13 may also turn off

the expression of markers. On close examination of grafts from embryos lacking ADAM13 and 19 treated by ISH, we found that the
main population of grafted CNC that did not migrate was not obviously stained by the combination of Sox10 and Twist probes (Supplemental Figure S3; see also Supplemental Figure S4, yellow oval).
In addition, we previously showed that ADAM13 and 19 activity was
essential in the leading CNC but that morphant cells could follow
wild-type cells in grafts (Cousin et al., 2012). Similarly, in chickens,
ADAM13 is expressed more abundantly in the leading cells than in
the followers (McLennan et al., 2012). Thus it is likely that some
CNCs do not depend on ADAM13 and 19 for their migration, and
these would be clearly detected by ISH markers. Combined with the
fact that the nonmigrating CNCs are not detected, this can explain
why the pattern of CNCs appears normal in morphant embryos. A
schematic drawing of this hypothesis is presented in Supplemental
Figure S4. In this figure, it is also possible to detect a small population of RFP-expressing cells that migrated from the graft despite the
absence of ADAM13 and 19 and overlap with the positive ISH staining (white arrowheads). This is consistent with the hypothesis that
some CNCs do not require ADAM13 and 19. It is important to keep
in mind that ISH detects cells expressing a given marker at a specific
time, which in some cases can be extrapolated to measure cell
movement but is never a direct visualization of cell migration. Thus,
by using multiple different techniques, such as graft and targeted
injection, can clearly demonstrate the role of proteins that have a
subtle function during cell migration, such as ADAM13.

GSK3 and Polo-like kinase regulate CNC migration
Our study also shows that GSK3 and Plk are critical for CNC migration. GSK3 is a well-known inhibitor of the canonical Wnt pathway,
where it phosphorylates B-catenin to induce its degradation. Both
canonical and noncanonical Wnt have been shown to play roles in
CNC induction and migration. In particular, Wnt signaling is essential for the induction of CNC (Garcia-Castro et al., 2002; Abu-Elmagd
et al., 2006), but evidence suggests that it needs to be turned off
during migration. Activating the Wnt pathway by either stimulating
with Wnt-1 or inhibiting GSK3 with LiCl blocks trunk neural crest cell
migration (de Melker et al., 2004), whereas genetic knockout of
GSK3 in mice leads to cleft palate, a defect generally due to cranial
neural crest cell migration defects (Liu et al., 2007). In Xenopus,
GSK3 phosphorylation of Twist modifies its activity, promotes its
binding to Slug, and results in the inhibition of Slug (Lander et al.,
2013). Slug is one of the first transcription factors induced in the
CNC and is progressively turned off during migration. GSK3 phosphorylation of Twist may help further inhibit the remaining Slug protein activity during migration. Our rescue using ADAM13 phosphomimetic mutant suggests that GSK3 activity could be involved
in part to activate one or more ADAMs required for neural crest cell
migration in other species. In the chicken embryo, ADAM10 and
ADAM19 cleave cadherin-6b during the exit of the trunk neural crest
cells from the neural tube (Schiffmacher et al., 2014). Because both
of these ADAMs have also been found to produce a cleaved cytoplasmic domain that can translocate in the nucleus, it is tempting to
speculate that a similar regulation by phosphorylation could be important (Arima et al., 2007; Tousseyn et al., 2009; Cousin et al.,
2011).
Although Plk regulates multiple aspects of development through
its control of cell cycle progression, there is no evidence of its role in
controlling cell migration in a developmental context. On the other
hand, Plk1 was previously shown to be important for the invasion of
breast cancer cells through a laminin-rich extracellular matrix by
phosphorylating the intermediate filament protein vimentin, which

Volume 25 December 15, 2014

!

Gsk3 and Polo kinase regulate ADAM13

167!

| 4079

in turn regulates the level of B1 integrin on the cell surface (Rizki
et al., 2007). Implication of Plk in cancer cell migration and invasion
is growing and extending to multiple cancer types, but the mechanism of action is not well understood, and in many studies, the increase in the number of cells invading could be the result of increases in cell proliferation due to Plk overexpression. One
interesting possibility is that at least part of Plk stimulation of cell
migration is via the phosphorylation of an ADAM in a mechanism
similar to what we observed for ADAM13.

MATERIALS AND METHODS
Morpholinos and DNA constructs
Morpholino antisense oligonucleotides (GeneTools, Philomath,
OR) against ADAM13 and ADAM19 were described previously
(McCusker et al., 2009; Neuner et al., 2009). All of the ADAM13 constructs used for the CNC migration assays contain seven silent mutations in the morpholino-binding region so that it is resistant to the
MO13. Phosphorylation mutations were introduced by site-directed
mutagenesis to replace the putative phosphorylated residue with
alanine or aspartate. The predicted GSK3 sites are serines 752 and
768, and the predicted Plk site is threonine 833. Dominant-negative
GSK3, containing the mutation K85R, has been characterized previously (Dominguez et al., 1995) and was a generous gift from Isabel
Dominguez (Boston University School of Medicine). The dominantnegative Plk construct (encoding the two Polo box domains of Plk1)
was published previously (Ito et al., 2008) and was a gift from Rafael
Fissore (University of Massachusetts Amherst).

ADAM13 were used. Embryos were raised at 15°C until they reached
tailbud stage (stages 24–27) and were scored for inhibition of CNC
migration by the absence of RFP-positive cells within the migration
pathways.
For in situ hybridizations, embryos were injected into one cell at
the two-cell stage with 200 pg of GFP mRNA plus 300 pg of the
mRNAs for Plk-DN, GSK3-DN, or ADAM13 variants. Embryos were
sorted for RFP expression on the left or right side and fixed at neurula or early tailbud stage (14 or 21, respectively). Whole-mount in
situ hybridizations were performed as described earlier (Harland,
1991). For ISH in Supplemental Figure S2, embryos were injected at
the one-cell stage with MO13 and MO19 and then again at the
eight-cell stage in one dorsal animal blastomere with RFP and the
various ADAM13 constructs. Tailbud-stage embryos were sorted according to RFP expression in the left or right dorsal anterior tissue
before ISH treatment. Quantification was performed by measuring
the length of CNC segment on the injected side (rescue) and comparing it to the contralateral side. Embryos with a 20% increase or
decrease in segment length were scored as rescued (green number)
or worse (red number), respectively.

Grafts

The following antibodies were used: g821, goat polyclonal antibody
to the ADAM13 cytoplasmic domain (Cousin et al., 2011); 6615F,
rabbit polyclonal antibody to the ADAM13 cytoplasmic domain
(Alfandari et al., 1997); 4A7, mouse monoclonal to the ADAM13 cytoplasmic domain; 7C9, mouse monoclonal to the ADAM13
cysteine-rich domain (Gaultier et al., 2002); PAPC, mouse monoclonal to the extracellular domain (Chen and Gumbiner, 2006), 8C8,
monoclonal antibody to B1 integrin (Gawantka et al., 1992); anti-Plk,
mouse monoclonal to Plk1 (Invitrogen, Carlsbad, CA); and antiGSK3, mouse monoclonal to GSK3 A/B (LifeSpan BioSciences,
Seattle, WA). P-A13, the antibody to phosphorylated ADAM13
(833T, Plk site), was generated by immunizing two rabbits (ProSci,
Poway, CA) with a phosphorylated peptide linked to KLH (EZBiolab,
Carmel, CA). Phosphospecific antibodies were affinity purified on
the phosphorylated peptide and immunodepleted using the nonphosphorylated peptide.

Embryos were injected in one cell at the two-cell stage and raised at
14°C. Embryos were sorted for optimum lineage tracer expression
(GFP or mRFP) at stage 15 (as soon as the anterior neural folds are
visible and raised). The vitelline envelopes of selected embryos
were removed, and embryos were placed in a dish of nontoxic modeling clay (Van Aken, Rancho Cucamonga, CA) containing 1r MBS
(88.0 mM NaCl, 1.0 mM KCl, 2.4 mM NaHCO3, 15.0 mM HEPES
[pH 7.6], 0.3 mM CaNO3-4H2O, 0.41 mM CaCl2-6H2O, 0.82 mM
MgSO4) and 50 µg/ml gentamicin. Embryo-sized cavities were
formed in the Plasticine using a Pasteur pipette whose tip had been
melted into a glass ball. The embryos were placed in the cavities,
oriented according to experimenter’s grafting preference, and immobilized by pulling back some modeling clay around them. Once
immobilized, the ectoderm covering the CNC was peeled off, the
CNCs were cut out using an eyelash knife and hair loop, and grafted
into host embryos whose CNCs were removed. Each CNC was
grafted according to its proper anteroposterior and dorsoventral
orientation. The grafted embryos were left to heal for 30 min in 1r
MBS, with an embryo-sized coverslip pressed onto the dissected
region of the embryo to maintain the ectoderm flush with the CNC
and mesoderm. The embryos were then raised in a tissue culture
dish coated with 1% agarose in 0.1r MBS and 50 µg/ml gentamicin
at 14°C overnight.

Injections

Cell culture and transfection

Capped mRNA were synthesized for all constructs except GSK3-DN
using SP6 RNA polymerase on DNA linearized with NotI as described earlier (Cousin et al., 2000). GSK3-DN was linearized with
SacI and transcribed with T7 RNA polymerase. For the CNC targeted injection assays, embryos were injected at the eight-cell stage
into either the left or right dorsal-animal blastomere (CNC precursor) with 200 pg of RFP or GFP mRNA as a lineage tracer. Morpholinos to ADAM13 and 19 (2MO, 1 ng each) were injected either alone
or in combination with 80 pg of mRNA encoding wild-type ADAM13
or the various phosphomutants. 2MO plus ADAM13-Plk/A or A13Gsk/A was rescued with 80 pg of calpain8-a mRNA. For the dominant negatives, 80 pg of Plk-DN mRNA was injected alone or together with 80 pg of ADAM13 mRNA, and 300 pg of GSK3-DN
mRNA was injected alone or with 300 pg of ADAM13 mRNA. For the
overexpression of cadherin-11, 300 pg of cadherin-11 and 300 pg of

293T cells were obtained from the American Type Culture Collection
(ATCC, Manassas, VA) and transfected using X-tremeGENE HP according to manufacturer’s instructions (Roche, Basel, Switzerland).
For detection of phosphorylated ADAM13, cells expressing
ADAM13 were treated overnight with 0.2% dimethyl sulfoxide,
0.1 µM Plk inhibitor GW843682X (Sigma-Aldrich, St. Louis, MO), or
1 µM GSK3 inhibitor AR-A014418 (Sigma-Aldrich). Cos-7 cells were
obtained from ATCC and transfected using Fugene-6 (Roche) according to manufacturer’s instruction. For PAPC and ADAM13 shedding assays, cells were incubated with medium containing 2% serum 24 h after transfection, and conditioned supernatants were
collected at 48 h. The shed extracellular domains were purified using concanavalin-A–agarose (Vector Laboratories, Burlingame, CA)
overnight, eluted in reducing Laemmli buffer, and blotted using the
PAPC or 7C9 antibodies.

Antibodies
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Immunoprecipitation and Western blots
Cells were extracted in RIPA buffer (Tris-buffered saline [TBS], 1%
NP-40, 1% deoxycholate, 0.1% SDS) with protease phosphatase
inhibitor cocktail (Pierce). Immunoprecipitation of ADAM13 was
performed using a monoclonal antibody to the cytoplasmic domain
(4A7), bound to protein G–agarose (Pierce Biotechnology, Rockford,
IL), for 2 h at 20°C. Immunoprecipitates (IPs) were washed three
times with extraction buffer before elution with Laemmli buffer.
ADAM13 IPs were blotted using the phosphospecific antibody at
0.1 µg/ml overnight at 4°C. Unless otherwise noted, Western blots
were performed on polyvinylidene fluoride membranes (Millipore,
Billerica, MA) and blocked with 5% nonfat dry milk in TBS with 0.1%
Tween-20. All antibody incubations and washes were also performed
in TBS 0.1% Tween-20. Embryos for Western blots and immunoprecipitations were extracted in 1r MBS, 1% Triton X-100, 5 mM EDTA,
and Halt Protease and Phosphatase inhibitor cocktail (ThermoScientific, Waltham, MA).

Kinase assays
For the in vitro phosphorylation, the 4A7 immunoprecipitates were
washed in kinase buffer (25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.2, 10 mM MgCl2, 10 mM MnCl2,
1 mg/ml bovine serum albumin, 40 mM B-glycerophosphate, 5 mM
p-nitrophenylphosphate, 10 µM aprotinin, and 10 µM leupeptin)
and incubated with active GSK3 (SignalChem, Richmond, Canada)
in the presence of 32P-ATP as previously described (Li et al., 2011).

Fluorescence microscopy
Cos-7 cells were transfected with the GFP-fusion proteins plus
membrane-bound mCherry to visualize the cell boundaries and
placed on fibronectin-coated (10 µg/ml) glass-bottom plates
(MatTek, Ashland, MA). Photographs were taken using a Zeiss 200M
inverted microscope equipped with an Apotome and a 63r oil immersion lens to obtain optical sections. For in vivo CNC migration
assays, embryos were imaged using a Zeiss Stereo Lumar-V12 fluorescence microscope.
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The Wnt receptor Frizzled-4 modulates ADAM13
metalloprotease activity

ABSTRACT
Cranial neural crest (CNC) cells are a transient population of stem
cells that originate at the border of the neural plate and the
epidermis, and migrate ventrally to contribute to most of the
facial structures including bones, cartilage, muscles and ganglia.
ADAM13 is a cell surface metalloprotease that is essential for CNC
cell migration. Here, we show in Xenopus laevis embryos that the
Wnt receptor Fz4 binds to the cysteine-rich domain of ADAM13 and
negatively regulates its proteolytic activity in vivo. Gain of Fz4
function inhibits CNC cell migration and can be rescued by gain of
ADAM13 function. Loss of Fz4 function also inhibits CNC cell
migration and induces a reduction of mature ADAM13, together with
an increase in the ADAM13 cytoplasmic fragment that is known to
translocate into the nucleus to regulate gene expression. We
propose that Fz4 associates with ADAM13 during its transport to the
plasma membrane to regulate its proteolytic activity.
KEY WORDS: ADAM, Development, Neural crest, Wnt, Xenopus
laevis

INTRODUCTION

The cranial neural crest (CNC) is a stem cell population that gives
rise to the craniofacial structures. Normal craniofacial development
depends on the correct induction, migration and differentiation of
these cells. Wnt signaling pathways play crucial roles at multiple
levels during CNC development. Whereas the canonical Wnt/bcatenin pathway is known to mediate CNC induction (Stuhlmiller
and Garcı́a-Castro, 2012), in Xenopus the non-canonical Wnt/PCP
(planar cell polarity) pathway is implicated in CNC cell migration
(Mayor and Theveneau, 2014). In contrast, knockout of the
membrane protein Vangl2, one of the PCP components, does not
affect neural crest migration in mouse, suggesting that Wnt/PCP
signaling is not crucial for neural crest cell migration in mammals
(Pryor et al., 2014). The canonical and non-canonical Wnt pathways
are generally regulated by specific combinations of Wnt ligands and
their Frizzled (Fz) receptors, together with specific co-receptors and
secreted modulators that compete for Wnt ligand binding (Niehrs,
2012). This, ultimately, leads to activation or inhibition of either
1
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b-catenin-mediated transcription (canonical) or PCP-signalingmediated remodelling of the actin cytoskeleton (non-canonical).
Frizzled-4 (Fz4) is a Wnt receptor that is essential for CNC cell
migration in Xenopus laevis (Gorny et al., 2013). Two variants
encoding a secreted and a transmembrane form have been
reported. The secreted variant, Fz4-v1 (previously called Fz4S),
is generated by intron retention and possesses the cysteine-rich
domain (CRD) of the receptor, but not the intracellular-signaling
domain and the seven transmembrane domains (Sagara et al.,
2001; Swain et al., 2005). Fz4-v1 has strong similarity to secreted
frizzled-related proteins (SFRPs), which are well-known Wnt
modulators that also contain a Fz-like CRD (Kawano and Kypta,
2003). These proteins can have both positive and negative
regulatory effects on the Wnt pathway, depending on their
concentration. At low concentration SFRPs can potentiate Wnt
signaling, whereas at high concentration they are thought to
sequester the Wnt ligand and inhibit pathway activation (Mii and
Taira, 2009; Uren et al., 2000). Both secreted Fz4-v1 in human
and Xenopus have been shown to activate Wnt/b-catenin
signaling under specific conditions (Gorny et al., 2013; Sagara
et al., 2001; Swain et al., 2005). Furthermore, it has been
reported, that the Xenopus Fz4-v1 has, like the SFRPs, also a
biphasic activity. In gain-of-function experiments, Fz4-v1
synergistically activates Wnt/b-catenin with low levels of Wnt
ligands; but it inhibits the pathway when expressed at high levels
(Gorny et al., 2013). In addition, Fz4-v1 can enhance activation
of the PCP pathway when expressed with non-canonical Wnts
such as Wnt11 (Gorny et al., 2013). Morpholino knockdown of
Fz4 and Fz4-v1 inhibits CNC cell migration, and this can be
rescued by re-expression of Fz4-v1 alone. However, whether the
function of Fz4-v1 in the neural crest involves the Wnt pathway
has not yet been shown.
In mice, SFRP1 and SFRP2 (hereafter referred to as SFRP1/2)
have a Wnt-independent function in the retina, where they bind
and inhibit ADAM10 (Esteve et al., 2011). ADAM (a disintegrin
and metalloprotease) proteins are transmembrane proteases that
regulate cell adhesion, as well as multiple signaling pathways that
require proteolysis of ligands or receptors to initiate activation or
termination of signaling. ADAM10 is the primary activator of the
Notch pathway by performing the initial cleavage of the Notch
receptor (Brou et al., 2000; Pan and Rubin, 1997). In the mouse
retina, the absence of SFRP1/2 leads to a defect in retinal
neurogenesis due to hyper activation of ADAM10, thereby
increasing Notch signaling (Esteve et al., 2011). In Xenopus, at
least three ADAMs, ADAM9, ADAM13 and ADAM19, are
involved in the induction and migration of CNC cells (Alfandari
et al., 1997; Cousin et al., 2011; Cousin et al., 2012; McCusker
et al., 2009; Neuner et al., 2009). ADAM13 stimulates migration
by both cleaving the adhesion molecule Cadherin-11 at the cell
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secreted variant interact with ADAM13 to regulate the level of
protease activity and the processing of the cytoplasmic domain
fragment.
RESULTS
ADAM13 cysteine-rich domain binds to Fz4

SFRP1/2 have been shown to interact with and inhibit ADAM10
proteolytic activity (Esteve et al., 2011). Therefore, we tested
whether such an interaction existed between Fz4 and ADAM13.
Indeed, ADAM13 and Fz4-v1, as well as the Fz4 receptor, coprecipitate when transfected into HEK293T cells (Fig. 1A). In
addition to the disintegrin and metalloprotease domains, ADAMs
also contain a cysteine-rich domain, an EGF-like domain, and
a transmembrane and cytoplasmic domain (see Fig. 1B). To
identify which of these domains is responsible for binding to Fz4,
we tested variants of ADAM13 that express either individual or
combinations of domains. We used Fz4-v1 in these experiments
because both proteins seem to have a similar binding, and the
potential surface contact in Fz4-v1 is smaller. In these

Fig. 1. ADAM13 binds to Fz4 and Fz4-v1. (A) Co-immunoprecipitation experiments of Fz4 and Fz4-v1 with ADAM13. HEK293T cells were transfected with the
various constructs cloned into the pCS2+ vector alone or in combination. ADAM13 was immunoprecipitated using the cytoplasmic domain antibody g821, and
Myc-tagged (mt) Fz4 constructs were detected with mAb 9E10. Fz4-mt and Fz4-v1-mt co-precipitate with ADAM13 only when both proteins are cotransfected. Bands observed in lanes 2 and 3 of the total extract blotted with ADAM13 are non-specific. (B) Schematic diagram of mature ADAM13 including the
metalloprotease (M), disintegrin (D), cysteine-rich (C), EGF repeat (E) and the cytoplasmic (Cy) domain. In co-immunoprecipitation experiments using a rabbit
polyclonal antibody to the Fz4-v1 protein, all ADAM13-mt constructs containing the cysteine-rich domain were co-precipitated, while the disintegrin domain
alone was not (D). (C) Real-time PCR on dissected CNC and stage-matched whole embryos (Total), detecting the level of Slug, Fz4, or Fz4-v1 expression,
represented as a percentage of GAPDH expression. The average cycle threshold (CT) values in the CNC were as follows (Slug 24.7, Fz4 28.3, Fz4-v1 29.7,
GAPDH 23.9). No CT was seen for water or no RT control. Error bars represent 6s.e.m. (D) Double in situ hybridization using short probes recognizing Fz4 or
Fz4-v1 (blue) as well as probes recognizing the two CNC markers Sox10 and Twist (both red). The arrowheads point to the tip of the CNC segment. Scale bar:
500 mm. In situ hybridization for ADAM13 is presented as a reference marker (A13).
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surface and regulating gene expression through its cytoplasmic
domain, which is cleaved by c-secretase and then translocates to
the nucleus. Given the similarities between SFRPs and the
secreted Fz4 variant, we investigated whether Fz4-v1 modulates
the activity of ADAM13 in the CNC.
Here, we show that both Fz4 and Fz4-v1 bind to the cysteinerich domain of ADAM13, and decrease its proteolytic activity in
a cell autonomous manner. In vitro, overexpression of Fz4 and
Fz4-v1 decrease proteolysis of cadherin-11 and the paraxial
protocadherin PAPC by ADAM13. In vivo, overexpression of
Fz4 or Fz4-v1 in the CNC inhibits cell migration, which can
be rescued by co-expressing ADAM13 or the cadherin-11
extracellular cleavage fragment EC1-3. We show that
knockdown of Fz4 in the CNC results in a decrease of the
mature form of ADAM13 and an increase of the cytoplasmic
fragment, suggesting that Fz4 is important for the stability of
ADAM13 at the cell surface and may control the timing of the
cytoplasmic domain processing. These gain- and loss-of-function
experiments indicate that both the full-length receptor and the
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Fig. 2. Fz4 colocalizes with ADAM13 in CNC cells. ADAM13-GFP, Fz4RFP and Fz4-v1 RFP were expressed in CNC explants placed on fibronectin
substrate. The fluorescence was detected using a spinning disc confocal
acquiring every 2 seconds for one minute. Frames from each movie were
extracted and annotated. ADAM13-GFP colocalizes with Fz4-RFP in
vesicles (boxed areas and arrowhead) 10 mm from the fibronectin substrate
(upper panel). At the plasma membrane in contact with the substrate,
ADAM13-GFP colocalizes with Fz4-RFP in both vesicles (arrowheads) and
at the membrane (arrow, middle panel). ADAM13-GFP is detected in close
association with Fz4-v1 in membrane protrusions in direct contact with the
fibronectin substrate (boxed areas, lower panel).

in which ADAM13 colocalizes with Fz4 and Fz4-v1. Fz4
expression was found in both the endoplasmic reticulum and
lysosomes (supplementary material Fig. S2), but was hardly
detected in the Golgi complex (supplementary material Fig. S2).
ADAM13 was associated with all three markers but appeared to
only colocalize with Fz4 in the ER in these cells (supplementary
material Fig. S2). The vesicles in which ADAM13 and Fz4
colocalized did not stain with any of the markers tested,
suggesting that they were neither Golgi nor lysosomal in origin.
The staining obtained for Fz4-v1 was much more obvious and
appeared to be restricted to the ER where it perfectly colocalized
with ADAM13 (supplementary material Fig. S2). Again, in
WGA-positive vesicles ADAM13 appeared to be mostly free of
Fz4-v1 suggesting that the proteins do not transit together to the
cell surface in XTC cells (supplementary material Fig. S2).
Unfortunately, these markers could not be used in a CNC explant,
as they all bind very strongly to the yolk-rich platelets (data not
shown). A similar distribution of ADAM13-GFP, Fz4-RFP and
Fz4-v1-RFP was found in transfected human osteosarcoma
(U2OS) cells, when using antibodies against calnexin and
GM130 to identify the ER and Golgi respectively (data not
shown).
Fz4 inhibits ADAM13 proteolytic activity and migration of
CNC cells

Having established that all three mRNAs are expressed in the
CNC and that, upon expression of fluorescent forms of the
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experiments, we found that the cysteine-rich domain of ADAM13
is sufficient to promote Fz4-v1 interaction, whereas the
disintegrin domain is not (Fig. 1B). Interestingly, this domain
of ADAM13 is also responsible for interacting with the second
heparin-binding domain of fibronectin (Gaultier et al., 2002) and
is thought to control proteolytic specificity (Smith et al., 2002).
Whereas the functional analyses – showing that Fz4/Fz4-v1
combined knockdown inhibits CNC cell migration – strongly
suggest that these proteins are present in the CNC (Gorny et al.,
2013), the published expression pattern reported for Fz4 and Fz4v1 (Shi and Boucaut, 2000) do not closely match neural crest
cells, suggesting that Fz4 and Fz4-v1 could act on the CNC from
adjacent tissues (for example, the placodes). To confirm that
mRNA of either Fz4 or Fz4-v1 is present, we performed
quantitative real-time PCR with dissected CNC explants using
primers designed to selectively amplify each form. The result
shows that both Fz4 and Fz4-v1 are, indeed, expressed in the
CNC, but their mRNAs are not restricted to these cells,
confirming the in situ hybridization (ISH) pattern. When
compared with the Zinc finger protein SNAI2 (also known as
and hereafter referred to as Slug), a typical CNC marker, the
overall expression levels of Fz4 and Fz4-v1 in whole embryos at
stage 17 are very similar and represent between 2% (Fz4-v1) and
4% (Slug, Fz4) of GAPDH expression. At the same stage, Slug is
expressed in the CNC at 57% of the GAPDH level, making it very
obvious by ISH. However, Fz4 and Fz4-v1 are expressed at 5%
and 2% of GAPDH, respectively, a level similar to the global
expression in the embryo. We also performed double ISH using a
Fz4-receptor-specific full-length probe and a short locked nucleic
acid (LNA)-probe specifically recognizing Fz4-v1 but not Fz4
(Gorny et al., 2013) to distinguish between the two Fz4 splice
variants (Fig. 1D and supplementary material Fig. S1, blue) and
the neural crest markers Sox10 and Twist (both red). With this
technique it is clear that Fz4-v1 is present in the CNC at both
stage 20 and stage 24, whereas Fz4 appears to be expressed in
placodes as well as in the extreme tips of the CNC segments
(Fig. 1D, arrowheads). Together these data show that ADAM13,
Fz4 and Fz4-v1 are all expressed in the CNC, and that ADAM13
and Fz4-v1 expression patterns clearly overlap.
To determine whether ADAM13 colocalizes with either form of
Fz4, we C-terminally tagged ADAM13 with GFP, and Fz4 and
Fz4-v1 with RFP, and co-expressed these constructs in Xenopus
CNC and cell lines (Fig. 2 and supplementary material Fig. S2). In
the CNC, Fz4 is detected in two main compartments, vesicles and
the plasma membrane associated with the fibronectin substrate
(Fig. 2; supplementary material Movie 1). ADAM13 protein is
detected in all membranes but enriched in vesicles as well as in
cellular protrusions that are in contact with the fibronectin
substrate. ADAM13 colocalizes with Fz4 in a subset of vesicles
(Fig. 2 upper and middle rows, arrowheads) and at the membrane
that is in contact with the substrate (Fig. 2 middle row, arrows).
The localization of Fz4-v1 is clearly distinct, surrounding the
nucleus in a pattern resembling the endoplasmic reticulum. In timelapse movies at the level of the substrate, Fz4-v1 appears to be
closely associated with ADAM13 in some membrane protrusions
(Fig. 2 lower row, boxed areas, and supplementary material Movie
2). Thus, the subcellular localization of ADAM13, Fz4 and Fz4-v1
is compatible with a potential interaction of these proteins in
migrating CNC cells.
In the Xenopus fibroblast cell line (XTC), we used sub-cellular
markers for the lysosome (Lysotracker), endoplasmic reticulum
(ER-tracker), Golgi complex (WGA) to identify the compartment
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full-length Fz4 more efficient (,100% inhibition) than secreted
Fz4-v1 (,50% inhibition). However, neither form effectively
prevented self-shedding of ADAM13 (Fig. 3A, Shed A13). We
also found that Fz4-v1 was able to inhibit ADAM13 cleavage of
cadherin-11 in HEK-293T cells (supplementary material Fig. S3).
We could not test Fz4 in this assay because the expression of both
Fz4 and cadherin-11 drastically reduced the level of ADAM13 in
transfected cells (data not shown), making the interpretation of
the absence of cleavage impossible. To test whether Fz4 simply
prevented the interaction of ADAM13 with PAPC, we performed
co-immunoprecipitation of PAPC with ADAM13 in the presence
or absence of Fz4. The result shows that presence of Fz4 or Fz4v1 does not prevent binding of ADAM13 to PAPC, and suggests
that Fz4 and Fz4-v1 inhibit ADAM13 activity using a different
mechanism (Fig. 3B).
Because ADAM13 proteolytic activity is essential for CNC cell
migration, we hypothesized that overexpression of Fz4 should
interfere with this process if both proteins interact in vivo. Indeed,
targeted overexpression of Fz4 or Fz4-v1 inhibited CNC cell
migration (Fig. 4A,B). To test whether Fz4 overexpression acts
by inhibiting ADAM13 activity we attempted to rescue CNC cell
migration by overexpressing either ADAM13 or the extracellular
cleavage fragment of cadherin-11 (EC1-3). Interestingly, whereas
ADAM13 and EC1-3 were capable of partially rescuing both
forms of Fz4 overexpressed, the rescue of full-length Fz4 was
much more efficient in our assay than that of the secreted Fz4-v1
(Fig. 4A,B).
To test whether secreted Fz4-v1 inhibits migration in a cell
autonomous manner we grafted CNC expressing Fz4-v1 into wild
type embryos, as well as wild type CNC into Fz4-v1-expressing
embryos (Fig. 4C). Our results show that CNC cell migration is
only inhibited when Fz4-v1 is expressed by the CNC. Similarly, we
found that mixing cells that express Fz4-v1 with those that express
ADAM13 and PAPC did not inhibit PAPC shedding, suggesting
that the secreted Fz4-v1 is unable to inhibit ADAM13 proteolytic
activity on adjacent cells (Fig. 4D). This result, taken together with
the data showing colocalization of ADAM13 with Fz4 and Fz4-v1
in mostly internal compartments (Fig. 2 and supplementary
material Fig. S2), and the co-immunoprecipitation with the proform of ADAM13 (Fig. 1B), suggests that the functional
interaction is occurring during the transit of ADAM13 to the cell
surface. Another possibility is that PAPC is already cleaved before
both proteins (ADAM13 and PAPC) reach the surface.
protein, they are expressed in overlapping compartments of the
CNC, we next tested whether the interaction between Fz4 and
ADAM13 affects the proteolytic activity of the latter. We tested
the ability of Fz4 and Fz4-v1 to inhibit ADAM13 cleavage of the
paraxial protocadherin (PAPC) (Fig. 3A, Shed PAPC) and found

Loss of Fz4 inhibits CNC cell migration and increases
ADAM13 processing

Our results suggest that both forms of Fz4 can interact with
ADAM13 and inhibit its proteolytic activity. To test whether this
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Fig. 3. Fz4 inhibits ADAM13 proteolytic activity. (A) Western blot showing
the cleavage of the proto-cadherin PAPC by ADAM13. The medium from
transfected cells was collected and glycoproteins purified using
concanavalin-A–agarose beads (ConA). The extracellular fragment of PAPC
(60 kDa) is present when ADAM13 is co-transfected (lane 1) but absent
when the protease dead ADAM13-E/A is used (lane 2). Co-transfection of
Fz4-v1 decreases PAPC cleavage by about 50%, whereras Fz4 completely
inhibits the cleavage (compare lanes 1, 3 and 4). Neither form inhibits
ADAM13 self-shedding. (B) Co-immunoprecipitation of ADAM13 and PAPC.
ADAM13 was co-transfected either with PAPC, Fz4-mt or Fz4-v1-mt alone,
or in various combinations. ADAM13 was immunoprecipitated with g877
antibody and associated PAPC and Fz4 or Fz4-v1 were detected by western
blot. Fz4 and Fz4-v1 do not compete for the binding of PAPC to ADAM13
(compare lanes 1 with 3, 4 and 6).
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is important in vivo, we performed loss-of-function experiments
by knocking down Fz4 (and Fz4-v1). As previously reported
(Gorny et al., 2013), Fz4 morpholino (MOFz4) inhibits CNC
cell migration both in grafting experiments (Fig. 5A,B, and
supplementary material Movie 3) and targeted injection
(Fig. 5C). In targeted injections we found that we could not
rescue CNC cell migration by overexpressing ADAM13 in
embryos lacking Fz4 (Fig. 5C). In embryos, decrease of Fz4 or
Fz4-v1 (the morpholino does not distinguish between the two)
results in a decrease of the mature form of ADAM13 and an
increase in the ADAM13 cytoplasmic domain during CNC cell
migration (Fig. 6A, stage 24). We have previously shown that the
cleavage of the cytoplasmic domain by c-secretase is preceded by
an initial self-cleavage of ADAM13 within its cysteine-rich
domain (Cousin et al., 2011). Our results here suggest that, in the
absence of Fz4 or Fz4-v1, ADAM13 self-processing is increased,

resulting in the decrease in the surface form of ADAM13 and a
corresponding increase in the cytoplasmic fragment. In gain-offunction experiments, when Fz4 or Fz4-v1 are overexpressed in
the embryo, we observed a reduction in the cleaved cytoplasmic
fragment of ADAM13 at stage 19 (Fig. 6B). This reduction
persists at stage 30 only for the overexpression of Fz4-v1. In the
case of Fz4, decrease of the mature ADAM13 is observed
together with that of the cytoplasmic fragment; however, this was
not the case when Fz4-v1 was overexpressed.
To confirm the role of endogenous Fz4 in ADAM13 longevity or
stability, we injected ADAM13-GFP together with membranebound mCherry (mb-Cherry) in embryos, and visualized the GFP
and mCherry signals in dissected CNC explants (Fig. 6C).
Whereas mb-Cherry was unaffected by Fz4 knockdown, we
found that ADAM13-GFP was drastically reduced following
Fz4 knockdown. Given the finite amount of mRNA encoding
1143
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Fig. 4. Overexpression of Fz4 inhibits CNC cell migration. (A,B) Histogram representing the percentage of embryos with no fluorescent CNC cells in the
migration pathway following targeted injection at the 8-cell stage in one dorsal animal blastomere (% inhibition of CNC cell migration). Injection of RFP
alone is used to normalize to zero and account for any mis-targeting. (A) Injection of Fz4 inhibits migration and can be rescued by either ADAM13 or the
cadherin-11 extracellular fragment EC1-3. Student’s t-test was performed to compare % inhibition to Fz4 alone. (B) Similarly, injection of Fz4-v1 inhibits
migration, and can be partially rescued with ADAM13, the extracellular domain of cadherin-11 (EC1-3) and ADAM13 lacking the cytoplasmic domain (Dcyto).
Student t-tests were used to compare values to Fz4-v1. (C) Fluorescently labeled CNC cells were grafted to determine whether the inhibition of CNC cell
migration was cell autonomous. CNC cells overexpressing Fz4-v1 do not migrate. Wild type CNC cells grafted into embryos overexpressing Fz4-v1 in the
pathway migrated similar to control. (D) Western blot from HEK293T cells transfected with ADAM13, or the non-proteolytic mutant of ADAM13 (E/A) and PAPC.
These cells were mixed with cells transfected with Fz4-v1 or RFP and incubated together for 24 h. The conditioned supernatant, which contains Fz4-v1,
does not inhibit ADAM13 cleavage of PAPC. *P,0.05, ***P,0.001. n5number of embryos scored from three or more independent experiments. Error bars
represent 6s.e.m. ns, not significant.
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Fig. 5. Loss of Fz4 inhibits CNC cell migration.
(A) Representative embryos grafted with fluorescent CNC cells
from control embryos (GFP) or embryos injected with the Fz4
morpholino (MO Fz4). Scale bar: 500 mm (B) Histogram
representing the percentage of embryos without CNC cell
migration following the grafts. (C) Histogram representing the
percentage of embryos without CNC cell migration following
targeted injection. Loss of Fz4 inhibits CNC cell migration and is
not significantly rescued by the overexpression of ADAM13. n:
represents the total number of embryos. Asterisks represent
statistical significance obtained by using student’s t-test.
***P,0.001, ns: not significant. At least three independent
experiments were performed. Error bars represent 6s.e.m.

DISCUSSION
Fz4 regulates ADAM13 maturation and stability

ADAM13 and Fz4 are both essential for CNC cell migration.
ADAM13 controls CNC cell migration first by cleaving cadherin11 in order to release an extracellular fragment, but also by
sending its own cytoplasmic domain into the nucleus to regulate
gene expression (Cousin et al., 2011; McCusker et al., 2009).
Thus, there are at least two functional forms of ADAM13, the
active protease at the cell surface (100 kDa) and the cytoplasmic
fragment within the nucleus (17 kDa). Although we know that
both forms are essential, it remains unclear how and when the
cytoplasmic fragment is generated. We know that cleavage by csecretase releases the cytoplasmic domain from the membrane
and that this follows an initial cleavage within the cysteine-rich
domain by ADAM13 itself (Cousin et al., 2011). Loss of Fz4
appears to increase the rate or induce precocious processing of
ADAM13, whereas overexpression reduces this processing
(Fig. 6). In cell culture, transfected Fz4 associates preferentially
with the pro-form of ADAM13, and appears to colocalize
with ADAM13 in the ER, vesicles and at the plasma
membrane (Figs 1,2; supplementary material Fig. S2). These
observations suggest that Fz4 regulates ADAM13 processing.
This regulation involves a physical interaction of ADAM13 with
Fz4 through the cysteine-rich domain of ADAM13 during transit
and at the cell surface. Although this domain is also involved in
binding ADAM13 substrate (e.g. fibronectin) (Gaultier et al.,
2002), binding of ADAM13 to Fz4 does not compete for binding
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ADAM13-GFP, it is understandable that the results are more
obvious than those observed for endogenous ADAM13, whose
mRNA is constantly produced.
These results suggest that expression of ADAM13 should
alleviate part of the Fz4-knockdown phenotype by, at least,
providing a larger pool of ADAM13 protein during the onset of
CNC cell migration. To test this hypothesis in more detail, we
used in situ hybridization with CNC markers (Sox10 and Twist)
to visualize the position of the CNC towards the end of migration
(Fig. 7). As seen for both graft and targeted injections we found
that the loss of Fz4 significantly affected the position of the CNC
(Fig. 5). Whereas targeted injections were scored by counting the
number of embryos that had no visible fluorescent cells in the
CNC pathway, the in situ hybridization was scored for the relative
lengths of segments (inhibited weak or strong), as well as the
position and the separation of each segment (fused). Using this
latter assay, we found that ADAM13 overexpression was, indeed,
capable of reducing the severity of the CNC defects in embryos
lacking Fz4 (Fig. 7). Accordingly, EC1-3 – the recombinant
cleavage fragment of cadherin-11 by ADAM13 – was also
capable of restoring the quality of CNC cell migration. This was
true when the injections were targeted to one dorsal blastomere,
either left or right, at the 4-cell stage (Fig. 7A) or when targeted
to one dorsal animal blastomere at the 8-cell stage (Fig. 7B).
Together, these data support the model by which one of the roles
of Fz4 or Fz4-v1 during CNC cell migration is to regulate the
proteolytic activity of ADAM13.
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to one of its substrates PAPC (Fig. 3B), suggesting that the
proteolytic inhibition is not due to competitive binding with the
substrate. Given that ADAM13 also binds to secreted Fz4 (Fz4v1), this suggests that interaction of the two proteins involves the
extracellular domain of Fz4 (common to both splicing variants).
However, our results indicate that full-length Fz4 protein is more
effective at inhibiting ADAM13 self-processing and proteolytic
activity than secreted Fz4-v1. To which extent and how the
cytoplasmic domain or the seven transmembrane domains of Fz
proteins are involved in the regulation of ADAM processing and
activity should be addressed in future studies. Recently, it has
been shown that furin-mediated maturation of ADAM17 and its
trafficking to the cell surface requires binding of another sevenpass transmembrane protein, iRhom2 (also known as Rhbdf2)
(Adrain et al., 2012). In addition, tetraspanin18, another
multi-spanning transmembrane protein, prevents cadherin-6B
degradation prior to neural crest cell migration (Fairchild and
Gammill, 2013), a degradation that is performed by two ADAM
proteins (ADAM10 and ADAM19) expressed in the neural crest
(Schiffmacher et al., 2014). Thus, it is possible that regulation by
multiple transmembrane-containing proteins is a common feature
of ADAM metalloproteases.

Fig. 6. Loss of Fz4 affects ADAM13 processing. (A) Western blot of
ADAM13 at various stages of embryo development (stage 19 to 30).
Embryos were injected with the Fz4 morpholino (+) or the ADAM13
morpholino (MO13, last lane) to visualize the specific bands. In control
embryos the pro-form (P, 120 kDa), the mature form (M, 100 kDa) and the
cytoplasmic domain (Cyto, 17 kDa) are visible, whereas these are absent in
MO13 embryos. There is no difference of processing at stage 19. At stage
24, the mature form of ADAM13 decreases while the cytoplasmic domain
increases in MOFz4 injected embryos (red line). At stage 30 the decrease of
the mature form is still obvious, whereas there is no visible difference for the
cytoplasmic domain fragment. The b1 integrin subunit was used as a
loading control. (B) Western blot for ADAM13 in embryos injected with RFP,
Fz4 or Fz4-v1 mRNA. Embryos injected with the morpholino to ADAM13
(MO13) serve as a control for the antibody specificity. At stage 19 embryos
expressing Fz4 or Fz4-v1 show less ADAM13 cytoplasmic domain fragments
(Cyto, 47% and 23%, respectively). At this stage Fz4 also reduces the
mature form of ADAM13 (M, 58%), whereas Fz4-v1 does not. At stage 30,
Fz4-v1 injected embryos have almost no cytoplasmic domain fragment,
whereas the mature form is not affected. (C) Representative example of
dissected CNC expressing ADAM13-GFP and mb-Cherry (total of eight
explants for each condition). ADAM13 GFP is clearly present in control CNC,
whereas it is undetectable in CNC injected with MO Fz4. The morpholino has
no effect on mb-Cherry expression. Scale bar: 50 mm.

Our results show that loss of Fz4 produces premature cleavage of
the cytoplasmic domain of ADAM13, together with a reduction
of the mature metalloprotease at the cell surface. In addition, loss
of Fz4 inhibits CNC cell migration. On the one hand, our targeted
injections suggest that ADAM13 cannot rescue CNC cell
migration in embryos that lack Fz4. This suggests that Fz4 is
involved in several other roles within the CNC that remain to be
investigated. On the other hand, the in situ hybridization data
(Fig. 7) suggest that the Fz4-knockdown phenotype can be
partially rescued by ADAM13 or the EC1-3 fragment of
cadherin-11, which mimics the cleavage by ADAM13. This
apparent contradiction of results can be explained by the nature of
each technique. In targeted injections and in grafts, CNC cells
that have received the morpholinos are fluorescently labeled so
that their migration can be directly monitored. A loss of cell
migration can be easily observed even if this inhibition results in
a loss of CNC markers. If non-targeted cells migrate from a
different location, even from the contra-lateral side, they will not
be visible in this assay, whereas they would be detected as
migrating CNC cells in an in situ hybridization assay. For
example, knockdown of ADAM13 results in a clear inhibition of
CNC cell migration when investigated by using targeted injection
but not by using graft or in situ hybridization (Abbruzzese et al.,
2014). This is because the grafting procedure and, in particular,
the separation of the CNC from the underlying mesoderm,
releases the CNC cells and rescues the phenotype (Cousin et al.,
2012). However, the use of in situ hybridization allows
comparison of the non-injected with the injected side of the
same embryo, sometimes allowing to measure more subtle effects
of CNC positioning. They also provide a single snap shot at a
specific time by showing a position of the CNC that may be
perturbed but will later recover.
Given that none of the used techniques yields a complete
rescue of the phenotype, it is clear that ADAM13 is not the only
target affected by knockdown of Fz4. As an example, other
ADAMs, such as ADAM9 and ADAM19 and their respective
targets, could also be affected by Fz4 KD and, therefore, cause
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part of the phenotype that is not rescued by ADAM13/EC1-3. It
should be noted that Fz4-v1 can also inhibit cleavage of cadherin11 by ADAM9 in vitro (our data not shown). Therefore, more
detailed analyses of the phenotypes will be required to understand
the complete molecular pathway that depends on Fz4 during CNC
cell migration.
Interaction of ADAM13 and Fz4 in the CNC – a model

Our data support a model in which ADAM13 is associated with
Fz4 during the initial stage of CNC cell migration to maintain
the proper level of ADAM13 activity at the cell surface. At this
time it could also control which substrates may interact with
ADAM13. Clearly, full-length cadherin-11 is required (Kashef
et al., 2009) and only about 20% of cadherin-11 needs to be
cleaved by ADAM13 to generate the EC1-3 fragment (McCusker
et al., 2009). In addition, proteolysis of ADAM13 generates a
cytoplasmic fragment that has a specific function in the nucleus to
regulate the expression of several genes (Cousin et al., 2011).
Again, Fz4 appears to control the level of this fragment during
migration. Interestingly, the two forms of Fz4 do not behave the
same way with regard to ADAM13. Fz4 is most efficient at
inhibiting ADAM13 activity but also reduces the ADAM13
protein level (Figs 3 and 6). This may explain why this form
of overexpression is rescued most efficiently following the
expression of additional ADAM13 or the cadherin-11 EC1-3

fragment. However, Fz4-v1 overexpression has little effect on
mature ADAM13 levels but does substantially reduce the
processing of the ADAM13 cytoplasmic domain (Fig. 6B).
The results obtained for Fz4 knockdown, showing an increase
in the fragment of the cytoplasmic domain of ADAM13, suggest
that the main form associated with ADAM13 in the CNC is the
secreted variant Fz4-v1, at least at stage 24. This would also be
consistent with the Fz4-v1 expression pattern and the fact that
Fz4-v1 can rescue CNC cell migration in Fz4 morphant embryos.
The expression pattern of Fz4 shows that it increases at the edges
of the migration path towards the end of their progression
(Fig. 1D; supplementary material Fig. S1). This increase could
block ADAM13 proteolytic activity so that cadherins and other
cell-adhesion molecules can accumulate in order to promote the
integration of the CNC into the target tissue. This process might
be coordinated by expression of Fz4, which would directly inhibit
the activity of ADAM13, reduce ADAM13 protein levels and,
also indirectly, shut down ADAM13 by decreasing the activity of
GSK3, a kinase required for the nuclear function of ADAM13
(Abbruzzese et al., 2014).
Is ADAM13 involved in the Wnt signaling pathway?

During gastrulation, PAPC directly interacts with the
extracellular domain of another Wnt receptor Fz7. This
interaction stabilizes PAPC and is increased by Wnt11 (Kraft
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Fig. 7. Overexpression of ADAM13 reduces the
severity of the CNC-positioning defect caused by
loss of Fz4. (A,B) In situ hybridization with Sox10 and
Twist to label neural crest cells in embryos injected with
various constructs. Representative examples of the
various phenotypes are on the left and are color-coded.
Asterisks indicate the injected side. The histogram on the
right represents the percentage of phenotypes observed
for each injection. The number of embryos (n) is
indicated at the top of each bar. Gray, wild type; yellow, a
mild inhibition; orange, embryos with a more-dorsal
position of the CNC and a less defined segment (fused);
red, embryos in which the CNC cells have migrated less
than half the distance from the control side (strong
inhibition). (A) Embryos were injected at the 4-cell stage.
Similar results were obtained by injecting one cell at the
8-cell stage (B), similar to the targeted injections. Scale
bars: 500 mm.

Journal of Cell Science (2015) 128, 1139–1149 doi:10.1242/jcs.163063

RESEARCH ARTICLE

et al., 2012). In the absence of Wnt11 or Fz7, PAPC is
internalized and the protein decreases. Although we have not
tested whether PAPC interacts with Fz4, Fz7 does bind to
ADAM13 as well (data not shown). It is, therefore, possible that
the interaction of Fz with ADAM13 is important in order to
protect PAPC from degradation during internalization. It should
be noted that Wnt11, Fz4, Fz7, PAPC and ADAM13 are all
expressed in the CNC cells during migration (Alfandari et al.,
1997; De Calisto et al., 2005; Matthews et al., 2008; Schneider
et al., 2014; Swain et al., 2005). Furthermore, ADAM13 is also
regulated by one of the kinases GSK3 that control the Wnt
pathway. Whereas GSK3 phosphorylates b-catenin to inhibit its
activity, phosphorylation of ADAM13 through GSK3 is required
for its correct function during CNC cell migration (Abbruzzese
et al., 2014). Thus, in theory, the Wnt pathway, by decreasing
GSK3 activity and by interaction of the Fz receptors with
ADAM13, could inhibit ADAM13 activity. It is unclear at the
moment whether Fz4 binding to a Wnt ligand increases, decreases
or has no effect on its ability to inhibit ADAM13. In addition, it is
also unclear whether binding of ADAM13 to Fz4 modifies its
ability to respond to Wnt and to signal. In Xenopus tropicalis, loss
of ADAM13 results in a severe decrease in Wnt signaling during
CNC cell induction (Wei et al., 2010). This is attributed to the
loss of cleavage of ephrinB, resulting in an abnormal
accumulation and increased signaling that, in turn, decreases
canonical Wnt signaling. In Xenopus laevis, although knockdown
of ADAM13 also increases the level of ephrinB protein, it has no
effect on Wnt signaling. In contrast, knockdown of the two
paralogues ADAM13 and MDC13 does result in a substantial
decrease in b-catenin levels during gastrulation (data not shown).
In this model, however, it is unclear whether this change is due to
cleavage of ephrinB or a more direct effect on the Wnt pathway.
Our new results show a direct interaction of ADAM13 with Fz
receptors, suggesting a more direct role of ADAM13 in regulating
the Wnt pathway, a role that will require further investigation.

Gaultier et al., 2002; McCusker et al., 2009). ADAM13-GFP was made
by replacing the Myc-tag of ADAM13-MT (Alfandari et al., 2001) with
GFP from the pCS2mt-UGP cut at Cla1 and Not1 (generous gift from
Mike Klymkowsky, University of Colorado, Boulder, CO).

MATERIALS AND METHODS

Non-injected embryos were raised at 15 ˚C until stage 17, at which point
CNC cells were dissected from ten embryos. Total RNA was extracted
from ten CNC or three sibling embryos at the same stage (High Pure
RNA Tissue kit, Roche). PolyA mRNA was purified on oligo-dT
cellulose (Qiagen) and cDNA was synthesized instruction using qScript
cDNA kit (Quanta), both according to manufacturer’s. Fz4 and Fz4-v1
primers were tested for specificity. Primer sequences are as follows (5939): gapdh- forward TTAAGACTGCATCAGAGGGCCCAA and reverse
GGGCAATTCCAGCATCAGCATCAA; slug- forward AAACACTTCAACACGACCAAAAA and reverse GCTGACCCGACCTAAAGATGAA; fz4- forward ACACGAGCTACAAGCAGATG and reverse GGACATACACTGAGCAGAGAAA; fz4-v1- forward CTCCAGCTCACCACCTTTAC and reverse AAGTTGCGCGTTGGTAGA.

The following antibodies were used: g821, goat polyclonal antibody
against the ADAM13 cytoplasmic domain affinity purified using
ADAM13 peptide corresponding to amino acids 821–914 (Cousin
et al., 2011); g877, goat polyclonal antibody against the ADAM13
cytoplasmic domain affinity purified using ADAM13 peptide
corresponding to amino acids 877–914; 6615F, rabbit polyclonal
antibody against the ADAM13 cytoplasmic domain (Alfandari et al.,
1997); 4A7, mouse monoclonal against the ADAM13 cytoplasmic
domain; 7C9, mouse monoclonal against the ADAM13 cysteine-rich
domain (Gaultier et al., 2002); PAPC, mouse monoclonal against the
extracellular domain (Chen and Gumbiner, 2006); 8C8, monoclonal
antibody against b1 integrin (Gawantka et al., 1992); 9E10, mouse antiMyc monoclonal (ATCC); a-his, anti-His mouse monoclonal (GE
Healthcare). Rabbit polyclonal antibodies against Fz4-v1 were obtained
by immunizing two rabbits with a peptide (STNAQLTRRPYSYA
conjugated to LPH) specifically recognizing the v1 transcript. The
antibodies were affinity purified with the peptide before use.
Morpholinos and DNA constructs

Morpholino antisense oligonucleotides (Gene Tools) against Fz4/Fz4-v1
and ADAM13 have been described previously (Cousin et al., 2011;
Gorny et al., 2013). pCS2-Fz4/Fz4-v1 with and without Myc-tag were
linearized with NotI (Fermentas) and in vitro transcribed using Sp6 RNA
Polymerase (Ambion) (Gorny et al., 2013). Fz4-RFP was made by
cloning RFP-Flag-tag downstream of Fz4 between the EcoRI and XbaI
sites previously used to introduce the Myc-tag. ADAM13 and cadherin11 constructs have been previously described (Alfandari et al., 2001;

All experiments complied with local and international guidelines for the
use of experimental animals. Xenopus laevis embryos were obtained, and
cultured as described previously (Gorny et al., 2013). For Fz4 loss-offunction grafts, 250 pg of GFP mRNA was injected alone or together
with 18.75 ng of MOFz4 into one cell at the 2-cell stage. For gain-offunction grafts, 334 ng of GFP mRNA was injected alone of together
with 666 ng of Fz4-v1 mRNA into one cell at the 2-cell stage.
Fluorescently labeled CNC cells were grafted into non-injected host
embryos at stage 15, prior to migration. For targeted injections, embryos
were injected into a single CNC precursor cell (dorsal-animal
blastomere) at the 8-cell stage. For gain-of-function, 200 pg RFP was
injected alone or with 100 pg Fz4 or 300 pg of Fz4-v1 mRNA, plus
300 pg ADAM13 or EC1-3 mRNA. In the loss-of-function targeted
injections, 200 pg RFP mRNA, 10 ng MOFz4, and 300 pg ADAM13
mRNA were used. All embryos were raised at 15 ˚C until tail-bud stage
(stage 24–27) when they were scored for inhibition of CNC cell
migration by the absence of GFP- or RFP-positive cells within the
migration pathways. For in situ hybridizations, embryos were injected
unilaterally in one dorsal blastomere at the 4-cell or 8-cell stage with
25 ng of MOFz4, and 250 pg ADAM13 or EC1-3 mRNA. When the
embryos reached stage 30, they were fixed in MEMFA (100 mM MOPS,
2 mM EGTA, 1 mM MgSO4, 3.7% formaldehyde) and whole-mount in
situ hybridization was performed as described (Gorny et al., 2013). To
examine ADAM13 protein levels in Fz4-knockdown or -overexpressing
embryos, 25 ng MOFz4 or 10 ng MO13 was injected at the 1-cell stage,
or 300 ng RFP, Fz4 or Fz4-v1 mRNA was injected into both dorsal cells
at the 4-cell stage. Embryos were raised at 15 ˚C and frozen at various
stages for later processing. To observe ADAM13-GFP fluorescence in
CNC explants, embryos were injected at the 2-cell stage with 200 pg
ADAM13-GFP and 200 pg membrane-bound mCherry (mbCherry)
mRNA, and 12.5 ng MOFz4.
Real-time PCR

Double in situ hybridization

For double in situ hybridization (double ISH) Digoxigenin (DIG)- and
Fluorescein-labeled antisense RNA probes were synthesized the using the
respective RNA polymerases and Labeling Mix from Roche according to
manufacturer’s instructions. Double ISH was carried out as described for
normal ISH (Gorny et al., 2013) with the following modifications.
Embryos were hybridized simultaneously by using the DIG- and the
Fluorescein-labeled antisense probes. First, the DIG-probe was detected
and stained in blue as described. When the desired staining was achieved,
the reaction was stopped by washing in PBS, 0.1% Tween-20 and
embryos were refixed for 1 h at room temperature (RT), followed by 1 h
EDTA (5 mM in PBS) treatment at 60 ˚C and six 10-min washes at RT in
PBS, 0.1% Tween-20. Blocking and second antibody reaction were
carried out as described for the DIG-probe but by using an antiFluorescein antibody (Roche). After washing, the Fluorescein-labeled
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Cell culture and transfection

Co-immunoprecipitation experiments were performed in HEK293T
obtained from ATCC and transfected with XtremeGENE HP (Roche)
according to manufacturer’s instructions. Total cellular protein was
extracted in TBS containing 1% Triton X-100, 5 mM EDTA, 16 Halt
Protease and Phosphatase Inhibitor Cocktail (Thermo Scientific) and
immunoprecipitated for either ADAM13 or Fz4. PAPC shedding and
cadherin-11 cleavage assays were performed in COS-7 and HEK293T cells
(ATCC). For PAPC shedding, COS-7 cells were incubated with medium
containing 2% serum 24 h after transfection, and conditioned supernatants
were collected at 48 h. The cellular proteins were extracted in reducing
Laemmli buffer and blotted for ADAM13, Fz4 or PAPC. The shed
extracellular domains were purified using concanavalin-A–agarose
(Vector) overnight, eluted in reducing Laemmli buffer and blotted using
antibodies against PAPC or 7C9. To test the cleavage of PAPC in trans,
HEK293T cells were transfected with ADAM13 and PAPC, or either RFP
or Fz4-v1. At 24 h after transfection, cells were resuspended in medium
containing 2% serum, and the ADAM13 plus PAPC cells were mixed with
the cells expressing RFP or Fz4-v1. At 48 h the conditioned supernatants
were collected and purified for shed PAPC or ADAM13 as described above.
Fluorescence

CNC explants from embryos injected with the various mRNAs (ADAM13GFP, Fz4-RFP, Fz4-v1-RFP, mbCherry) were dissected and placed on a
glass-bottomed dish (Matek Corp) coated with gelatin (1 mg/ml) followed
by fibronectin (20 mg/ml). Low magnification photographs (Fig. 5) were
obtained using an Axiovert200M fluorescence microscope (Zeiss) with a
206 objective, 5 h after dissection of the explants. High-magnification
photographs (Fig. 2) were obtained using a Nikon spinning disc confocal
with a 606objective. To identify subcellular compartments, Xenopus XTC
cells were transfected with the various fluorescent constructs, plated on
fibronectin-coated (10 mg/ml) glass-bottomed dishes (In vitro scientific)
and incubated for 30 min in 16MBS with ER-tracker (blue), Lyso-tracker
(blue) or WGA (blue), all from Molecular probes. Cells were rinsed once
with 16MBS and once with complete XTC medium (67% L15, 10% FBS,
2 mM L-Glutamine, pen/strep, sodium pyruvate). Photographs were taken
using a Zeiss 200M inverted microscope equipped with an Apotome and a
636 oil-immersion lens to obtain optical sections. For in vivo CNC cell
migration assays, embryos were imaged using a Zeiss Stereo Lumar
fluorescent stereoscope.
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The cranial neural crest (CNC) is a population of cells that arises from the lateral part of the developing
brain, migrates ventrally and coordinates the entire craniofacial development of vertebrates. Many
molecules are involved in CNC migration including the transmembrane metalloproteases ADAM13 and 19.
We have previously shown that these ADAMs cleave a number of extracellular proteins and modify the
transcription of a number of genes, and that both of these activities are important for cell migration.
Here we show that the knock down of ADAM13 inhibits CNC migration in vivo but not in vitro,
indicating that ADAM13 function is required in the 3-dimentional context of the embryo. We further
show that the migration of CNC that do not express ADAM13 and ADAM19 can be rescued in vivo by
co-grafting wild type CNC. Furthermore, the migration of CNC lacking ADAM13 can be rescued by
mechanically separating the CNC from the surrounding ectoderm and mesoderm. Finally, we show that
ADAM13 function is autonomous to CNC tissue, as the migration of morphant CNC can only be rescued
by ADAM13 expression in the CNC and not the surrounding tissues. Together our results suggest that
ADAM13 changes CNC interaction with the extracellular environment and that this change is necessary
for their migration in vivo.
Published by Elsevier Inc.
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Introduction
The neural crest is a pluripotent population of cells specific to
vertebrates that arises from the dorsal neural tube during or after
neurulation. It undergoes extensive cell migration and gives rise to
many derivatives depending of their antero-posterior origin and
their final resting place. The most anterior neural crest, called the
cranial neural crest (CNC), originates from the midbrain and
hindbrain and coordinates craniofacial development (Minoux and
Rijli, 2010). Their extensive migration is the result of the coordinated
function of cell adhesion molecules, contact mediated cell polarity
and guidance cues (Alfandari et al., 2010; Kulesa et al., 2010;
Theveneau and Mayor, 2011b). In the amphibian Xenopus laevis,
the molecules involved in CNC migration include the a5b1, fibronectin, syndecan4 and the Planar Cell Polarity pathway (Alfandari
et al., 2003; Carmona-Fontaine et al., 2008; Matthews et al., 2008).
In recent years, we discovered that another family of transmembrane proteins is also involved in CNC migration: the ADAM family.
ADAMs are cell surface metalloproteases that contain a disintegrin and cysteine rich domain. Half of these ADAMs have been
shown or are predicted to possess the metalloprotease activity
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(Alfandari et al., 2009). This includes the subgroup of meltrins
composed of ADAM9, 12, 13, 19 and 33. ADAMs are key players in
many biological processes including cell adhesion and cell signaling. Their role in cell signaling is linked to their ability to cleave
signaling molecules that results in either the activation (EGF, TNF-a,
Notch), or termination (ephrins) of signaling pathways (Alfandari
et al., 2009). Some ADAM proteins have been shown to regulate
cell–cell adhesion by cleaving N- and E-cadherin to promote
epithelial to mesenchymal transition (EMT) (Maretzky et al.,
2005; Reiss et al., 2005).
We have previously shown that ADAM13 is required for CNC
cell migration (Alfandari et al., 2001; Cousin et al., 2011;
McCusker et al., 2009). While the single knock down of either
ADAM13 or 19 is sufficient to significantly inhibit CNC migration,
the double knock down induces an almost complete inhibition
that can be rescued by the re-expression of either one of these
ADAMs, indicating that these two meltrins have partially redundant function (Cousin et al., 2011; McCusker et al., 2009). The
ADAM13 metalloprotease domain is capable of cleaving many
substrates, including fibronectin (FN) and Cadherin-11 (Alfandari
et al., 2001; Gaultier et al., 2002; McCusker et al., 2009). In a
related species, Xenopus tropicalis, ADAM13 cleaves ephrin B
ligands and contributes to neural crest cell induction (Wei et al.,
2010) but this role does not appear to be conserved in Xenopus
laevis (Cousin et al., 2011). While we do not yet know the
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relevance of FN cleavage during CNC migration, we have shown
that Cadherin-11 cleavage is critical (McCusker et al., 2009). The
disintegrin and cysteine rich domains are involved in substrate
recognition. In the case of FN, the cysteine rich domain of
ADAM13 binds to the second Heparin-binding domain (hepII) of
FN (Gaultier et al., 2002). The cytoplasmic domain of ADAM13 has
multiple functions, one of which is to control the metalloprotease
activity of ADAM13 by interacting with the cytoplasmic adapter
protein PACSIN2 (Cousin et al., 2000). Recently, we discovered
that this cytoplasmic domain is released in the cell cytosol
through a series of proteolytic cleavages, translocates to the
nucleus and modifies the transcription of hundreds of genes.
Some of these genes, like the cytoplasmic protease Calpain-8a, are
critical for CNC migration (Cousin et al., 2011).
To date, two types of assays are used to assess xenopus CNC
migration in vivo. In the targeted injection assay, the compounds of
interest (mRNA, morpholino (MO) and a lineage tracer like GFP) are
injected at the 8 to 16-cell stage in the dorso-animal blastomere that
will give rise to the CNC cells (McCusker et al., 2009). This assay
offers the advantage of perturbing the development of a finite
number of tissues and does not usually perturb earlier events like
mesoderm induction or gastrulation. However, the injected dorsoanimal cell also gives rise to other tissues in addition to the CNC,
including some head ectoderm and dorsal mesoderm. Moreover, not
all CNC are targeted. Given these restrictions, the analysis has to be
done carefully to account for defects that may be due to the knock
down (KD) of the protein in a different tissue, as well as defects that
are not apparent because some CNC cells that did not receive the
MO may still be migrating. The latter is of particular concern if CNC
migration is inferred by in situ hybridization using CNC markers but
is not as critical if CNC migration is visualized by GFP, which is only
present in cells that also receive the MO. The second assay used to
assess CNC migration in vivo is the graft assay. Embryos are injected
in one blastomere at the two-cell stage. At the early neurula stage
(stage 15–17), CNC can be excised and grafted back into a host
embryo (Alfandari et al., 2001). The injection at the two-cell stage
followed by the graft at neurula stage ensures two things. Firstly, all
the CNC cells have received the compounds of interest. Secondly,
any defects observed using this assay is truly CNC-specific. Unfortunately, the compound injected at the two-cell stage may also impact
earlier stages of development like mesoderm induction or gastrulation, which in turn could affect proper CNC development (Wei et al.,
2010). Such problems need to be assessed thoroughly before
interpreting any results related to CNC migration.
In this article, we show that the knock down of ADAM13 does
not yield the same results by graft or targeted injection assays.
We investigated the causes of this difference and uncovered a
novel function for ADAM13 that was only hypothesized until
now: the modification of the extracellular environment to a state
more permissive to CNC migration.

Material and methods
Embryos
Xenopus laevis embryos were obtained by in vitro fertilization
and staged according to Nieuwkoop and Faber (1967).
Morpholinos
Morpholino antisense oligonucleotides (Gene Tools) were
designed to complement the 50 untranslated sequences of xenopus
ADAM13 (TGCTCAGCCGACCCTCCGTCCCCAT), ADAM19 (GAGTCCTGTAGCTCCTTCCATCCGA) and Cadherin-11 (AGTCTTTCTTCATTTTTGGTAGTGT). All were tested for efficiency using specific antibodies to

!

visualize the endogenous protein expression (Cousin et al., 2011;
Kashef et al., 2009; McCusker et al., 2009; Neuner et al., 2009).
Control-morpholino corresponding to a random generated sequence
of 25-mer was used.

Constructs
All ADAM13 constructs used were described in Cousin et al.
(2011). The EC1-3 construct was described in McCusker et al.
(2009).

Antibodies
The following antibodies were used; gA13: goat polyclonal
antibody to ADAM13 cytoplasmic domain (Cousin et al., 2011),
1B4: monoclonal antibody to Cadherin-11 cytoplasmic tail
(McCusker et al., 2009), 8C8: monoclonal antibody to b1 integrin
(Gawantka et al., 1992).

Injections
Capped mRNA were synthesized using SP6 RNA polymerase on
DNA linearized with NotI as described before (Cousin et al., 2000).
For the CNC migration assays, embryos were injected at the
16-cell stage in one dorsal animal blastomere with 1 ng of
morpholino, 0.2 ng of RFP mRNA and 0.08 ng of mRNA encoding
various constructs. For graft assays, embryos were injected at the
two-cell stage with 5 ng of morpholino, 300 pg of GFP mRNA,
400 pg of ADAM13 mRNA or 200 pg of ADAM19 mRNA constructs.
In both cases, embryos were raised at 15 1C until they reach tail
bud stage (stage 24–28) at which time the phenotypes were
scored. Embryos were scored for the absence of CNC migration.
The percentage of inhibition was normalized to embryos injected
with RFP or GFP alone. Error bars correspond to standard deviation assuming unequal variances. Photographs of embryos were
taken using a Nikon SMZ dissecting scope equipped with a Nikon
color digital camera and the Spot image acquisition software.

CNC migration in vitro
CNC explants were excised at stage 15 and placed on 96 well
plates (Probind, BD Falcon) coated with 10 mg/ml of bovine
fibronectin (Sigma) in Danilchik media (53 mM NaCl, 11.7 mM
Na2CO3, 4.25 mM potassium gluconate, 2 mM MgSO4, 1 mM
CaCl2, 17.5 mM Bicine, 1 mg/ml BSA, pH 8.3), and imaged by
time-lapse microscopy using a Zeiss 200M inverted microscope
and the OpenLab 4 software (Improvision). Relief substrates were
produced on microscope coverslips (22 ! 22 mm) by serial spin
coating using 100 nm silicon nitride followed by SU-8 2000.5 at
3000 rpm for 1 min (Brewer Sciences CEE 100CB Spin Coater).
Coverslips were baked at 95 1C for 2 min, flood exposed 24 mJ/cm2
for 20 s (Suss MicroTec MA6 Mask aligner) and baked again for
30 min at 170 1C. To produce the relief patterns, substrate was
spin coated with SU-8 2100 at 2000 rpm for 1 min, and baked for
7 min at 65 1C and 50 min at 95 1C prior to exposure with the
specific mask (see Fig. 7) to form the channels (24 mJ/cm2 for
15 s). Following exposure, the coverslips were baked at 65 1C for
5 min and 95 1C for 15 min before PGMEA development (15 min).
Developed coverslips were rinsed with isopropanol and water
prior to coating with fibronectin (10 mg/ml) for 2 h at 20 1C or
overnight at 4 1C. SDF-1 beads were prepared as described in
Theveneau and Mayor (2011a) using purified mouse SDF-1
protein (ImmunoTools GmbH).
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CNC biotinylation and immunoprecipitation (IP)
CNC were dissected from embryos grown at 14 1C for 48 h post
fertilization when they reached stage 15–17. Dissected CNC were
placed on FN substrate for 2 h at 18 1C in Danilchik media as
previously described (Alfandari et al., 2003). The Danilchik media
was thoroughly replaced by 1XMBS with 5 washes and biotinylation
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was performed at 14 1C in 1XMBS containing 1 mg/ml of NHS-lcBitotin (Pierce) for 20 min. Excess biotin was removed by 4 washes
with 1XMBS 100 mM glycine. Protein extraction was done in
1XMBS, 1% tritonX100, 5 mM EDTA and a protease, phosphatase
inhibitor cocktail (HALT protease and phosphatase inhibitor, Fisher).
Protein extracts were centrifuged for 30 min at 4 1C at 13,000 rpm
and were pre-cleared using protein-G-agarose beads bound to
non-immune goat and mouse Ig for 1 h at RT. All IP were
performed overnight at 4 1C and were sequential. Antibodies used
were goat anti-ADAM13 affinity purified on the 37 C-terminal
amino acids of the ADAM13 cytoplasmic domain (3 mg/IP), mouse
mAb 1B4 to Cad-11 (10 mg/IP) and mouse mAb 8C8 to b1 integrin
subunit (5 mg/IP).

Graft procedure
Embryos were injected in one cell at the 2-cell stage and raised
at 14 1C. Embryos were sorted for optimum lineage tracer expression (GFP or mRFP) at stage 15 (as soon as the anterior neural
folds are visible and raised). The vitelline envelopes of selected
embryos were removed and embryos were placed in a dish of
non-toxic modeling clay (Van Aken, CA) containing 1XMBS 50 mg/
ml gentamycin. Embryo-sized cavities were formed in the plasticine using a Pasteur pipet whose tip has been melted into a glass
ball. The embryos were placed in the cavities, oriented according
to experimenter’s grafting preference and immobilized by pulling
back some modeling clay around them. Once immobilized, the
ectoderm covering the CNC was peeled off, the CNC were cut out
using an eyelash knife and hair loop and grafted into host
embryos whose CNC were removed (Fig. 2A). Each CNC was
grafted according to its proper antero-posterior and dorso-ventral
orientation. The grafted embryos were left to heal 30 min in 1X
MBS, with an embryo-sized coverslip pressed onto the dissected
region of the embryo to maintain the ectoderm flush with the
CNC and mesoderm. The embryos were then raised in a tissue
culture dish coated with 1% agarose in 0.1XMBS 50 mg/ml gentamycin at 14 1C overnight. When double grafts were performed,
only half the CNC territory was dissected (in this case the most
ventral half to prevent neural tissue contamination).
Fig. 1. ADAM13 knock down in the neural tube does not affect morphant crest
migration. (A) Embryos were injected with mRNA encoding GFP alone (Ctl) or
together with antisense morpholino for ADAM13 alone (MO13) or ADAM13 and 19
(2MO). The compounds were injected either in one cell at the 2-cell stage (for graft)
or in one dorso-animal cell at the 8–16 cell stage (for targeted injection). The graft
procedure was carried out at stage 15 and the embryos were scored for their lack of
CNC migration at tailbud stage (26–28) for both assays. The pictures show the typical
result obtained for each case. The histogram represents the percentage of embryos
with no CNC migration normalized to embryos injected with GFP alone and
corresponds to the mean of seven (targeted injection) and at least six (graft)
independent experiments. The number of embryos scored is as follows. For grafts:
Ctl; n¼42, MO13; n¼25, 2MO; n¼ 61. For targeted injection: Ctl; n¼ 248, MO13;
n¼258, 2MO; n¼281. While 2MO inhibits CNC migration at similar levels for both
the grafts and the targeted injection assays, MO13 alone is 5 times more efficient at
inhibiting CNC migration in the targeted injection assay than the graft assay.
(B) Embryos were injected in one cell at the 2-cell stage with either GFP (Ctl donor),
GFP and MO13 (MO13 donor) or RFP and MO13 (MO13 recipient). At stage 15, three
types of grafts were performed: 1-GFP expressing CNC were grafted into non-injected
embryos (Ctl-4NI), 2-GFPþMO13 injected CNC were grafted into non-injected
embryos (MO13-4NI), 3-GFPþ MO13 injected CNC were grafted into embryos
injected with RFPþMO13 (MO13-4MO13). The pictures show the typical result
obtained for each case. The histogram represents the percentage of embryos with no
CNC migration normalized to embryos injected with GFP alone and corresponds to
the mean of three independent experiments, representing the scoring of 20 embryos
for each case. Results show that morphant CNC display a statistically identical level of
migration inhibition whether they are grafted into a wild type embryo or a morphant
embryo. The error bar represents standard deviation from the mean. n ¼ Statistically
different from controls (po0.05). Arrowheads point to the segments of the CNC. m:
mandibular, h: hyoid, b1 and b2: branchial.
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Scoring of CNC migration in vivo
The presence or absence of fluorescent CNC in the hyoid and
branchial arches was assessed at the end of CNC migration,
between stage 25 and 28, for each embryo. No qualitative
assessment was incorporated into this scoring: either CNC cells
were present or absent in these arches, whether they migrated
partway or all the way to the ventral side of the embryo.
However, partial migrations were seldom observed. The percentage of CNC inhibition was then calculated as follows:

and crest lifted away from the underlying mesoderm (Ectoþ Meso
peel), 3—crest completely taken out of the embryos and put back
into the same embryo (autograft) (Fig. 2A). The results show that
the inhibition of CNC migration due to the lack of ADAM13 is not
rescued when the ectoderm alone is peeled away (Fig. 2B).
However, the peeling of both ectoderm and mesoderm from the
CNC rescues morphant crest migration to the same extent as the
autograft (Fig. 2B) and the graft into a wild type host embryo
(Fig. 1). This suggests that while the interaction of CNC with the

%I ¼ ½1#½ða=naÞ=ðb=nbÞ&& ' 100
a is the number of embryos displaying CNC cells in the pathways
in experimental case. b is the number of embryos displaying CNC
cells in the pathways in embryos injected with the lineage tracer
alone. n is the total number of embryos scored for the experimental (na) or for the control (nb). %I is the percentage of
inhibition.

Results
Targeted knock down of ADAM13 inhibits CNC migration more
robustly than grafting ADAM13 morphant CNC
Using morpholino antisense oligonucleotides (MO), we have
previously shown that ADAM13 and 19 double knock down (KD)
inhibits CNC migration similarly whether targeted injection (65%
inhibition) or CNC graft assay (79% inhibition) are performed
(Cousin et al., 2011) (Fig. 1A). However, the single KD of ADAM13
inhibits CNC migration significantly better by targeted injection
(35%) than by grafting (8%). Since ADAM13 is also expressed in
the neural tube (Alfandari et al., 1997), it is possible that the
neural expression of ADAM13 is also involved in CNC migration,
possibly by facilitating the release of CNC from the neural tube.
This neural expression of ADAM13, present in embryos undergoing grafting but not targeted injection, could explain the higher
level of CNC migration in grafted embryos. To test this hypothesis,
we grafted CNC lacking ADAM13 into either non-injected
embryos or embryos knocked down for ADAM13. Results show
that the percentage of inhibition of CNC migration between the
grafted morphant crest in either wild type (MO13-4NI) or
morphant (MO13- 4MO13) embryos is not statistically different
(Fig. 1B).
These results show that the difference in the migration of the
CNC lacking ADAM13 between the grafting and targeted injection
assays is not caused by the presence of ADAM13 in the neural
tube or dorsal mesoderm.
Physical disruption of the morphant CNC from the environment
rescues CNC migration
We have previously observed that the mandibular crest
migration around the optic vesicles is more difficult to inhibit
than the migration of the other two segments of the CNC
(Alfandari et al., 2001). We hypothesized that this was caused
by the optic vesicle pushing the ectoderm away from the
mesoderm, hence opening the migration pathway and allowing
a better migration of morphant crest (Alfandari et al., 2001).
Based on this observation, we hypothesized that the grafting
technique introduces a similar bias: mechanically opening the
pathways allowing the morphant CNC to migrate.
To test this hypothesis, we performed targeted injection of
MO13 as previously described. At stage 15, these embryos were
either left alone or subjected to the following grafting procedures:
1—ectoderm was peeled off (Ecto peel), 2—ectoderm peeled off
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Fig. 2. Manually separating CNC from the surrounding tissue partially rescues
CNC migration induced by ADAM13 knock down. (A) Schematics of the experimental procedure. Either GFP mRNA alone, or a mixture of GFP mRNA and
ADAM13 morpholino was injected into the dorso-animal cell at the 8-cell stage.
At stage 15, embryos were sorted for their expression of GFP and underwent one
of the following procedures. 1—The ectoderm was peeled off (ecto peel). 2—The
ectoderm was peeled off and the crest lifted away from the underlying mesoderm
(ectoþ meso peel). 3—The CNC were excised from the embryo and placed back in
(autograft). 4—After the procedure, the ectoderm was pulled back on and left to
heal. The embryo was left to develop until tailbud stage and scored for their lack of
CNC migration. (B) The histogram represents the percentage of embryos with no
CNC migration normalized to embryos injected with GFP alone and corresponds to
the mean of three independent experiments. As previously reported, ADAM13 KD
significantly inhibits CNC migration in the targeted injection assay. The ectoderm
peel procedure did not affect this inhibition. However, the ectoderm þmesoderm
peel and the autograft procedures rescued CNC migration to levels not statistically
different from the GFP control. The number of embryos scored was as follows:
GFP; n¼ 159, MO13; n¼ 154, MO13 ecto peel; n¼ 47; MO13; n¼ 45; MO13
autograft; n¼ 43. The error bar represents standard deviation from the mean.
n ¼ Statistically different from GFP (p o0.05).
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underlying mesoderm is critical for ADAM13 function, neither the
ectoderm nor the neural plate contacts are.
This experiment suggests that the grafting technique is capable of partially compensating for the loss of ADAM13 in the CNC
by mechanically altering the extracellular environment of the
CNC and making it more amenable to cell migration. However, it
should be pointed out that the grafting technique is unable to
rescue the CNC migration when both ADAM13 and 19 are
knocked down (Fig. 1A), indicating that the grafting procedure
can compensate for an impaired function of ADAM13 but not a
complete loss of function of both proteins. In particular, it is
obvious that the grafting procedure may not rescue the expression of genes controlled by ADAM13/19 cytoplasmic domains
(Cousin et al., 2011).

ADAM13 and 19 functions are not critical for CNC migration on a
two-dimensional surface
The previous results indicate that mechanically altering the
environment of the CNC facilitates their migration. This strongly
suggests that one role of ADAM13 could be to facilitate CNC
migration in a dense three-dimensional ECM pathway. To test this
hypothesis, we tested the ability of morphant crests to migrate
in vitro on a two-dimensional FN substrate.
Embryos were injected at the two-cell stage with MO13, MO19
or both as previously described. At stage 15, CNC explants were
excised and grown in plastic dishes coated with 10 mg/ml of FN
(Fig. 3A). In these conditions, the wild type CNC (Ctl) displayed
the typical pattern of migration with an initial phase of sheet
migration where all the migrating cells maintain their cell–cell
adhesion (t ¼6 h), followed by a second phase where cells have
lost their cell–cell adhesions and begin migrating as single cells
(t ¼16 h). CNC depleted of ADAM13 protein were capable of
migrating with no obvious delays. Interestingly, crest explants
depleted of both ADAM13 and 19 proteins migrated as well
(Fig. 3A). In order to make sure that the lack of defect was not
due to an incomplete knock down of ADAM13, the expression of
ADAM13, Cadherin-11 and integrin a5b1 in CNC explants was
assessed (Fig. 3B). After 2 h of migration on FN, proteins
expressed at the cell surface of wild type or ADAM13 morphant
CNC were biotinylated and then immunoprecipitated sequentially
with antibodies against ADAM13, Cadherin-11 and integrin b1
subunit. Our results show that, as expected, ADAM13 is no longer
expressed in morphant CNC while the expression of integrin a5b1
is unaffected. Interestingly, while Cadherin-11 overall expression
seems unaffected, its cleavage is inhibited in the morphant CNC.
This concurs with our previous findings (McCusker et al., 2009).
These ex-vivo experiments show that the loss of ADAM13 and
19 does not alter the migration machinery necessary for these
cells to migrate, including a5b1 integrin (Alfandari et al., 2003).
More importantly, these results demonstrate that ADAM13 function is required in the three-dimensional context of the embryo
and that, once taken out of the embryo context, ADAM13 and
Cadherin-11 cleavage fragment functions are dispensable. Combined with our previous findings, it is clear that ADAM13 function
is not involved in releasing the CNC from the neural tube and is
unlikely to be involved in a classical EMT like the one previously
described for the trunk neural crest (Shoval et al., 2007). However
our observations are compatible with the hypothesis that
ADAM13 modifies the interactions of the CNC with its environment, thereby facilitating their migration. Two theories could
explain this facilitation. First, ADAM13 could digest partially or
modify the ECM proteins like FN to make it more amenable to
CNC migration (Machete theory). Second, ADAM13 could loosen
the cell–cell interactions within the CNC, making this tissue more

!

Fig. 3. ADAM13 function is dispensable for CNC migration in vitro. (A) ADAM13
and 19 knock down has no effect on CNC migration in vitro. Embryos were injected
in one cell at the two-cell stage with a mixture of GFP mRNA and either control
morpholino (Ctl), ADAM13 morpholino (MO13) or ADAM13 and 19 morpholino
(2MO). At stage 15, embryos were sorted and CNC explants placed on fibronectincoated 96-well plates. For each case, pictures of typical explants are shown before
migration (t¼ 0), at the end of the sheet migration phase (t¼ 6 h) and at the end of
the single cell migration phase (t¼ 16 h). Morphant CNC cells were capable of
migrating in vitro in a pattern indistinguishable from the control CNC. (B) ADAM13
knock down in CNC is efficient and prevents Cadherin-11 cleavage. Twenty CNC
were dissected at stage 15 and placed on FN substrate for 2 h before cell surface
proteins were biotinylated. Proteins were extracted and immunoprecipitated
sequentially using a goat anti-ADAM13 antibody (gA13), the mouse mAb to
Cadherin-11 (1B4) and the mouse mAb to integrin b1 (8C8). Both gA13 and 1B4
recognize the cytodomains of ADAM13 and Cadherin-11, respectively. ADAM13
knock down completely abolishes the expression mature ADAM13 at the cell
surface (ADAM13, arrowhead). The full length Cadherin-11 protein is still strongly
expressed (Cad-11, arrowhead a) but is no longer cleaved (Cad-11, arrowhead b).
Integrin a5b1 cell-surface expression is unaffected by ADAM13 knockdown.

flexible and therefore capable to migrate through the dense ECM
matrix (Relaxation theory).
ADAM13 and 19 functions are crest autonomous but not cell
autonomous
In order to test our two theories (Machete or Relaxation), we
performed a series of experiments to study the cell and tissue
autonomy of ADAM13 function during CNC migration. One prediction of the Machete model is that wild type CNC should be able to
open the pathway for KD cells that are immediately following. This
was tested by performing a double graft procedure (Fig. 4). Morphant crest (2MO, labeled with GFP) were co grafted with wild type
crest (Wt, labeled with RFP) at stage 15 in either one of two
configurations. In the first configuration, the wild type CNC were
grafted ventrally (Wt leader), while in the second configuration the
wild type CNC were grafted dorsally (Wt follower) relative to the
morphant CNC. Photographs of each grafted embryo were taken at
the end of the grafting procedure to ascertain the successfulness of
the graft (Fig. 4, stage 15) as well as at the end of the experiment
(Fig. 4, stage 26). The results show that in both configurations, some
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Fig. 4. ADAM13 function is not cell autonomous. Embryos were injected in one
cell of two-cell stage embryos with both GFP mRNA and morpholino against
ADAM13 and 19 (GFPþ 2MO) or with RFP mRNA. At stage 15, CNC expressing the
lineage tracer were dissected and grafted into non-injected embryos in either one
of the following configurations. Either the RFP expressing explant was grafted
ventrally to the morphant crest (Wt leader and 2MO follower) or the RFP
expressing crest was grafted dorsally to the morphant crest (Wt follower and
2MO leader). Pictures represent a typical example of each type of grafted embryo
before (stage 15) and after migration (stage 26). The histogram represents the
percentage of failed migration of each type of CNC (Wt or 2MO) for each grafting
configuration. Controls (Ctl) correspond to the graft of GFP expressing CNC alone.
Student t-tests between the 2MO CNC grafted alone and all other experimental
cases were performed. The experiments show that the co-grafting of wild type
CNC significantly rescues morphant CNC migration. The configuration of the graft
has no impact on the efficiency of the rescue. The co-grafted morphant CNC had no
effect on the ability of wild type CNC to migrate. The histogram represents the
average of 7 independent experiments. The number of embryos scored was as
follows: Ctl; n¼ 42, 2MO alone; n¼40, 2MO leader þWt follower; n¼38; 2MO
followerþ Wt leader; n¼33 n¼ 47. The error bar represents standard deviation
from the mean. * ¼Statistically different from 2MO alone (p o 0.05).

In order to test the tissue autonomy of ADAM13 function, we
grafted CNC depleted of both ADAM13 and 19 in either wild type
embryos (2MO-4Wt) or in embryos mis-expressing the metalloprotease activity of ADAM 13 in the surrounding ectoderm and
mesoderm (2MO-4 DCyto). We chose to express a version of
ADAM13 lacking a cytoplasmic domain for two reasons. Firstly,
the DCyto mRNA produces eight times more active protein than
its full-length counterpart (Cousin et al., 2000) ensuring an
optimal level of metalloprotease activity present in the pathways.
Secondly, the absence of cytoplasmic domain minimizes the risk
of changing the transcriptome of the mesoderm and ectoderm,
which could result in the mis-expression of multiple genes that
could interfere with the interpretation of the data. The results
show that CNC migration was not rescued by the expression of
DCyto-ADAM13 in the pathway (Fig. 5). To investigate whether
this lack of rescue was due to a lack of transcriptional modulation
by ADAM13 cytodomain in the CNC, morphant crest expressing
the cytoplasmic domain of ADAM13 (C13) were grafted into
embryos expressing DCyto in the ectoderm and mesoderm
(2MOþ C13-4 DCyto). While these conditions marginally
increased CNC migration, the rescue was not statistically significant when compared to the 2MO alone. A similar trend was
observed when these CNC were grated into a non-injected embryo
(2MOþC13-4NI). Interestingly, we previously showed that
expression of both C13 and DCyto in morphant CNC rescue their
migration as efficiently as wild type ADAM13 (Cousin et al., 2011).
Therefore, the absence of rescue in these experiments is not due to
the dissociation of the proteolytic activity from the cytoplasmic
domain function. Lastly, the grafting of morphant CNC expressing
C13 in embryos expressing the soluble fragment of Cadherin-11 in
the pathways (2MOþC13-4EC1-3) rescued their migration to
levels indistinguishable from the positive controls (RFP-4NI).
Together these experiments allowed us to make three observations.
First, wild type CNC are capable of partially rescuing morphant
CNC, indicating that part of ADAM13 function is non-cell autonomous supporting the Machete hypothesis. Second, ADAM13
metalloprotease activity needs to be carried out by the CNC in
order to migrate properly. In other words, the metalloprotease
activity of ADAM13 and 19 is crest autonomous. Third, the lack
of ADAM13 metalloprotease activity can be compensated fully by
the expression of the cleaved fragment of Cadherin-11 (supporting
the Relaxation hypothesis). This indicates that, regardless of any
other proteins ADAM13 and 19 may be shedding, the generation of
Cadherin-11 cleavage fragment EC1-3 is necessary and sufficient to
restore complete CNC migration, as long as the cytoplasmic domain
of ADAM13 is also expressed in the CNC.
We previously observed that the loss of ADAM13 results
in an increase in full length Cadherin-11 (McCusker et al.,
2009). To test if the inhibition of CNC migration observed in the
morphant embryos was due to the overexpression of Cadherin11, we used various doses of a morpholino to Cadherin-11 in
combination with MO13 and measured both Cadherin-11
protein level and CNC cell migration (Fig. 6). The results show
that while 1 ng of the Cad11-MO was sufficient to decrease the
level of Cad-11 protein in MO13 embryos to that of the control,
none of the concentrations tested rescued CNC migration. This
confirms that the main role of ADAM13 is to produce the
extracellular fragment and not simply to reduce the overall level
of Cadherin-11.
Testing the Relaxation hypothesis

of the morphant CNC were capable of migrating following wild type
cells (Fig. 4, graph). Interestingly, careful analysis of the migration of
these explants showed that Wt crest always migrate ahead of
morphant crest, regardless of their original position relative to the
KD crest (Fig. 4, stage 26).

!

In order to test if the CNC from morphant embryos have
increased cell adhesion that would prevent the cells from
changing their relative positions to fit through small openings
(Relaxation hypothesis), we created a new device that challenges

187!

H. Cousin et al. / Developmental Biology 368 (2012) 335–344

the migration of cells forcing them to migrate through channels of
variable sizes (Fig. 7, the corresponding time-lapse movies are
available in the supplemental materials, see Appendix A). CNC
explants, which are about 500 mm wide, were placed in front of
small tunnels (20 mm) and were attracted to the other side using
the chemoattractant SDF-1 (Theveneau et al., 2010). We found
that both control and morphant CNC were able to migrate
through these openings and reached the opposite side of the
tunnel (200 mm) at the same time. This assay was performed
during the first phase of migration while cell contacts are
maintained, showing that in the absence of ADAM13, cells within
the explant are able to modulate their adhesion to fit through the
opening.

341

Discussion
We previously showed that ADAM13 performs at least two
functions during CNC migration. First, it binds and cleaves
Cadherin-11 to release an extracellular fragment that stimulates
CNC migration (McCusker et al., 2009). Second, the cytoplasmic
domain of ADAM13 is cleaved and translocates into the nucleus,
where it regulates gene expression to promote cell migration
(Cousin et al., 2011). In this report, we show that the requirement
for ADAM13 function depends on the CNC environment. In vitro
on a flat FN substrate, ADAM13 is not required for migration,
while it is essential in vivo. Furthermore, physically separating the
CNC from the underlying mesoderm in vivo is sufficient to rescue
migration of CNC lacking ADAM13.
The comparison of morphant CNC migration in vivo and in vitro
shows that ADAM13/19 does not affect the function of other
molecules critical for CNC migration. For example, cells lacking
ADAM13 and ADAM19 are still capable of migrating on FN,
indicating that the proteins involved in CNC cell migration,
including integrin a5b1, are still expressed and functional
(Alfandari et al., 2003). This indicates that ADAM13/19 acts
differently from other ADAMs involved in cell adhesion and
migration or invasion (McGinn et al., 2011; Toquet et al., 2010).
Another example is that morphant CNC cultured in vitro also
segregates into 3 segments, indicating that the mechanisms
responsible for the cell sorting of CNC into these segments are
still functional (Smith et al., 1997).
ADAM13 function during CNC migration: Machete or Relaxation?
Taken together, our results suggest that the role of ADAM13 is
to modulate the interaction of CNC with their environment. Given
the known substrates of ADAM13, we propose two mutually nonexclusive functions for ADAM13 in vivo. The first one, named the
Machete model, would involve cleaving FN and/or other proteins
of the ECM to open or widen existing openings in the dense ECM
that surrounds the CNC during their migration. This model is
supported by the ability of ADAM13 to bind, cleave and remodel a
FN substrate (Alfandari et al., 2001; Gaultier et al., 2002), as well
as the ability of wild type CNC to allow morphant CNC to migrate
immediately behind them (Fig. 4). It is also consistent with the
lack of defect observed in ADAM13 KD in vitro or after grafting
when the ECM has been manually opened (Figs. 3 and 1,
respectively). The fact that the ADAM13 cytoplasmic domain also
Fig. 5. ADAM 13 metalloprotease function is required crest autonomously.
Embryos were injected in one cell of 2-cell stage embryos with the following
mixture. Donor embryos were injected with RFP as a lineage tracer and either the
morpholinos against ADAM13 and 19 alone (2MO) or the two morpholinos plus
the mRNA encoding the cytoplasmic domain of ADAM13 (2MO þC13). The
recipient embryos were injected with a mixture of GFP and either a form of
ADAM13 lacking the cytoplasmic domain (DCyto) or the cleaved form of Cadherin11 (EC1-3). At stage 15, embryos were sorted for their expression of lineage tracer,
CNC explants taken out from donor embryos (RFP, 2MO or 2MO þ C13) and grafted
into various recipient embryos (NI, DCyto or EC1-3). The embryo was left to
develop until tailbud stage and scored for their lack of CNC migration. The
histogram represents the percentage of embryos displaying no CNC migration
normalized to embryos injected with RFP alone and corresponds to the mean of
three independent experiments. Results show that morphant crest migration is
not rescued if the metalloprotease activity of ADAM13 is not expressed by the CNC
themselves (2MO- 4 DCyto). The expression of the cytodomain of ADAM13 in the
morphant crest partially rescues CNC migration (2MO þ C13- 4NI). This partial
rescue is not enhanced when these CNC are grafted in embryos expressing DCyto
(2MO þC13- 4 DCyto) confirming that ADAM13 can exert its metalloprotease
function only when expressed by the CNC. The rescue is complete when the
2MOþC13 CNC are grafted in embryos expressing EC1-3 (2MO þC13- 4EC1-3).
The number of embryos scored was as follows: RFP- 4NI; n¼15, 2MO- 4NI;
n¼14, 2MO-4 DCyto; n ¼16, 2MO þC13- 4 DCyto; n¼ 15. The error bar represents standard deviation from the mean. * ¼ Statistically different from 2MO- 4NI
(po 0.05).
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Fig. 6. The partial knock down of Cadherin-11 does not rescue CNC migration of
ADAM13 morphants. Embryos were injected at the 1 cell stage with either
ADAM13 morpholino (MO13 1 ng) alone or together with various doses of
morpholino against Cadherin-11 (MOC11) ranging from 5 ng to 25 ng. At stage
20, the proteins of 10 embryos equivalent were extracted, immunoprecipitated
with either the cadherin-11 mAb 1B4 or ADAM13 rabbit pAb 6615F and blotted
with the cadherin rabbit pAb C11 and the ADAM13 goat pAb 877 respectively. The
knock down of ADAM13 alone leads to an increase of the full-length form of
Cadherin-11 that can be decreased by a partial cadherin-11 knock down using
5 ng of MOC11. (B) Embryos were injected at the 8-cell stage with either ADAM13
morpholino (MO13 1 ng) alone or together with various doses of morpholino
against Cadherin-11 (MOC11) ranging from 1 ng to 5 ng. The mRNA encoding GFP
was either co-injected or injected alone as lineage tracer. Embryos were raised
until stage 28 and scored for their lack of CNC migration. The histogram represents
the percentage of embryos displaying no CNC migration normalized to embryos
injected with RFP alone and corresponds to the mean of four independent
experiments. The partial knock down of Cadherin-11 with either 1 or 2.5 ng of
MOC11 did not significantly rescue the inhibition of CNC migration induced by
ADAM13 knock down. The co-injection of 5 ng of MOC11 produced a significantly
more severe inhibition than ADAM13 knock down alone. The error bars represent
standard deviation from the mean. The number of embryos scored for each case
ranged between 207 and 218. * ¼ Statistically different from MO13 (p o 0.05).

increases the expression of the metalloprotease MMP13 offers yet
another way to remodel the ECM (Cousin et al., 2011). The ECM
modification by metalloproteinases has been extensively documented for the Matrix Metalloproteinases (MMP). MMPs promote
cell migration and metastasis by degrading a number of ECM
components. This degradation in turn could reveal cryptic sites,
create microtracks or free growth factors necessary for cell
migration and invasion (Fowlkes et al., 1995; Giannelli et al.,
1997; Ilina et al., 2011; Stamenkovic, 2003; Whitelock et al.,
1996; Xu et al., 2001). Some evidence suggests that ADAMs could
do the same (Alfandari et al., 2001; Mazzocca et al., 2005).
However, since the expression of ADAM13 metalloprotease
domain in the migrating pathways cannot rescue morphant crest
migration, it is unlikely that ADAM13 plays a role in freeing
growth factors crucial for CNC migration such as Sdf-1
(Theveneau et al., 2010; Theveneau and Mayor, 2011b). To further
test this hypothesis we measured CNC invasion in Rat tail
collagen gels containing fibronectin and SDF-1 beads, but in this
assay CNC cells invaded poorly with or without ADAM13 suggesting that the composition of this artificial ECM was not conducive
for CNC migration (data not shown). Since the exact composition
of the CNC migration pathway is not known, additional tests are
required to define a compatible in vitro environment. While
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Fig. 7. CNC cells can migrate through 20 mm openings. Migration of CNC through
small openings. Photographs of explants (10 " ) taken from time-lapse movies are
represented. The width of the obstacle is 200 mm (horizontal arrows) while the
opening is 20 mm. Frames from non-injected control (NI) or morphant (MO13)
CNC are presented at 0, 3 and 6 h of migration. The arrowhead points to the
leading edge of cells migrating in the tunnel. The mask used to obtain the
substrates is represented below. The white sections represent the walls of the
chambers (200 mm high). Each of the two rectangular chambers has four opening
for each of their long side ranging from 15 to 30 mm). The center of the rectangles
are filled with SDF-1-coated beads and sealed by covering it with a small coverslip
fixed with vacuum grease. Explants are placed with their ventral (leading) edge
facing each opening.

multiple invasion studies use Matrigel, this represents a laminin-rich ECM similar to a basement membrane and xenopus CNC
do not survive in it for the length of the assay (Alfandari,
unpublished).
Our finding that ADAM13 metalloprotease activity is required
specifically in the CNC offers a unique twist on the Machete
model. If ADAM13’s role in CNC migration was to simply digest
the ECM surrounding the CNC, then ADAM13 expression in the
tissue surrounding the CNC should rescue their migration, which
it does not. However, morphant CNC migration can be rescued if
the pathways have been primed by migrating CNC. This suggests
that migrating cells reorganize the ECM in a way that is conducive
to the migration of morphant cells in vivo. Similar polarization of
the ECM has been observed in numerous migrating tissues during
development and cancer metastasis. This includes, the developing
drosophila follicles, the zebrafish and frog gastrula, as well as
during primitive streak formation in avian embryos (Calvo and
Sahai, 2011; Davidson et al., 2006; Friedl and Alexander, 2011;
Haigo and Bilder, 2011; Latimer and Jessen, 2010; Zamir et al.,
2008). The polarization of the ECM is thought to play multiple
roles during morphogenesis. One hypothesis is that migrating
cells reorient the ECM to provide directional cues that further
facilitate the migration of following cells. This has been elegantly
shown in vitro in breast cancer invasion assays on collagen
matrices (Ilina et al., 2011). Another possibility is that ECM
remodeling constrains tissue shape, which generates polarized
biomechanical forces that facilitate directional cell movement.
We propose that ADAM13 activity in the leading edge of the CNC
is required to both open the pathway through a dense ECM, like a
Machete, and to rearrange and reorient the ECM to promote the
migration of following cells.
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On the other hand, the ability of the EC1-3 domain of
Cadherin-11 in combination with the ADAM13 cytoplasmic
domain to rescue CNC migration in embryos lacking both
ADAM13 and 19 cannot easily be explained by the Machete
theory. In a second model named the Relaxation model, the
cleaved extracellular fragment of Cadherin-11 would increase
the relative fluidity of the CNC tissue so that it may deform to
migrate through openings within the ECM. As mentioned before,
this model does not eliminate the possibility that ADAM13 also
contributes to the opening of these pathways. The control of
tissue fluidity could be achieved in two ways. First, ADAM13
would reduce the total amount of Cadherin-11 present at the cell
surface and therefore decrease cell-cell adhesion. As seen in Fig. 6,
simply reducing Cadherin-11 protein level using morpholino does
not rescue migration, suggesting that this is not the main role of
ADAM13. Second, the released EC1-3 may interact with either
Cadherin-11 or other proteins at the CNC surface to favor cell
shuffling. In the latter model we envision the EC1-3 as a lubricant
that facilitates the movement of cells within a population. In an
attempt to test this hypothesis, we challenged CNC explant to
migrate during the first phase through opening as small as 20 mm
forcing them to rearrange. Surprisingly we did not observe any
difference between control and morphant CNC capacity to
migrate through such openings. It should be noted that the walls
of our tunnels (200 mm long), which are 200 mm high, were also
coated with FN and thus it is possible that cells were using the
entire surface available to migrate, thereby decreasing their
constraint. Additional work will be needed to create an in vitro
environment in which ADAM13 function is required.
Alternatively, EC1-3 could directly or indirectly activate a
signaling pathway that could change either the shape of the cells
or their protrusive activity, ultimately making them more amenable for migrating in a three-dimensional ECM. Our data suggest
that the EC1-3, while not a chemoattractant per se, enhances CNC
migration in vitro (McCusker, 2010). Soluble N-cadherin has been
shown to promote neurite outgrowth by promoting FGF signaling
(Boscher and Mege, 2008; Paradies and Grunwald, 1993; Utton
et al., 2001). Similarly, the soluble E-cadherin ectodomain shed by
MMP-7 promotes invasive behavior of cancer cells (Noe et al.,
2001). The extracellular cleavage fragment of E-cadherin was also
shown to interact with ErbB receptors and initiate downstream
signaling that resulted in cell migration and cell proliferation in
cultured cells (Najy et al., 2008). The cleavage of the CAM L1 by
ADAM10 and/or 8 releases a soluble fragment capable of promoting neurite outgrowth possibly by binding and activating integrins
(Mechtersheimer et al., 2001; Naus et al., 2004). Thus, while our
observations with EC1-3 fit with the Relaxation model to promote
CNC migration, there are a number of alternative mechanisms
possible.
Collective cell migration: CNC and cancer
Xenopus CNC migration is biphasic (Alfandari et al., 2003). A
collective migration phase of 5 h is followed by a single cell
migration. This behavior appears uncommon among vertebrates
since the CNC of most species, including the Mexican Axolotl,
appear to migrate as single cell from the start (Epperlein et al.,
2000). On the other hand, in species with monophasic CNC
migration like zebrafish, contact between migrating CNC has been
shown to be critical to maintain cell identity suggesting that
while cell cohesion is not as obvious as in xenopus, it is a
conserved and essential characteristic of these pluripotent cells
(Schilling et al., 2001). Moreover, such behavior has been
observed in some cancer undergoing metastasis, in particular
mesenchymal tumors and melanoma (Alexander et al., 2008;
Hegerfeldt et al., 2002). This has been correlated with the ability
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of the cells to perform partial EMT, allowing them to migrate and
invade without losing the contact with their neighbor (Friedl and
Alexander, 2011). This collective migration gives the migrating
cells a better ability to invade the surrounding tissue. Using the
collective force of cell migration, they are capable of remodeling
the surrounding tissue either mechanically or biochemically to
facilitate the migration of the group. To our knowledge, no role of
ADAM metalloproteases or the cleavage of a type II cadherin like
Cadherin-11 has been associated with these types of tumor. Since
the cleavage of Cadherin-11 and the release of its EC1-3 fragment
into the extracellular environment is critical for CNC migration, it
would be interesting to see if such cleavage also occur in the
aforementioned cancer.
In conclusion, our findings support a role for ADAM13 modulating the direct or indirect (via the ECM) interaction with the
underlying mesoderm. This role involves the cleavage and release
of the extracellular domain of Cadherin-11. The receptor of the
Cadherin-11 fragment remains to be identified, as does the exact
mechanism by which this promotes cell migration. More generally, the comparison of data obtained in vitro versus in vivo shows
that ADAM13 function is only required in the three-dimensional
context of the embryo and cannot be studied using solely tissue
culture assays. At a more fundamental level, this finding emphasizes the fact that while two-dimensional assays yield interesting
and fundamental results, three-dimensional assays need to be
developed in order to fully understand the function of proteins
during cell migration.
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